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Abstract
Prolyl oligopeptidase is a serine peptidase characterised by oligoendopeptidase 
activity. Definitive evidence for the discrete biological role o f  prolyl oligopeptidase 
remains unknown, though its role in the maturation and degradation o f peptide 
hormones and neuropeptides has been implicated. A second activity that readily 
cleaves the specific prolyl oligopeptidase substrate Z-Gly-Pro-AMC was previously 
discovered in bovine serum. Due to its complete insensitivity towards the classic 
prolyl oligopeptidase inhibitor Z-Pro-prolinal, this peptidase was designated Z-Pro- 
prolinal Insensitive Peptidase (ZIP). The study o f this new and specific proline 
cleaving endopeptidase from bovine serum is presented.
ZIP was separated from prolyl oligopeptidase by phenyl sepharose hydrophobic 
interaction chromatography. The enzyme was further purified 30,197-fold, to 
homogeneity, using calcium phosphate cellulose, cibacron blue 3GA and gel filtration 
chromatography in an overall recovery o f  12% from bovine serum.
Substrate specificity studies using kinetic, HPLC and LC-MS analysis o f proline- 
containing peptides suggest that ZIP has an extended substrate-binding region in 
addition to the primary specificity site Sj. This analysis revealed at least five subsites 
to be involved in enzyme-substrate binding, with the smallest peptide cleaved being a 
tetrapeptide. A proline residue in position Pi was absolutely necessary therefore 
showing high primary substrate specificity for the Pro-X bond, while a preference for 
a hydrophobic residue at the C-terminal end o f the scissile bond (Pi) was evident. An 
affinity constant (Kn) o f270fM  using Z-Gly-Pro-AMC was determined.
Diisopropylfluorophosphate inactivated ZIP resulting in an IC$o value o f lOOnM 
suggesting catalytic classification as a serine peptidase. ZIP showed complete 
insensitivity to the prolyl oligopeptidase specific inhibitors, Fmoc-Ala-pyrrCN and Z- 
Phe-Pro-BT and showed no immunological cross-reactivity with an anti-human prolyl 
oligopeptidase antibody. Internal peptide sequence analysis o f ZIP identified it as 
seprase, a member o f the serine integral membrane peptidases. This protein is 
overexpressed by tumour cells and may possibly play a significant role in their 
invasion.
XXI
INTRODUCTION
1.0 Introduction - The Prolyl Oligopeptidase Family
1.1. Proteolytic Enzymes: Serine Proteases
Proteolytic enzymes or proteases represent a class of enzymes with important roles in 
physiological process. These enzymes are involved in essential biological processes 
like blood clotting, controlled cell death, and tissue differentiation. They catalyse 
important proteolytic steps in tumour invasion or in infection cycle of a number of 
pathogenic microorganisms and viruses, making them valuable targets for new 
pharmaceuticals. They also participate in protein catabolism in degradative or 
biosynthetic pathways and in the release of hormones and pharmacologically active 
peptides from precursor proteins. They are also well known to conduct highly specific 
and selective modifications of proteins such as activation of enzymes by limited 
proteolysis and collaborate with the transport of secretory proteins across membranes.
Proteases catalyse the cleavage of peptide bonds in proteins or peptides. They are 
enzymes of class 3, the hydrolases, and subclass 3.4, the peptide hydrolases or 
peptidases. They constitute a large family (EC 3.4) divided as endopeptidases 
(proteinases) or exopeptidases according to the point at which they cleave the peptide 
bond. These proteases can be ordered further, according to the reactive groups at the 
active site involved in catalysis.
Proteolytic enzymes dependent on a serine residue for catalytic activity are 
widespread and very numerous. Serine proteases are ubiquitous, being found in 
viruses, bacteria and eukaryotes and include proteins with endopeptidase, 
oligopeptidase, exopeptidase and omega-peptidase activity. These proteases conduct 
proteolysis using a serine side chain as the active site nucleophile. Over 20 families 
(denoted S1-S27) of serine proteases have been identified, these being grouped in 6 
clans (SA, SB, SC, SE, SF and SG) on the basis of structural similarity and other 
functional evidence (Rawlings and Barrett, 1994). Structures are known for at least 
four of the clans (SA, SB, SC and SE) and appear to be totally unrelated, suggesting at 
least four evolutionary origins of serine proteases. There are, however, similarities in 
the reaction mechanisms of several proteases even with different evolutionary origins. 
They contain a common catalytic triad of three amino acids: serine (nucleophile), 
aspartic acid (electrophile) and histidine (base). The geometric orientations of the 
catalytic residues are similar between families, despite different protein folds. The
2
linear arrangements of the catalytic residues commonly reflect clan relationships. For 
example the catalytic triad is ordered HDS in clan SA, DHS in clan SB and SDH in 
clan SC, of which the prolyl oligopeptidase family is a member (Rawlings and 
Barrett, 1993; Rawlings and Barrett, 1994).
The prolyl oligopeptidase family represents a relatively new group of serine 
peptidases, unrelated to the well-known trypsin and subtilisin families. This group 
includes dipeptidyl peptidase IV, acylaminoacyl peptidase, prolyl oligopeptidase and 
oligopeptidase B (Rawlings et al. 1991; Rawlings and Barrett, 1994). The prolyl 
oligopeptidase group called family S9 is a member of the SC clan of serine proteases. 
Due to the structural relationship between these enzymes and lipases (Polgar, 1992a), 
on secondary structural studies (Goosens et al. 1995) and most recently on three- 
dimensional (3D) structures these enzymes are considered to be members of the a/p 
hydrolase fold enzymes. The amino acid sequence homology of the four main 
peptidases is quite low but as shown with prolyl oligopeptidase and dipeptidyl 
peptidase IV they all possibly share a similar tertiary structure. They display distinct 
specificities and represent different types of peptidases. Prolyl oligopeptidase and 
oligopeptidase B are endopeptidases (oligopeptidases) which are found in the cytosol. 
Dipeptidyl peptidase IV and acylaminoacyl peptidase are exopeptidases; dipeptidyl 
peptidase IV is a membrane bound ectoenzyme, whereas acylaminoacyl peptidase is a 
cytoplasmic omega peptidase. The structural basis of these enzymes specificity, 
selectivity, which is restricted to oligopeptides, and catalytic functional regulation has 
recently been understood by the three-dimensional structures of prolyl oligopeptidase 
and dipeptidyl peptidase IV (Fulop et al. 1998 and 2000; Rasmussen et al. 2003; 
Engel et al. 2003).
The catalytic triad residues (Ser, Asp, His) of these enzymes are located in the 
peptidase domain within about 130 residues of the C-terminus with amino acid 
sequence homology more significant in this domain between proteins. The enzymes 
are much larger (about 80 kDa, greater for dipeptidyl peptidase IV due to the 
transmembrane domain) than the trypsin and subtilisin serine proteases (25-30kDa), 
and do not possess any zymogen form. The enzymes of this family are involved in 
important physiological processes (Polgar, 2002a).
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Subfamily Peptidase EC No. Peptidase Type
Subfamily S9A Prolyl oligopeptidase 3.4.21.26 Endopeptidase
Oligopeptidase B 3.4.21.83 Endopeptidase
Subfamily S9B Dipeptidyl peptidase IV 3.4.14.5. Exopeptidase-
Dipeptidase
Dipeptidyl aminopeptidase A - Aminopeptidase
Dipeptidyl aminopeptidase B - Aminopeptidase
Prolyl tripeptidyl peptidase - Tripeptidase
Dipeptidyl peptidase 8 - Dipeptidase
Dipeptidyl peptidase 9 - Dipeptidase
Fibroblast activation protein a/Seprase Endopeptidase-
Gelatinase
Subfamily S9C Acylaminoacyl peptidase 3.4.19.1 Exopeptidase-
Omega peptidase
Subfamily S9D Glutamyl endopeptidase (plant) - Endopeptidase
Table 1.1. Members o f the Prolyl Oligopeptidase (S9) Family of Serine Proteases
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1.2. Prolyl oligopeptidase
Prolyl oligopeptidase (EC 3.4.21.26) is a member of the new serine peptidase group, 
the prolyl oligopeptidase family, classified under family S9A of the clan SC (Barrett 
et al. 1998). This activity was first reported as an oxytocin-inactivating enzyme in 
human uterus (Walter et al. 1971). Further studies on this oxytocin-degrading enzyme 
(Walter, 1976; Koida and Walter, 1976) revealed a high specificity for the amino acid 
proline, cleaving the peptide bond on its carboxyl side. It was subsequently called post 
proline cleaving endopeptidase (PPCE). Several enzymes with similar specificity like 
thyrotropin-releasing hormone deaminase from rat brain (Rupnow et al. 1979), brain 
kinase B from rabbit brain (Oliveira et al. 1976) and endo-oligopeptidase B were 
previously described, which later proved to have been identical to prolyl 
oligopeptidase. The selectivity of the enzyme for oligopeptides was discovered in the 
nineteen seventies by Camargo et al. (1979). The name prolyl endopeptidase was first 
recommended by the Enzyme Nomenclature in 1981, but later was changed to prolyl 
oligopeptidase, emphasising the special characteristics of this enzyme.
1.2.1. Distribution
Although prolyl oligopeptidase is predominantly a cytosolic enzyme (Dresdner et al.
1982), the presence of prolyl oligopeptidase activity has been detected in the 
particulate fractions of brush border kidney cells (Sudo and Tanabe, 1985), N1E 115 
(neuroblastoma) cells (Checler et al. 1986) and human and rat brain neurons (Irazusta 
et al. 2002). O’Leary and O’Connor (1995) reported the purification and 
characterisation of a novel membrane bound form of prolyl oligopeptidase from 
bovine brain. The synaptosomal membrane localisation and the higher affinity of this 
particulate form compared to cytosolic enzyme for certain peptide substrates (O’Leary 
et al. 1996) may be of potential physiological significance in relation to neuropeptide 
hydrolysis.
Localisation studies performed by Irazusta et al. (2002) compared rat tissular 
distribution of soluble and particulate prolyl oligopeptidase activity. The levels of 
activity in both cases was more than two-fold greater in the brain than in any other 
tissue studied. Similar localisation studies performed by Kato et al. (1980) and 
Orlowski et al. (1979) on human and rabbit tissues showed considerable species to
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species variation. While uniformly high levels were reported in brain tissue, high 
prolyl oligopeptidase activity in humans was observed in skeletal muscle, testes and 
kidneys compared with rabbit tissue where high activity was seen in the small 
intestine, lung and spleen with lowest activity observed in skeletal muscle.
As previously mentioned, consistently high prolyl oligopeptidase levels are present in 
mammalian brain but Irazusta et al. (2002) found that both soluble and particulate 
prolyl oligopeptidase activities were higher in the human brain than the rat brain. 
Regional distribution of prolyl oligopeptidase activity was highest in the brain cortices 
and lowest in the cerebellum of human brain. These results agree with previous work 
by Kato et al. (1980). In the rat brain, regional distribution of prolyl oligopeptidase 
was different to that in human brain with homogenous soluble activity present in most 
regions but lowest in the cerebellum (Irazusta et al. 2002). Tate (1981) has also 
previously documented this species to species variation in the regional distribution of 
prolyl oligopeptidase in brain tissue regions.
Subcellular localisation studies showed highest prolyl oligopeptidase activity present 
in the cytosol with activities lower than those present in nuclear, microsomal and 
mitochondrial soluble fractions. Particulate prolyl oligopeptidase activity was 
enriched in the synaptosomes correlating well with previous work by O’Leary and 
O’Connor (1995) (Irazusta et al. 2002).
Prolyl oligopeptidase activity has also been reported in human bodily fluids, although 
the activities were much lower than that present in tissues (Goosens et al. 1996).
1.2.2. Purification
Prolyl oligopeptidase was first isolated from human tissue (Walter et al. 1971) and 
has subsequently been isolated from tissue sources of other mammals (Yoshimoto et 
al. 1981 and 1983), fungi (Yoshimoto et al. 1988; Sattar et al. 1990), bacteria 
(Chevallier et al. 1992; Kanatani et al. 1993) and archaea (Harwood et al. 1997). 
Wide ranges of sources for isolation were initially available due to the enzymes 
ubiquitous distribution (Goosens et al. 1996) and consistently elevated enzyme levels 
in mammalian brain. The first steps usually employed for the isolation of prolyl 
oligopeptidase from tissue source involved homogenisation using mechanical and 
centrifugal forces (Polgar, 1994), followed usually by an ammonium sulphate 
precipitation step (Yoshimoto et al. 1981 and 1983; Kalwant and Porter, 1991).
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Yoshimoto et al. (1983) employed an anion exchange resin twice for the purification 
of bovine brain prolyl oligopeptidase, while four DEAE cellulose steps were utilised 
for the purification of prolyl oligopeptidase from human erythrocytes, giving a 
64,000-fold purification (Rosens et al. 1991).
Purification of the recombinant enzyme expressed in Escherichia coli provides much 
better yields than the isolation from various tissues (Szeltner et al. 2000). Prolyl 
oligopeptidase has been cloned from several sources such as porcine brain, bovine 
brain, human lymphocytes, Flavobacterium meningosepticum and Pyrococcus 
furiousus (Rennex et al. 1991; Yoshimoto et al. 1997; Shirasawa et al. 1994; 
Diefenthal et al. 1993; Robinson et al. 1995).
1.2.3. Activity Detection
When prolyl oligopeptidase was first discovered, its known substrates oxytocin and 
arginine-vasopressin were employed in native or radiolabelled forms for enzyme 
detection (Walter, 1976). Koida and Walter (1976) used Z-Gly-Pro-Leu-Gly as 
substrate, detecting cleavage product Leu-Gly with the ninhydrin assay. Since then 
assays of prolyl oligopeptidase have been performed spectrophotometrically and 
spectrofluorometrically utilizing N-blocked proline containing dipeptides linked to a 
cleaved molecule as synthetic substrate. Initially p-nitro phenyl esters (Walter and 
Yoshimoto, 1978), p-nitroanilides (Yoshimoto et al. 1978) and naphthylamides 
(Yoshimoto et al. 1979) were used. In 1979, Yoshimoto et al. reported the first use of 
Z-Gly-Pro-AMC (7-amino-4-methylcoumarin), a fluorescent substrate with a Km of 
20|aM for prolyl oligopeptidase from lamb kidney. As mentioned above many prolyl 
oligopeptidase assays incorporate 2-NNAp (P-naphthylamide), an alternative 
fluorogenic substrate and pNA (p-nitroanilide) that is a colorimetric substrate but Z- 
Gly-Pro-AMC shows enhanced sensitivity over these (Polgar, 1994). A succinyl 
group in the substrate Z-Gly-Pro-AMC has often replaced the benzyloxycarbonyl 
group making the substrate much more soluble and without requiring organic solvent 
for solubility. These compounds are poor substrates though, their specificity rate 
constants being lower by two orders a magnitude than those of the benzyloxycarbonyl 
derivatives (Polgar, 1994). In a study on the secondary specificity of prolyl 
oligopeptidase, a ten fold lower Km was achieved using 7-amino-4-methyl-2-quinoline
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(Meq) as an alternative to AMC. This lower affinity constant was due to glycine in the 
P2 position being replaced by positively charged or bulky hydrophobic groups (Noula 
et al. 1997). An added advantage in these substrates is the reduction in solvent 
required for solubilisation. The discovery of a second peptidase activity in bovine 
serum (Cunningham and O’Connor, 1997a) capable of cleaving Z-Gly-Pro-AMC, 
questions its classification as a specific prolyl oligopeptidase substrate.
1.2.4. Structural and Biochemical Aspects
The first structural information about prolyl oligopeptidase was deduced from the 
cDNA of the porcine brain enzyme (Rennex et al. 1991). This study revealed a single 
chain protein having a molecular mass of 80,751 Da, calculated from the 710-residue 
sequence. The peptidase domain was located at the carboxyl terminus and exhibits a 
characteristic a/p  hydrolase fold (Goosens et al. 1995). The active site residues serine 
and histidine were the first to be identified as Ser554 (Rennex et al. 1991) and His680 
(Stone et a l 1991) in the porcine brain enzyme. This order of the catalytic residues is 
the reverse of that found with the trypsin and subtilisin sequences, but corresponds to 
some lipase sequences (Polgar, 2002a). A structural relationship between lipases and 
the peptidase domain of oligopeptidases has been indicated. Comparison of the 
sequences of lipases and oligopeptidases identified Asp641 as the third member of the 
catalytic triad (Polgar, 1992a). Goosens et al. (1995) also identified Asp641 as the third 
member based on sequence alignment and secondary structure prediction of 
dipeptidyl peptidase IV, acylaminoacyl peptidase and prolyl oligopeptidase.
Fulop et al. (1998) revealed the three dimensional structure of prolyl oligopeptidase 
by x-ray crystallography, in complex with its inhibitor Z-Pro-prolinal. It consists of 
two domains, a peptidase and asevenbladed [3-propeller (Figure 1.1.).
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Figure 1.1. Three-Dimensional Structure Representation of Prolyl oligopeptidase
The ribbon diagram is colour-ramped blue to red from the N  to the C terminus. The catalytic residues 
are shown in a ball-and-stick representation (Fulop et al. 1998).
The peptidase or catalytic domain is built up of residues 1-72 and 428-710. This 
region was observed to exhibit an a /p  hydrolase fold as predicted by Goosens et al. 
(1995). The peptidase domain contains a central eight-stranded p-sheet with all 
strands except the second one aligned in a parallel manner. The p-sheet is 
significantly twisted and it is flanked by two helices on one side and six helices on the 
other.
The p-propeller domain is located between residues 73-427 and is connected to the 
catalytic domain mainly by hydrophobic forces. The propeller domain is based on a 
sevenfold repeat of four-stranded antiparallel p-sheets, which are twisted and radially
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Figure 1.2. Structural Diagram of the P-Propeller Domain
The protein chain o f the p-propeller domain of prolyl oligopeptidase is coloured as in Figure 1.1. The p 
sheets of the seven blades are joined in succession around the central axis. The “Velcro” is not closed; 
there are only hydrophobic interactions between the first (blue) and last (green) blades. Residues 
narrowing the entrance to the tunnel of the propeller are shown by ball-and-stick representation (Fulop 
etal. 1998)
arranged around their central tunnel. The central tunnel of this p-propeller covers the 
catalytic triad but unlike other p-propellers the Velcro is not closed between the first 
and last blades. This structural feature permits partial opening of the propeller and 
provides access via its tunnel to the active site (Figure 1.2.).
The structure and localization of the mouse prolyl oligopeptidase gene has been 
accomplished (Kimura et al. 1999). It is located at chromosome 10B2-B3, consists of 
92 kilobases and contains 15 exons.
Preliminary studies of prolyl oligopeptidase reported this protein to have a dimeric 
structure with a possible molecular weight of 115-140kDa (Koida and Walter, 1976). 
It is now known that prolyl oligopeptidase is a monomeric protein ranging in 
molecular weight from 65-85kDa. Yoshimoto et al. (1981) reported a molecular 
weight of 74-77kDa for lamb brain, while prolyl oligopeptidase from human brain 
was reported to have a molecular weight of 76.9kDa (Kalwant and Porter, 1991). As 
mentioned previously, cDNA cloning of porcine brain prolyl oligopeptidase allowed 
deduction of a monomeric structure with a molecular weight of 80,751kDa. Studies 
on prolyl oligopeptidase from Flavobacterium meningosepticum (Yoshimoto et al.
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1992) deduced a molecular mass of 78.71kDa for the 705 residues sequenced. This 
sequence was discovered to contain a signal peptide of twenty amino acids, loss of 
this peptide resulted in a molecular weight of 76.78kDa (Chevallier et al. 1992; 
Kanatani et al. 1993;).
pH optimum values of between 6.5 and 8.5 are reported for bacterial and mammalian 
prolyl oligopeptidase (Yoshimoto et al. 1980 and 1983). Isoelectric points of between 
4.8 and 4.9 indicate an acidic nature of mammalian prolyl oligopeptidase (Yoshimoto 
et al. 1983; Goosens et al. 1995), while bacterial pi seem to be slightly higher with
Treponema denticola having a reported pi of 6.5 (Makinen et al. 1994).
Source MW
kDa
Pi pH
optima
Temp, 
optima (°C)
Reference
Human Brain 76.9 4.75 6.8 ND Kalwant and Porter, 1991
Human Lymphocytes 76 4.8 ND ND Goosens etal. 1995
Bovine Brain 62-65 4.8 7.0-7.5 40 Yoshimoto etal. 1983
Bovine Sérum 69.7 ND 8.0 37 Cunningham and O’Connor, 
1998
Lamb Brain 74-77 4.9 7.0 45 Yoshimoto etal. 1981
Porcine Liver 72-74 4.9 6.5 37 Moriyamaand Sasaki, 1983
Daucus carota 75 4.8 7.3 37 Yoshimoto etal. 1987a
F. meningosepticum 74 9.6 7.0 40 Yoshimoto etal. 1980
A. hydrophilia 76.4 5.5 8.0 30 Kanatani et al. 1993
T. denticola 75-77 6.5 6.5 ND Makinen et al. 1994
L. cinerascens 76 5.2 6.8 37 Yoshimoto etal. 1988
P. furiosos 72 5.76 7.5 85-90 Harwood and Schreier, 2001
Table 1.2. Biochemical Properties of Prolyl Oligopeptidase from Mammalian, 
Plant and Microbial Sources
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1.2.5. Catalytic classification
Prolyl oligopeptidase is an endopeptidase due to its ability to cleave at the carboxyl 
side of proline residues within oligopeptides (Camargo et al. 1979; Wilk, 1983). This 
enzyme has been classified as a serine protease due to its sensitivity to DFP, Z-Gly- 
Pro-CFbCl and to a lesser extent PMSF (Rennex et al. 1991; Walter et al. 1980; 
Goosens et al. 1995). The classification of prolyl oligopeptidase as a serine protease 
was confirmed by the cloning of the prolyl oligopeptidase gene and subsequent 
deduction of its amino acid sequence (Rennex et al. 1991).
When the amino acid sequence of prolyl oligopeptidase was deduced, no similarity 
with proteases of known tertiary structure was observed. In 1992, it was first observed 
that a similarity existed between prolyl oligopeptidase and dipeptidyl peptidase IV 
(Polgar and Szabo, 1992). They noticed a 21.7% identity between these enzymes in 
their C-terminal regions. Rawlings et al. (1991) agreed with these observations but 
went on to show an even greater similarity between prolyl oligopeptidase and 
acylaminoacyl-peptidase based also on their C-terminal residues. This led to the 
general acceptance that a prolyl oligopeptidase family of serine proteases existed 
(Barrett and Rawlings, 1992).
The amino acids that surround the active site seryl residue are conserved in each 
family. With the sequencing of prolyl oligopeptidase by Rennex et al. (1991), the 
amino acids around the active site serine were discovered to be Gly-Gly-Ser-Asn-Gly- 
Gly. This sequence showed no homology to those from the subtilisin, trypsin or 
carboxypeptidase families (Table 1.3.). When Barrett and Rawlings (1992) postulated 
that the greatest similarity between members of the prolyl oligopeptidase family 
existed at the C-terminal end of the sequence, which contains the catalytic domain, the 
general consensus sequence GxSxGGzz (x = any amino acid, z = hydrophobic amino 
acid) was used for identifying other members of this family.
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Serine Protease (Family) Sequence about active site serine
Trypsin Gly-Asn-Ser-Gly-Glv-Pro
Subtilisin Gly-Thr-Ser-Met-Ala-Ser/Thr
Carboxypeptidase Gly-Glu-Ser-Tyr-Ala-Gly
Prolyl oligopeptidase Gly-Xaa-Ser-Y aa-Gly-Gly
Prolyl oligopeptidase family
Porcine prolyl oligopeptidase Gly-Gly-Ser-Asp-Gly-Gly
Rat dipeptidyl peptidase IV Gly-Trp-Ser-Tyr-Gly-Gly
Porcine acylaminoacyl-peptidase Gly-Gly-Ser-His-Gly-Gly
E.coli oligopeptidase B Gly-Gly-Ser-Ala-Gly-Gly
Seprase Gly-Trp-Ser-Tyr-Gly-Gly
Table 1.3. Amino Acid Sequences Surrounding the Active Site Serine of Families 
of Serine Proteases
Another distinguishing feature of prolyl oligopeptidase is the order of its catalytic 
triad residues. The linear arrangement of the active site residues o f prolyl 
oligopeptidase, nucleophile-acid-base, differs from that of the established serine 
proteases but is similar to that of lipases (Polgar, 1992a). In 1995, Goosens et al. 
while studying the secondary structure of prolyl oligopeptidase reported Asp641 as its 
third member and showed striking similarity in its secondary structure to dipeptidyl 
peptidase IV and acylaminoacyl-peptidase. This showed that the order of the catalytic 
triad of prolyl oligopeptidase (Ser-Asp-His) was unique compared to trypsin (His- 
Asp-Ser) and subtilisin (Asp-His-Ser) families. Based on the structural similarity 
between prolyl oligopeptidase and lipases (Polgar, 1992a) and reports on the 
secondary structure (Goosens et al. 1995) of this enzyme, prolyl oligopeptidase was 
the first known endopeptidase to adopt an a/p  hydrolase fold structure. It was also 
postulated that the prolyl oligopeptidase structure could be an evolutionary link 
between the exopeptidases and the endopeptidases.
13
1.2.6. Catalytic and Structural Mechanism
Active site and substrate binding
The catalytic triad (Ser554, Asp641, His680) is located in a large cavity at the interface of 
the p-propeller and catalytic domains (Fulop et a l 1998). These three catalytic amino 
acids play an essential role in the catalysis. The histidine acts as a general acid-base 
catalyst activating the nucleophilic group, the hydroxyl group of the serine acts as a 
nucleophile in the attack on the peptide bond while the aspartic acid stabilizes charged 
tetrahedral intermediates formed in the reaction (Fink, 1987; Rennex et al. 1991).
Serine Protease
1 Serine nucleophilically attacks the scissile 
peptide’s carbonyl group to form the 
tetrahedral intermediate
U noccup ied  "oxya n ion  ho le '
2. The conformational distortion that 
occurs with the formation o f the 
tetrahedral int causes the carbonyl 
oxygen lo move deeper into the active 
site so as to occupy a previously 
unoccupied "oxyanion hole".
>A sp a rtic  ac id  is the acid. His 
It stabilizes the prctonated 
form of histidine
O xyan ion  hole stabilizes tel int. 
through two hydrogen bonds
O ccup ied  "o xya n io n  ho le "
Ser
A Sp-------f ° -
O
Serine  is the nucleophile.
It attacks the scissile peptide's 
carbonyl group to form the 
"tetrahedral intermediate"
Ser
Te trahedra l Int.
H is tid in e  acts as base 
It abstracts prolon from 
serine to make serine a 
better nucleophile
"C a ta ly tic  T riad "
I
3. The tetrahedral intermediate 
collaspses to the acyl-enzyme 
intermediate under the driving force 
o f proton donation From histidine 
(which now acts as acid) The amine 
leaving group is released from the 
enzyme and replaced by water
5. Regeneration o f the active enzyme, 
followed by the release o f the resulting 
carboxylate product
4. The acyl-enzyme intermediate 
undergoes hydrolytic cleavage
asP- y °-
O
OH
■O.--------h n  ^ n -
HI*
- - H - 0 -
Ser
Figure 13. Schematic Representation of the Catalytic Mechanism of Serine 
Proteases
14
The mechanism of action of serine proteases (Figure 1.3.) involves an acyl-enzyme 
intermediate. Both the formation and decomposition of the acyl-enzyme proceed 
through the formation of a negatively charged tetrahedral intermediate (Polgar,
2002a).
Fulop et al. (1998) were the first to provide information on substrate binding during 
prolyl oligopeptidase catalysis (Figure. 1.4 ). Due to the serine OH group being well 
exposed and readily accessible to the catalytic imidazole group on one side and to the 
substrate on the other, Figure 1.4. shows that the catalytic serine side chain attacks the 
aldehyde carbon atom forming a covalent hemiacetal adduct. Proline is accepted well 
in the Si specificity pocket, with specificity also being enhanced by ring stacking 
between the indole ring of Trp595 and the inhibitor/substrate proline residue. The 
binding of the peptide main chain to the enzyme is different with prolyl 
oligopeptidase and the classic serine proteases. Proline as an imino rather than an 
amino acid does not possess the main chain NH group for SiPi hydrogen bonding 
which is essential for trypsin and subtilisin catalysis as they form antiparallel p-sheets 
with the NH groups of the substrate main chain. So in the binding to prolyl 
oligopeptidase the S2P2  hydrogen bond is very significant. This shows that the 
architecture of the Si binding site has evolved to be much more specific in prolyl 
oligopeptidase.
Figure 1.4. A View of the Active 
Site of Prolyl oligopeptidase
The carbon atoms of the enzyme and the 
covalently bound inhibitor, Z-Pro- 
prolinal, are coloured gray and green, 
respectively. Dashed lines indicate 
hydrogen bonds (Fulop et al. 1998).
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The oxyanion-binding site, which stabilizes the oxyanion of the tetrahedral 
intermediate, is an essential feature of serine protease catalysis. The hydrogen bonds 
provided by the oxyanion binding site in order to stabilize the negatively charged 
oxyanion come from distinct groups in prolyl oligopeptidase compared to the classic 
serine proteases. The main chain NH group of Asn555 provides one and the second, 
which is a special feature of prolyl oligopeptidase, is provided by the OH group of 
Tyr473 (Fulop etal. 1998; Polgar, 2002a).
Oligopeptide selection
The narrow opening at the bottom of the propeller tunnel that is opposite the entrance 
to the active site is much too small for entrance of an average peptide. It has been 
reported (Fulop et al. 2000) that prolyl oligopeptidase uses the partial opening 
between its propeller blades 1 and 7 (Figure 1.2.) for regulating entrance to its active 
site. This would prevent proteins and large structured peptides from hydrolysis. They 
verified this mechanism by engineering a disulfide bond between blades 1 and 7, thus 
closing the velcro (circular structure) with the elfect of causing complete inactivation 
of the enzyme (Figure. 1.5.). So prolyl oligopeptidase shows a novel strategy of 
regulation in which oscillating propeller blades act as a gating filter mechanism 
during catalysis.
Figure 1.5. P-Propeller Domain Representation With Closed Velcro Topology
The protein chain of the p-propeller domain only, showing the engineered disulfide bond connecting 
blades 1 and 7 in red (Fulop et al. 2000).
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Effect of propeller domain on catalysis
The inhibition of mammalian and plant prolyl oligopeptidase by cysteine protease 
inhibitors is well documented (Polgar, 1991;Yoshimoto et al. 1987a). This effect was 
presumed to be due to a cysteine residue in close proximity to the active site. Szeltner 
et al. (2000) reported that the cys255 side chain (Figure. 1.4.), which is located close to 
the Si and S3 binding sites accounts for this effect. This finding has indicated that in 
addition to the regulatory effect the propeller domain, which is independent of the 
catalytic domain, provides a residue that can modify the catalytic action of the 
peptidase domain.
Kinetic properties of catalysis
Polgar (1991) reported that kinetic analysis indicated that prolyl oligopeptidase is 
remarkably sensitive to ionic strength and postulated the existence of two catalytically 
active forms, which exhibit different activities and interconvert with changing pH. 
Usually the ionisation of the histidine residue in the active site of serine proteases 
governs the pH dependence of catalysis, exhibiting a pKa of 7.0. It has been noticed 
that a second ionisation event in the pH dependent kinetics was observed at pK, 5.0 
(Polgar, 1991).
An additional difference between prolyl oligopeptidase and the classical serine 
proteases is the rate-limiting step of catalysis. Kinetic deuterium isotope effects of the 
chymotrypsin enzyme reaction show that the rate limiting step involves general 
base/acid catalysis, as the reactions proceed 2-3 times slower in deuterium oxide than 
water (Polgar, 2002a). No significant isotope effects were noticed in prolyl 
oligopeptidase catalysis of different substrates that, along with the lack of leaving 
group effects on Kuat/KIn indicate the possibility of a substrate induced conformational 
change being the rate-limiting step (Polgar, 1991; Polgar, 1992b; Polgar et al. 1993; 
Polgar 2002a). This conformational change induced by the substrate may be the 
opening of the propeller blades as mentioned earlier.
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1.2.7. Substrate Specificity
The general substrate specificity of prolyl oligopeptidase from various sources is well 
documented (Koida and Walter, 1976; Walter and Yoshimoto, 1978; Yoshimoto etal. 
1988; Kreig and Wolf, 1995). In general the ability of prolyl oligopeptidase to 
hydrolyse a peptide bond is dictated by the presence o f a particular residue (proline or 
alanine), location of the residue and the length of the peptide. Prolyl oligopeptidase is 
a proline specific endopeptidase, cleaving peptides with a proline residue in the Pi 
position (Pro-Xaa) in peptides consisting of an acyl-Yaa-Pro-Xaa sequence (Nomura, 
1986). Cleavage will not occur if a free a-amine exists in the P2 position. Pro-Pro 
bonds and N-blocked peptides o f the sequence Z-Pro-Xaa are also not hydrolysed. 
Nomura (1986) investigated the importance of the residue in the Pi position and its 
effect on the Si subsite of the enzyme (Figure 1.6. for terminology). It was concluded 
that the Si subsite of prolyl oligopeptidase is designed to specifically fit pro line 
residues but can tolerate residues carrying substituent groups, provided they do not 
exceed the size of the pyrrolidine ring of proline. There is a preference for a 
hydrophobic residue at the C-terminal end of the scissile bond (Pi') with lower 
specificities observed for basic and acidic residues in this position.
------------ - --1
Figure 1.6. Schematic Representation of an Enzyme-Substrate Complex
Residues of the substrate and enzyme subsites are numbered according to their distance from the 
scissile bond and their location on the N- or C-terminal side of the cleavage site (Schechter and Berger, 
1967).
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The smallest peptide cleaved by prolyl oligopeptidase is an N-blocked tripeptide or a 
tetrapeptide containing residues in positions P3-P1'. Further studies showed that prolyl 
oligopeptidase has an extended substrate binding region in addition to the primary 
specificity site, Si. It is seemingly comprised of three subsites located at the amino- 
terminal site (Si, S2  and S3) and two located at the carboxyl site from the scissile bond 
(Si' and S2'). High stereospecificity was observed for subsites Si, S2 and Si' (Walter 
and Yoshimoto, 1978; Yoshimoto et al. 1988; Sattare/a/. 1990). Fulop et al. 2001 by 
showing the binding of an octapeptide substrate to an inactive prolyl oligopeptidase 
active site, have clarified the above findings that were based on kinetic analysis. They 
concluded that their structure determination revealed that substrate binding is 
restricted to the P3-P2 ' region only.
As an oligopeptidase, prolyl oligopeptidase has a substrate size limitation that enables 
it to cleave low molecular weight peptides much faster than larger peptides. The 
enzyme is unable to cleave proteins or peptides greater than 25 amino acids in length 
(Koida and Walter, 1976; Walter et al. 1980; Moriyama et al. 1988). The presence of 
a gating filter mechanism by the P-propeller domain of prolyl oligopeptidase explains 
this substrate size limitation (see section 1.2.6.).
Most peptide hormones and neuropeptides comprise one or more proline residues. 
Seeing as prolyl oligopeptidase has a broad specificity for proline containing 
oligopeptides, its ability to degrade many bioactive peptides is well documented. In 
vitro, prolyl oligopeptidase is able to degrade several neuropeptides, such as substance 
P and arginine-vasopressin (Wilk, 1983; Mentlein, 1988; Makinen et al. 1994). Table
1.4. summarises some of the peptides reported to be degraded by prolyl 
oligopeptidase and their identified cleavage site.
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Peptide AA Sequence and cleavage point Reference
Substance P 11 Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met O’Leary et al. 1996
Oxytocin 9 Cys-Tyr-Ile-Gln-Asn-Lys-Pro-Leu-Gly-NH2 Walter etal. 1971
Neurotensin 13 Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu Camargo etal. 1984
Angiotensin I 11 Asp-Arg-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu Morivama et al. 1988
Angiotensin II 8 Asp-Arg-Val-Tyr-Ile-His-Pro-Phe Moriyama etal. 1988
Angiotensin III 7 Arg-V al-Tyr-Ile-His-Pro-Phe Moriyama etal. 1988
Bradykinin 9 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg Tate, 1981
TRH 3 pGlu-His-Pro-NH2 O’Leary et al. 1996
Vasopressin 8 Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly Moriyama et al. 1988
Tuftsin 4 Thr-Lys-Pro-Arg Tate, 1981
LHRH 10 Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 Wilk et al. 1979
Arg-vasopressin 9 Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 Walter, 1976
Melanotropin 13 Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Tate, 1981
Table 1.4. Bioactive Peptides Hydrolysed by Prolyl Oligopeptidase
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1.2.8. Inhibitors
Specific inhibitors of prolyl oligopeptidase are typically substrate analogues, which 
interact with the enzyme in a substrate like manner and prevent enzyme catalysis. 
This mode of action of these inhibitors, which are very specific due to the proline 
residue in the Pi position, will play a role in identifying the physiological role of the 
enzyme. Therefore, the continuing development of specific inhibitors that inactivate 
prolyl oligopeptidase in vivo and can readily cross the blood brain barrier is very 
important.
The first highly potent and specific inhibitor of prolyl oligopeptidase synthesised was 
the peptidyl aldehyde N-benzyloxycarbonyl (Z)-Pro-prolinal (Wilk and Orlowski, 
1983), which is effective in vivo as well as in vitro. A IQ of 14nM was reported for 
this non-competitive, transition state aldehyde inhibitor for rabbit brain prolyl 
oligopeptidase. After intraperitoneal administration Z-Pro-prolinal traverses the blood 
brain barrier to inhibit the brain enzyme (Friedman et al. 1984). Both the alcohol and 
acid derivatives of Z-Pro-prolinal were found to be 3000 times less inhibitory towards 
the rabbit enzyme than the aldehyde (Friedman et al. 1984; Wilk and Orlowski,
1983). In 1990, Bakker et al. proposed that Z-Pro-prolinal was in fact a competitive 
slow tight binding inhibitor of mouse and human prolyl oligopeptidase with Ki values 
of 0.35nM and 0.5nM respectively. The potency of Z-Pro-prolinal is attributed to this 
transition state peptide aldehyde forming a hemiacetal adduct with the active site 
serine (Kahyaoglu et al. 1997).
Yokosawa et al. (1984) using Z-Pro-prolinal substituted the P2 proline with various 
amino acids. Z-Val-prolinal was found to be the most potent with a K¡ of 2.4nM for 
prolyl oligopeptidase from ascidian (Halocynthia roretzi) sperm. Further studies 
reported that Z-Thiopro-thioprolinal gave a Ki of lOpM for bovine brain prolyl 
oligopeptidase. Replacement of the thioprolinal with thiazolidine also remained very 
potent giving a Ki of 0.36nM (Tsuru et al. 1988). Although Z-Thiopro-thiazolidine 
doesn’t have an aldehyde group, it shows potent activity comparable to Z-Pro- 
prolinal. These studies on Z-Pro-prolinal and its derivatives indicate that the length of 
the main chain of the inhibitor corresponding with the subsites, Si, S2 and S3 is most 
suitable for inhibition. Also it showed that there seems to be a hydrophobic pocket at 
the S3 subsite with bulkiness and length of the acyl group important for firm binding.
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Many potent prolyl oligopeptidase inhibitors are variations of the N-blocked dipeptide 
chain. SUAM 1221, a phenyl butanoyl prolyl-pyrrolidine derivative has a reported 
IC5o of 190nM (Saito et al. 1991). Fmoc-aminoacylpyrrolidine-2-nitriles are also 
potent prolyl oligopeptidase inhibitors. Both Fmoc-Ala-PyrrCN and Fmoc-Pro- 
PyrrCN inhibition resulted in K;’s of 5nM. They were also found to be stable, cell 
permeable and crossed the blood brain barrier (Li et al. 1996). Goosens et al. (1997) 
reported the inhibition of prolyl oligopeptidase (K; of 0.8nM) by converting Z-Pro- 
pyrrolidine to Z-Pro-3-fluoropyrrolidine. A well-studied inhibitor, JTP-4819 that 
contains a benzylaminocarbonyl blocked dipeptide carboxamide (Toide et al. 1995a) 
shows an IC50 of 0.83nM. As can be seen most described low molecular weight prolyl 
oligopeptidase inhibitors contain an acyl-L-prolyl-pyrrolidine backbone, with the 
lipophilic acyl end group reported to be important for high inhibition. Most recent 
prolyl oligopeptidase inhibitors (Wallen et al. 2002) synthesised dicarboxylic acid bis 
(L-prolyl-pyrrolidine) amides and studied their inhibitory activity. These new 
compounds have in common an L-prolyl-pyrrolidine moiety, but the typical lipophilic 
acyl end group is replaced by another L-prolyl-pyrrolidine moiety connected 
symmetrically via a short dicarboxylic acid linker, they are a new type of 
peptidomimetic prolyl oligopeptidase inhibitor. The most potent new inhibitor gave an 
IC50 of 0.39nM.
Many compounds, which are bacterial and fungal in origin, were discovered to be 
potent inhibitors of prolyl oligopeptidase. Postatin that was isolated from 
Streptomyces viridochromogenes (Aoyagi et al. 1991) was a potent inhibitor resulting 
in an IC50 of 0.03fxg/ml. A variety of derivatives of postatin have been chemically 
synthesised in an attempt to obtain a greater inhibitory potency and selectivity (Tsuda 
et al. 1996). Propeptin (Kimura et al. 1997) and Lipohexin (Heinze et al. 1997) were 
isolated from fugal origins and both reported to be inhibitors of prolyl oligopeptidase. 
A K; of 0.70|iM was obtained for propeptin. Many prolyl oligopeptidase inhibitors 
have been isolated from the mushroom Polyozellus multiplex. The most recent 
Kynapcin-24 was shown to non-competitively inhibit prolyl oligopeptidase, with an 
IC50 value of 1.14[xM (Song and Raskin, 2002),
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Inhibitor Potency Reference
Z-Pro-prolinal Kj = 14nM Wilk and Orlowski, 1983
Z-Val-prolinal IQ = 2.4nM Yokosawa et al. 1984
Z-Thiopro-thioprolinal Kj = O.OlnM Tsuru et al. 1988
Z-Thiopro-thiazolidine Ki = 0.36nM Tsuru et al. 1988
Z-Indolinyl-prolinal Kj = 2.4nM Bakkerefa/. 1991
SUAM-1221 Kj = 190(oM Saito et al. 1991
Y-27924 IC50 = 0.95(jM Nakajima et al. 1992
JTP-4819 IC50 = 0.83nM Toide et al. 1995 a
Fmoc-Ala-PyrrCN Ki = 5nM Li et al. 1996
Fmoc-Pro-PyrrCN Ki = 5nM Li et al. 1996
Z-Pro-3-fluoropyrrolidine Ki = 0.8nM Goosens et al. 1997
S-l 7092-1 K, = InM Barelli et al. 1999
Postatin IC50 = 0.03^ig/ml Aoyagi et al. 1991
Propeptin Kj = 0.7pM Kimura et al. 1997
Lipohexin Ki = 3.5}jM Heinze et al. 1997
Kynapcin-24 IC50 = 1.14p.m Song and Raskin, 2002
Table 1.5. Prolyl Oligopeptidase Specific Inhibitors
Z-Pfu-prolinal X S17092-1
Figure 1.7. Chemical Structure of Some Prolyl Oligopeptidase Inhibitors
23
1.2.9. Physiological Relevance
On the basis that processing and degradation of peptide hormones and neuropeptides, 
which comprise one or more proline residues, require the use of proline specific 
peptidases it was important to study the contribution of prolyl oligopeptidase to a 
number of biologically important functions. The biology of prolyl oligopeptidase is 
consistent with a potential neuromodulatory role. They cleave peptides of less than 
3kDa after proline residues, which include peptide hormones and neuropeptides such 
as substance P and p-endorphin (Cunningham and O’Connor, 1997b). It is still 
somewhat unclear though if these are physiologically relevant substrates because 
prolyl oligopeptidase activity appears to be predominantly cytosolic (Kato et al. 1980; 
Irazusta et al. 2002).
As an important brain enzyme, prolyl oligopeptidase is implicated in a variety of 
disorders of the central nervous system. Prolyl oligopeptidase activity has been 
associated with the mental disorders of unipolar and bipolar depression. Serum prolyl 
oligopeptidase activity is lowered during depression, but raised during mania and 
schizophrenia (Maes et al. 1994 and 1995). The antidepressant fluoxetine and the 
antimanic drug valproate restore prolyl oligopeptidase activity levels to normal (Maes 
et al. 1995). It is also worth noting that peptides involved in the pathophysiology of 
depression like thyroliberin, substance P and P-endorphin are all substrates of the 
enzyme. The most recent studies on depression, for which lithium is the oldest and 
simplest agent for treatment, have indicated that an inverse relationship between 
prolyl oligopeptidase activity and inositol (l,4,5)-trisphosphate (IP3) signalling is 
evident (Williams et al. 1999; Williams and Harwood, 2000; Williams et al. 2002). 
The low prolyl oligopeptidase activity may cause neurotrophic effects (depression) 
through elevation of IP3 , the process being reversed by lithium. Schulz et al. (2002) 
also demonstrated an influence on IP3 metabolism by prolyl oligopeptidase. They 
concluded that reduced prolyl oligopeptidase activity was found to amplify substance 
P mediated stimulation of IP3. This effect of reduced prolyl oligopeptidase activity on 
second messenger concentration indicates a possible novel intracellular function of 
this peptidase, therefore maybe having an impact on the reported cognitive 
enhancements due to prolyl oligopeptidase inhibition.
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The effects of various prolyl oligopeptidase inhibitors have revealed a further 
physiological role of the enzyme. In vitro, substrates such as TRH, substance P and 
arginine-vasopressin (AVP) are known to exert neuroprotective effects like improving 
the performance of animals in learning and memory tasks (De Wied et al. 1984; 
Griffiths, 1987). The first effective inhibitor, Z-Pro-prolinal was shown to reverse 
scopolamine-induced amnesia in rats (Yoshimoto et al. 1987). These findings were 
confirmed for a number of other prolyl oligopeptidase inhibitors such as JTP-4819, 
0no-1603 and S-17092-1 and they are known as cognitive enhancers (Toide et al. 
1995a; Katsube et al. 1996; Barelli et al. 1999). For instance, JTP-4819 in rats with 
lesions of the nucleus basalis magnocellularis ameliorated memory impairment by 
increasing the levels of substance P, TRH and arginine-vasopressin (Shinoda et al. 
1999).
More studies on the biological relevance of prolyl oligopeptidase show evidence that 
this enzyme could be linked with Alzheimer’s disease, with specific inhibitors having 
a therapeutic value for its treatment (Toide et al. 1997a). It was reported (Shinoda et 
al. 1997) that the prolyl oligopeptidase inhibitor JTP-4819 was able to suppress in 
vitro p-amyloid protein (Ap) formation in neuroblastoma cells. This importance, due 
to the deposition of P-amyloid protein in brains being a hallmark of Alzheimers was 
studied but later findings indicate that specific inhibitors do not affect formation and 
degradation of P-amyloid peptides and p-amyloid precursor proteins. This would be 
expected, as prolyl oligopeptidase is known to only degrade small peptides. It is now 
accepted that low prolyl oligopeptidase activity is associated with neuronal 
degeneration rather than p-amyloid accumulation (Petit et al. 2000; Laitinen et al. 
2001).
Prolyl oligopeptidase also possibly plays a role in the regulation of blood pressure 
through the metabolism of bradykinin and angiotensin I, thus participating in the 
renin-angiotensin system (Polgar, 2002b).
The protozoan parasite Trypanosoma cruzi also contains prolyl oligopeptidase. Using 
specific prolyl oligopeptidase inhibitors, the role of the enzyme in the invasion of 
target cells has been studied showing that these specific inhibitors can block the entry 
of the parasite into host cells (Grellier et al. 2001).
Although the enzymatic and structural properties of prolyl oligopeptidase are well 
known, its biological function is far from being fully understood.
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1.3. Dipeptidyl Peptidase IV
The ectoenzyme dipeptidyl peptidase IV (DP IV, EC 3.4.14.5) is a serine 
exopeptidase catalysing the release of N-terminal dipeptides from oligo- and 
polypeptides preferentially with proline or to a lesser extent alanine in the penultimate 
position (Ikehara et al. 1994). Among the rare group of proline specific proteases, 
dipeptidyl peptidase IV was originally believed to be the only membrane-bound 
enzyme specific for proline as the penultimate residue at the amino-terminus of the 
polypeptide chain. However, recent studies have identified many proteins with DP 
IV-like enzymatic activity (Sedo et al. 2001). Dipeptidyl peptidase IV was first 
identified as glycylproline naphthylamidase by Hopsu-Havu and Glenner (1966) and 
also called dipeptidyl aminopeptidase IV (DAP IV) or postproline dipeptidyl 
peptidase IV in earlier work. It’s cellular localization and enzymatic properties differ 
from those of the other dipeptidyl peptidases. Dipeptidyl peptidases I and II are 
localized in lysosomes, whereas dipeptidyl peptidase III is found in the cytoplasm. 
The specificity of dipeptidyl peptidase II is similar to dipeptidyl peptidase IV but 
neither dipeptidyl peptidase I or III can cleave post proline (Polgar, 2002a). 
Dipeptidyl peptidase IV is grouped in subfamily S9B of the peptidase family S9 
(Prolyl oligopeptidase family), clan SC (Barrett et al. 1998). It is different from both 
prolyl oligopeptidase and oligopeptidase B in that it’s a dimer, an exopeptidase, a 
glycoprotein and an ectoenzyme bound to the cell membrane. Dipeptidyl peptidase IV 
is reported to be identical to CD26 (Fleisher, 1994), a T-lymphocyte surface antigen 
and to adenosine deaminase (ADA) binding protein. Dipeptidyl peptidase is thus often 
referred to/called CD26 and ADA-binding protein.
1.3.1. Distribution
Dipeptidyl peptidase is predominantly a cell membrane bound glycoprotein widely 
distributed in a variety of species and tissues. In addition to the integral membrane 
form, a soluble form of dipeptidyl peptidase occurs in serum (Iwaki-Egawa et al. 
1998). Dipeptidyl peptidase IV is found in all organs, primarily on apical surfaces of 
epithelial and acinar cells, with lower levels on lymphocytes and capillary endothelial 
cells (Gorrell et al. 2001). Dipeptidyl peptidase IV was detected by enzyme 
cytochemistry using Gly-Pro substrates in human tissues such as kidney, placenta, 
gastrointestinal tract and on endothelia of all organs examined such as liver, spleen,
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lungs and brain. Rat tissues produced identical data and showed that endothelial cells 
of capillaries in all organs including lymphoid organs, muscle and brain contain 
dipeptidyl peptidase activity. In the kidney, where the enzyme is exceptionally 
enriched, it is located primarily in the cortex and also found in the brush-border and 
microvillus fractions. In the liver, dipeptidyl peptidase IV activity is primarily located 
on hepatocytes at the plasma membranes around bile caniculi and on the bile duct 
epithelia.
Lojda (1977) showed for the first time dipeptidyl peptidase IV activity on human 
peripheral blood lymphocytes. Within the hematopoietic system, dipeptidyl peptidase 
IV is expressed on the surface of resting and activated T cells, activated B and 
activated NK cells (Reinhold et al. 2002).
Much work has been carried out on the soluble form of dipeptidyl peptidase IV. This 
activity was reported to be present in the cytoplasm of guinea-pig brain indicating the 
existence of a soluble form (Gilmartin and O’Cuinn, 1999). Dipeptidyl peptidase IV 
activity can be found in many mammalian bodily fluids, such as serum, urine and 
seminal fluid. Most reports are on the serum dipeptidyl peptidase IV that is derived 
from cell surface dipeptidyl peptidase IV but its cellular origin is still unclear (Gorrell 
et al. 2001).
Yoshimoto and Tsuru (1982) reported the presence of dipeptidyl peptidase IV in 
Flavobacterium meningosepticum although its biochemical properties differed to the 
mammalian enzyme.
1.3.2. Purification
Since dipeptidyl peptidase was first isolated from rat liver by Hopsu-Havu and 
Glenner (1966), it has been isolated with various degrees of purity since due to its 
wide distribution in a variety of species and tissues. The enzyme has been purified to 
homogeneity from liver (Ikehara et al. 1994), Kidney (Kenny et al. 1976; Wagner et 
al. 1999) and serum (Shibuya-saruta et al. 1996; Iwaki-Egawa et al. 1998; Durinx et 
al. 2000). The intact membrane form can be prepared by solubilizing the enzyme with 
Triton X-100, while the soluble form is obtained by autolysis of microsomes 
incubated at low pH or by digestion of membrane form with papain, which cleaves a
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peptide bond of the stalk linking the peptidase to the membrane. The intact membrane 
form is usually separated from the soluble form by centrifugation, if they both co­
exist in that source.
Conventional column chromatographic techniques are usually employed with varying 
degrees of success for purification. DEAE anion exchange chromatography is a 
widely used step for dipeptidyl peptidase IV purification (De Meester et al. 1992 and 
1996; Ohkubo et al. 1994) and the concept of re-chromatographing on this same resin 
is commonly employed (Yoshimoto and Walter, 1977; Puschel et al. 1982; Iwaki- 
Egawa et al. 1998). The cation exchange resin CM-cellulose has also been employed 
in tandem with anion exchange chromatography (Kenny et al. 1976; Yoshimoto and 
Walter, 1977). Hydrophobic interaction chromatography is not reported to be used 
often in dipeptidyl peptidase IV purification. The enzymes soluble form purification 
from guinea-pig brain (Gilmartin and O’Cuinn, 1999) and its isolation from human 
serum (Iwaki-Egawa et al. 1998) both employed hydrophobic interaction 
chromatography, the latter group obtaining an overall purification of 14,400 with its 
use. Gel filtration chromatography is also widely used, pore sizes ranging from G150 
for Flavobacterium meningosepticum (Yoshimoto and Tsuru, 1982), an S200HR for 
guinea pig brain cytoplasm (Gilmartin and O’Cuinn, 1999) and an S300HR for human 
serum dipeptidyl peptidase IV isolation (Iwaki-Egawa et al. 1998).
The use of affinity resins in the purification of dipeptidyl peptidase IV report the 
greatest purification factors. Lectin affinity chromatography using concanavalin A- 
sepharose and wheat germ-agglutinin sepharose which exploit the glycoprotein 
characteristic of dipeptidyl peptidase IV were employed widely for its isolation (De 
Meester et al. 1992; Ikehara el al. 1994). Shibuya-saruta et al. (1996) employed Gly- 
L-Leu affinity chromatography along with the use of a monoclonal antibody, Tal 
bound to EAH sepharose 4B for dipeptidyl peptidase IV purification from human 
serum. They achieved an overall purification factor of 18,000 with their use. Durinx et 
al. (2000) also employed a monoclonal antibody recognising the adenosine 
deamidase-binding site for dipeptidyl peptidase IV purification from human serum. 
De Meester et al. (1996) exploited the adenosine deamidase-binding site of dipeptidyl 
peptidase IV by purifying it from human seminal plasma using immobilized 
adenosine deamidase (ADA) on CNBr-activated sepharose. The use of immobilized
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metal affinity chromatography using Cu2+ as metal ligand was very successful in 
removing contaminating protein, which proved difficult to remove otherwise in 
dipeptidyl peptidase IV purification from ostrich kidney and human lymphocytes (De 
Meester et al. 1992; Wagner et al. 1999).
Recent studies have employed a two-step purification of the recombinant human 
dipeptidyl peptidase IV enzyme that was overexpressed in Spodotera frugiperda 
(SF9) insect cells as a more readily achievable preparation compared with tissue 
isolation (Dobers et al. 2002).
1.3.3. Activity Detection
Dipeptidyl peptidase IV cleaves N-terminal dipeptides from substrates consisting of 
three or more amino acid residues or dipeptides linked to C-terminal chromogenic or 
fluorogenic compounds. Gly-Pro- is normally the dipeptide attached C-terminally to a 
compound that can be measured and quantified either spectrophotometrically or 
fluorometrically. A number of dipeptide substrates such as p-nitroanilides (Nagatsu et 
al. 1976), P-naphthylamides (Hopsu-Havu and Glenner, 1966) and 4-methoxy-p- 
naphthylamides (Puschel et al. 1982) have been used for characterisation of dipeptidyl 
peptidase IV. Gly-Pro-AMC is being increasingly used for detection of dipeptidyl 
peptidase IV activity due to its high sensitivity. The hydrolysis of the assay substrate 
selected is dependant on the enzyme source and the substrate choice should be 
optimised as such (McDonald etal. 1971),
Sensitive fluorogenic rhodamine 110-based substrates are becoming increasingly 
employed for the detection and quantification of dipeptidyl peptidase IV on the 
surface of immune cells. Rhodamine 110 (R110), a highly fluorescent xanthene dye 
was used to synthesise dipeptidyl peptidase IV substrates Gly(Ala)-Pro-R110-R thus 
facilitating a stable binding of the fluorescent moiety on the cell surface. These 
substrates provide the opportunity to determine cell surface-associated dipeptidyl 
peptidase IV activity on single cells (Lorey et al. 2002).
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1.3.4. Structural and Biochemical Aspects
The amino acid sequences of dipeptidyl peptidase IV have been determined from 
different species by complementary DNA (cDNA) cloning and sequencing. The 
human (Misumi et al. 1992; Darmoul et al. 1992), murine (Marguet et al. 1992), rat 
(Ogata et al. 1989) and porcine (Engel et al. 2003) enzymes contain 766, 760, 767 
and 766 amino acid residues. The bacterial enzyme from Flavobacterium 
meningosepticum displays a shorter peptide chain of 711 residues (Kabashima et al. 
1995). Each protein is anchored to the lipid bilayer by a single hydrophobic segment 
located at the N-terminus, and has a short cytoplasmic tail of six amino acids. A 
flexible stalk links the membrane anchor to a large glycosylated region, a cysteine 
rich region and a C-terminal catalytic domain. The extracellular domain contains 
several glycosylation sites, mostly in the amino-terminal half. This glycosylation 
accounts for the difference in the molecular mass between the predicted and the native 
forms (Ogata et al. 1989). The essential residues of the human enzyme are Ser630, 
Asp708 and His740. This order of the catalytic triad is characteristic of the a/p 
hydrolase fold secondary structure.
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Figure 1.8. Secondary Structure of DP-IV Shown Over the Amino Acid Sequence
Arrows indicate P-strands, bars indicate helices. Colour code is as propeller blade numbers in Figure 
1.10. Hydrolase domain is gray. Glycosylated residues are marked with a cyan square. Cysteines in S-S 
bonding are yellow circles. Catalytic residues are marked with a red asterisk (Rasmussen et al. 2003).
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Recent crystal structures of human (Rasmussen et al. 2003) and porcine (Engel et al. 
2003) have reported the most important three-dimensional structural information on 
dipeptidyl peptidase IV. The 2.5A structure of the extracellular region of human 
dipeptidyl peptidase IV in complex with the inhibitor Valine-Pyrrolidide was 
elucidated. It consists of two domains, a peptidase and an eight-bladed p-propeller 
(Figure 1.10.). Dipeptidyl peptidase IV was seen as a dimer in the crystal structure, 
agreeing with reports that the active enzyme is a dimer (Gorrell et al. 2001). The N- 
terminus of each subunit is located at the same site of the dimer (Figure 1.9.), 
indicating that full length, membrane bound dipeptidyl peptidase IV could exist as 
homodimers at the cell surface. Interestingly, from this Engel et al. (2003) in their 
crystal structure indicated that tetramerization of dipeptidyl peptidase IV is a key 
mechanism for possible cell-cell contacts.
(1 f  f  Cytosol
Ceil membrane
Figure 1.9. Structure of Dipeptidyl Peptidase IV
DP-IV forms a homodimer (subunit A in green, B in magenta). Each subunit consists of two domains: 
an a/p-hydrolase domain, located closest to the membrane, and an eight-bladed P-propeller. The 
inhibitor Val-Pyr is shown and coloured by element: carbon (gray), nitrogen (blue) and oxygen (red). 
Five S-S bridges (yellow) have been identified in each molecule. Carbohydrates (blue) have been 
located at seven of the possible nine-glycosylated positions in both subunits. These sites are all situated 
in the p-propeller, except one (Rasmussen et al. 2003).
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Each subunit consists of two domains, an a/p  hydrolase domain and an eight-bladed 
P-propeller (Figure 1.10a.). The C-terminal residues 506-766 and a short stretch of N- 
terminal sequence, residues 39-51, assemble the peptidase domain. It adopts atypical 
a/p  hydrolase fold with a central eight stranded p-sheet sandwiched by several 
helices. The p-propeller domain is formed from residues 55-497. It consists of eight- 
blades each containing four antiparallel p-strands (Figure 1.10b). The propeller is 
divided into two domains with blades 2-5 forming one subdomain and blades 1 and 6- 
8 forming the other.
Figure 1.10. Structural Comparison of DP-IV and Prolyl Oligopeptidase
The eight (DP-IV) and seven (PO) bladed [i-propellcr domains are illustrated by solid ribbons and 
coloured by blade number (as shown in Figure 1.8. for a & b). The <x/p hydrolase domain is gray, a) 
Side view of DP-IV. The extended arm involved in dimerization is off yellow, while the black helix 
holds Glu205 and Glu206. b) DP-IV viewed from bottom, c) View of PO from the side. The N-terminal 
extension relative to DP-IV and covering dimer contact area is shown in dark gray, d) PO viewed from 
the bottom (Rasmussen et al. 2003)
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The P-propeller of dipeptidyl peptidase IV is similar to prolyl oligopeptidase in that it 
displays open “Velcro” topology. The inside of the propeller of dipeptidyl peptidase
IV forms a funnel shaped tunnel between the active site and the bottom of the 
monomer. However, the funnel is not the only opening to the active site of dipeptidyl 
peptidase IV. A side opening to the active site is generated by the kinked arrangement 
of blades 1 and 2. On the basis of size and electrostatic characteristics, both the tunnel 
and side opening may serve as entrance/exit to the active site (Rasmussen et al. 2003).
The formation of cysteine bridges has an important impact on the correct folding of 
proteins. Incorrect folding leads to retention in the endoplasmic reticulum and the 
misfolded proteins are degraded (Dobers et al. 2000). With the exception Cys649- 
Cys762 all disulfide bonds are located in the P-propeller domain where they form 
intrablade-stabilizing crosslinks (Figure 1.8.). This cysteine rich domain is responsible 
for binding of extracellular matrix components and extracellular adenosine 
deaminase. The structures reported by Rasmussen et al. (2003) and Engel et al. (2003) 
also offer an insight into the ADA-binding site of dipeptidyl peptidase IV. By using 
site-directed mutagenesis Leu294 and Val341 were identified as two ADA-binding sites 
(Abbott et al. 1999). The dipeptidyl peptidase IV structure shows that these amino 
acids are distant from both possible active site openings, which could explain the lack 
of interference of ADA-binding with dipeptidyl peptidase IV catalytic activity.
The gene structure of human dipeptidyl peptidase IV has been reported. It spans about 
70kbp and contains 26 exons. The widely varying transcriptional activity of the gene 
may explain why the enzyme is expressed ubiquitously, but at different levels in 
different tissues (Abbott et al. 1994).
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Source MW (Mono) 
kDa
MW (Dimer) 
kDa
Pi Assay Temp.
(°Q
pH
Optima
Reference
Human Placenta 120 200 3-4 37 8.0 Puschel et al. 1992
Human Lymphocytes ND 264 5.0 ND 8.7 De Meester et al. 1992
Human Serum 100 250 ND 37 8.5 Shibuya-Saruta et al. 1996
Porcine seminal Plasma 115 300 6.85 37 8.0 Ohkubo et al. 1994
Ostrich Kidney 133 270 4.7 45 8.0 Wagner et al. 1999
Lamb Kidney 115 230 4.9 ND 7.8 Yoshimoto and Walter, 1977
F. meningosepticum 75 160 9.5 45 7.4-7.8 Yoshimoto and Tsuru, 1982
Table 1.6. Biochemical Properties of Dipeptidyl Peptidase from Mammalian and Bacterial Sources
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Human dipeptidyl peptidase IV is a llOkDa glycoprotein, which is only catalytically 
active as a dimer. The relative molecular mass of the membrane bound dimer is 220- 
264kDa by gel filtration (De Meester et al. 1992). Dipeptidyl peptidase IV also exists 
as a soluble circulating form of ~100kDa. Bacterial dipeptidyl peptidase IV seems to 
be smaller with a molecular mass of 160kDa, so 75-80kDa monomers (Yoshimoto 
and Tsuru, 1982; Koreeda et al. 2001).
Due to the presence of sialic acids in the carbohydrate structures, dipeptidyl peptidase 
IV has an acidic isoelectric point, pi values of 3-5 have been reported. A pi of 4.7 was 
reported for ostrich kidney enzyme (Wagner et al. 1999), while human lymphocyte 
dipeptidyl peptidase IV gave a pi of 5.0 (De Meester et al. 1992).
The pH optimum of dipeptidyl peptidase IV, though dependent to some degree on the 
substrate used, ranges from 8.0 to 9.0. Whether the enzyme is soluble or membrane 
bound has no apparent effect on its pH optimum. Lamb kidney dipeptidyl peptidase 
IV and soluble dipeptidyl peptidase IV from guinea pig brain both degraded their 
respective substrates optimally at pH 7.8 (Yoshimoto and Walter, 1977; Gilmartin and 
O’Cuinn, 1999). A pH optimum of 8.7 for human lymphocyte dipeptidyl peptidase IV 
using the substrate Gly-Pro-4-Methoxy-2-naphthylamide was also reported (De 
Meester et al. 1992). On the stability characteristics, human placenta dipeptidyl 
peptidase IV maintained activity at room temperature from pH 6-12, while been 
completely inactivated at pH 3 (Puschel et al. 1982).
Temperature optimum reported for ostrich kidney was 45°C (Wagner et al. 1999) 
with the same value been obtained for the bacterial enzyme from Flavobacterium 
meningosepticum (Yoshimoto and Tsuru, 1982). Ogasawara et al. (1996) confirmed 
this bacterial temperature optimum with a value of between 40-50°C for 
Pseudomonas dipeptidyl peptidase IV enzyme.
1.3.5. Catalytic Classification
Dipeptidyl peptidase IV is a serine exopeptidase that cleaves dipeptides from a free 
NH2-terminal end of peptides. It has been classified as a serine protease due to its 
inhibition by diisopropylfluorophosphate (DFP) and its resistance to sulphydryl 
blocking agents and chelators (Ohkubo et al. 1994). A concentration of 1 OOfiM DFP 
resulted in an IC50 on human placenta dipeptidyl peptidase IV activity (Puschel et al. 
1982). De Meester et al. (1992) reported 47% inhibition using phenylmethane-
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sulfonylfluoride (PMSF) on human lymphocyte dipeptidyl peptidase IV activity, 
whereas DFP resulted in 97% inhibition. This may be due to PMSF inhibiting serine 
proteases less potently or via a different mode to the organophosphate, DFP.
Although dipeptidyl peptidase IV lacks significant homology with chymotrypsin or 
subtilisin, it has a -200 amino acid extracellular domain, which exhibits a high degree 
of sequence similarity with prolyl oligopeptidase and acylaminoacid hydrolase. 
Analysis of the similarity of secondary structures and amino acid sequences between 
these enzymes in their COOH terminal regions led to the identity of Ser624, Asp702 and 
His734 as the catalytic triad residues for murine dipeptidyl peptidase IV (Marguet etal. 
1992; David et al. 1993). The identification of the serine protease Gly-X-Ser-X-Gly 
consensus motif, which is the consensus sequence proposed for serine proteases, for 
murine dipeptidyl peptidase IV, its significant structural and sequence similarities in 
the catalytic domain to prolyl oligopeptidase and the linear order of the catalytic triad 
Ser-Asp-His indicates that this enzyme is a member of the prolyl oligopeptidase 
family of serine proteases. All members of this family contain the active site residues 
within 130 amino acids of the C-terminus while the membrane bound members 
contain the membrane spanning domain at the N-terminus (Rawlings and Barrett, 
1994).
1.3.6. Catalytic and Structural Mechanism
Serine protease catalysis as mentioned earlier (section 1.2.6.) follows a predefined 
mode. Catalysis generally involves an acylation reaction in which the acyl (RCO-) 
moiety of the substrate is transferred to the enzyme’s serine group. This is the first 
half of the catalysis. The second stage involves deacylation, where the imidazole 
group of the histidine residue activates a water group molecule by general-base 
catalysis leading to the formation of an acid product and enzyme (Fink, 1987).
Active Dimer
Dimerization is mediated by the three C-terminal secondary structure elements on the 
catalytic domain namely, helix Met746-Ser764, helix Gln714-Asp725 and strand Asp729- 
Thr736, and an extended arm from the P-propeller. The function of the arm is to 
stabilize the dimeric structure. An N-terminal extension of ~ 60 amino acids present
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in prolyl oligopeptidase covers the dimeric contact area of dipeptidyl peptidase IV, 
explaining why prolyl oligopeptidase does not dimerize (Figure 1.10.). Besides 
participating in the dimerization of dipeptidyl peptidase IV, this extended arm if the 
dimer dissociated could move towards the side opening to the active site and close it. 
These structural observations raise the possibility that dipeptidyl peptidase IV may 
exist as an open, enzymatically active dimer or as a closed inactive monomer. This 
may suggest that dimerization-mediated arm movement may regulate activity 
(Rasmussen et al. 2003).
Active site and substrate binding
A complex of dipeptidyl peptidase IV with its substrate analog, the competitive 
inhibitor valine-pyrrolidide (Val-Pyr) gave the first insight into substrate binding 
(Rasmussen et al. 2003). Between the peptidase and p-propeller domain lies a large 
cavity. The Val-Pyr molecule is bound in a smaller pocket within the cavity, next to 
the catalytic triad, Ser630, Asp708, and His740. Residues from both the hydrolase and 
propeller domains take part in substrate analog inhibitor binding (Figure. 1.11.).
Tyr547
ms¡740 Asp708
Tyr666!
Asn710
Arg125
Glu206,
Figure 1.11. Active Site View of DP-IV
Val-Pyrollidide is shown coordinated in the active site pocket, with selected residues shown in stick 
and coloured by element type as in Figure 1.9. Hydrogen bonds/electrostatic interactions are shown 
with dotted lines. Glu205 and Glu206 coordinate the N-temuniis. Arg125 and Asn710 coordinate the 
carbonyl group of the peptide bond before the cleavage point, with the pyrollidide ring stacked between
Tyr547, Tyr662 and Tyr666 (Rasmussen et al. 2003).
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The pyrollidide moiety of Val-Pyr is buried in a hydrophobic pocket next to the active 
serine. The hydrophobic Si pocket fits pro line as well as other small-uncharged 
residues such as alanine or serine. Tyr662 and Tyr666 stack at each side of the 
pyrollidide ring of Val-Pyr. Tyr547 and Tyr631 probably form the oxyanion hole. 
Proper orientation of the proline in the Pi position is achieved by its side chain 
interaction along with its binding to the oxyanion pocket.
Two glutamic acids, Glu and Glu , form salt bridges to the free amino terminus of 
the P2 residue, which corresponds to the N-terminus of a peptide substrate. These two 
residues are situated in a small horizontal helix (residues 201-207, Figure 1.8.) in 
blade four of the propeller domain. This small horizontal helix narrows the active site, 
leaving room for only two amino acids before the peptide substrate/inhibitor reaches 
the active site serine. This novel feature is the reason for DPIV being a dipeptidyl 
peptidase. The spatial arrangement of Ser630 with respect to Glu205 and Glu206 in 
dipeptidyl peptidase IV makes these two residues the most important feature for 
alignment of the peptide prior to catalysis. The carbonyl oxygen of the P2 residue is 
stabilized and activated by Arg125 and Asn710. The valine side chain of Val-Pyr points 
into the large cavity thus making no specific contact with dipeptidyl peptidase IV. 
This explains why dipeptidyl peptidase IV has no specific requirements for the N- 
terminal amino acid in the P2 position.
As a post proline cleaving enzyme dipeptidyl peptidase IV has to meet an additional 
requirement for efficient catalysis. As known, proline-containing peptides can adopt 
cis- and trans- peptide bond conformations. Only a peptide in the trans conformation 
is able to productively bind to the active site (Fischer et al. 1983). In dipeptidyl 
peptidase IV catalysis the conformation of the peptide bond at the amino terminal side 
of the proline is important (P2-P0- Reports suggest a conformational two-step 
mechanism for substrate hydrolysis where a trans substrate binds to the active site, 
followed by a trans-cis isomerization to enable proteolytic cleavage. In dipeptidyl 
peptidase IV the Arg125 residue is responsible for destabilizing the trans conformation 
(Engel et al. 2003).
Oligopeptide access and product release from the active site
As highlighted in section 1.3.6., Rasmussen et al. (2003) favoured access of substrate 
to the active site of dipeptidyl peptidase IV through the negatively charged side
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opening, with product egress through the P-propeller. Functionally, the side opening 
only model fails to explain dipeptidyl peptidase IV’s high substrate selectivity, as 
even secondary structured peptides could access the active site through the side 
opening. Also comparisons to prolyl oligopeptidase show that their open p-propeller 
is responsible for channelling substrates to and products away from the active site 
(Fulop et al. 1998). Engel et al. (2003) believe that the p8-propeller of dipeptidyl 
peptidase IV provides substrate access to and its side opening product release from 
the active site. Passage through the p-propeller tunnel requires substrates to unfold. 
Once the peptides amino terminus approaches the active site, it is still held in place by 
the C-terminus interacting with the P-propeller. This may contribute to the bending of 
the substrate for cleavage. The product is then directly released through the side exit. 
This hypothesis could explain why degradation of glucagons by dipeptidyl peptidase 
IV is not processive but occurs sequentially in two independent steps (Pospisilik et al.
2001).
Catalytic cavity and P-propeller architecture comparisons
The eight-bladed P-propeller widens from the surface towards the active site of 
dipeptidyl peptidase IV, this was also a feature of the prolyl oligopeptidase structure 
(Fulop et al. 1998). The residue in prolyl oligopeptidase structurally and functionally 
equivalent to Asn710 and Arg125 of dipeptidyl peptidase IV is Arg643. The side chain of 
Tyr662 in dipeptidyl peptidase IV aligns structurally with the side chain of Trp595 of 
prolyl oligopeptidase, whereas the backbone of Trp595 aligns structurally with Tyr666 
of dipeptidyl peptidase IV. The Cys255 residue of prolyl oligopeptidase shows no 
homologous counter residue in dipeptidyl peptidase IV. So dipeptidyl peptidase IV 
and prolyl oligopeptidase show good homology in the upper part of their catalytic 
cavities orientating the molecule. In contrast, significant differences are present in the 
bottom part of these molecules, like the Glu-Glu motif of dipeptidyl peptidase IV, 
explaining their different substrate specificities. The most interesting discovery from 
the structure of dipeptidyl peptidase IV is the extent, in comparison to prolyl 
oligopeptidase, with which the propeller domain regulates its peptidase activity.
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1.3.7. Specificity
Dipeptidyl peptidase IV exhibits relatively restricted substrate specificity (Figure 
1.12.). In the Pi position almost exclusively proline and alanine are accepted. In a 
study with growth hormone-releasing factor (GRF) analogues, other Pi residues such 
as serine, leucine and glycine were also cleaved but with lower rates (Bongers et al. 
1992; Martin et al. 1993). The P2 position can contain any proteinogenic amino acid 
including the proline residue. Substrates with hydrophobic or basic residues in this 
position are better hydrolysed than those with acidic ones. S configuration of the 
amino acids in both Pi and P2 positions in the case of proline substrates (Heins et al. 
1988) and in the Pi position in the case of alanine substrates (Heins et al. 1988), a free 
N-terminus as well as trans conformation of the peptide bond to be cleaved (Fischer 
et al. 1983) are important for enzymatic hydrolysis. The Pi' position also accepts all 
amino acid residues but hydrolysis will not take place with proline or hydroxyproline 
in this position (Kenny et a l 1976). Extensive studies into the specificity of dipeptidyl 
peptidase IV using growth hormone-releasing factor of different peptide lengths have 
shown that the specificity extends beyond the Pi' position. The requirement for an L 
residue in position P4' indicates that the enzyme-binding site extends possibly to the 
S4' subsite (Bongers et al. 1992). The chain length of the peptides cleaved has not 
been systematically investigated. Peptides up to 80 residues appear to be good 
substrates (Mentlein, 1999).
DP IV
v d i
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Leu
Figure 1.12. Substrate Selectivity of Dipeptidyl Peptidase IV (Reinhold et a l 
2002)
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1.3.8. Inhibitors
Many dipeptidyl peptidase IV inhibitors have been synthesised and their effect 
measured both enzymatically and physiologically. Demuth et al. (1988) investigated 
the inhibitory effect ofTV-peptidyl-O-aroylhydroxylamines on dipeptidyl peptidase IV. 
They were reported as mechanism based inhibitors of dipeptidyl peptidase IV with 
only modest potency. A comparison by this group of the turnover values for different 
Xaa residues in the P2 position demonstrated that the more hydrophobic or longer the 
side chain of the amino acid, the more potent the inhibitor towards dipeptidyl 
peptidase IV.
The simple tripeptides diprotein A (Ile-Pro-He) and diprotein B (Val-Pro-Leu) are 
competitive inhibitors of dipeptidyl peptidase IV. Even though they are substrates for 
dipeptidyl peptidase IV, an apparent competitive inhibition of dipeptidyl peptidase IV 
by these compounds is an interesting kinetic artifact, which originates from the 
substrate-like nature of these tripeptides with a penultimate proline residue (Rahfeld 
et al. 1991). These compounds have been used widely for dipeptidyl peptidase IV 
characterisation studies (De Meester et al. 1992; Ohkubo et al. 1994).
Flentke et al. (1991) used Xaa-boroPro (boroPro is an analog of proline in which the 
carboxylate group is replaced by a boronyl group) as potent and specific inhibitors of 
dipeptidyl peptidase IV. They belong to a class of serine protease inhibitors known as 
peptide boronic acids with their potency being attributed to the ability of the boronyl 
group to form a tetrahedral adduct with the active serine, which closely mimics the 
transition state of the enzyme catalysed reaction. Ala-boroPro gave a Ki of 2nM, 
while Pro-boroPro gave a Kj of 3nM against porcine kidney dipeptidyl peptidase IV 
activity. N-terminus blocking of Ala-boroPro abolished affinity of the inhibitor, while 
removal of the N-terminus leaving boroPro reduced affinity of inhibitory for 
dipeptidyl peptidase IV by five orders of magnitude. The dipeptide boronic acids 
exhibit slow-binding kinetics, while boroPro does not. Unfortunately, these 
compounds are highly unstable with im  of Ala-boroPro between 2-30 minutes and 
that of Pro-boroPro is 1.5 hours in aqueous solution. Guitheil and Bachovchin (1993) 
fractionated L-Pro-DL-boroPro into its component L-L and L-D diastereomers, with the 
L-L compound giving a Kj of 16pM but the L-D isomer bound 1000 fold less weakly.
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A series of aminoacylpyrrolidine-2-nitriles in which a nitrile group replaces the 
carboxyl group of proline were synthesised as dipeptidyl peptidase IV inhibitors (Li et 
al. 1995). Four aminoacylpyrrolidine-2-nitriles were prepared. These compounds 
studied had varied N-terminal amino acids. Arg-Pyrr-2-CN inhibits dipeptidyl 
peptidase IV with a K; of 0.37|jM but when the bulky PMC (2,2,5,7,8-pentamethyl 
chroman-6-sulfonyl) guanidine blocking group was introduced, Arg(PMC)-Pyrr-2-CN 
gave a Kj of 0.19|xM. This is more than likely due to the bulky group present in the P2 
position. All compounds tested were competitive inhibitors. Aminoacylpyrrolidine-2- 
nitriles are easily synthesised, relatively potent, specific and stable inhibitors of 
dipeptidyl peptidase IV.
Many chemical classes of dipeptidyl peptidase IV inhibitors have been synthesised 
and evaluated but most suffer from significant toxicity and instability in vivo which 
prohibits their introduction into biological systems. De Meester et al. (1997) prepared 
and characterised a number of peptide-derived diphenylphosphonates. One of these 
slow-binding and irreversible inhibitors of dipeptidyl peptidase IV, Pro-Pro- 
diphenylphosphonate or prodipine was investigated for its in vivo applicability. 
Treatment with prodipine led to inhibition of plasma and tissue dipeptidyl peptidase 
IV activity in animals. The in vivo use of this non-toxic, chemically stable, 
irreversible inhibitor of dipeptidyl peptidase IV would help in unravelling the 
biological function of this ectopeptidase.
Amino acid pyrrolidides (Pyr) and thiazolidides (Thia) are another set of dipeptidyl 
peptidase IV inhibitors. Such compounds are known to be effective competitive 
dipeptidyl peptidase IV inhibitors with K; values in the low micromolar to nanomolar 
range (Hoffman and Demuth, 2002). They represent a minimal recognition structure 
necessary for inhibition of dipeptidyl peptidase IV characterized by a free N-terminus, 
the a-carboxyl function of the peptide bond and a C-terminal proline analog. They 
also harbour no chemical reactive group and are stable for weeks in aqueous solution. 
These inhibitors are recently gaining recognition as potential new treatments for type 
2 diabetes. Glucagon and glucagon-like peptide (GLP-1), which are directly involved 
in type 2 diabetes, are known biological substrates of dipeptidyl peptidase IV in vitro 
and in vivo. Pospisilik et al. (2001) reported the prevention of glucagon degradation
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by dipeptidyl peptidase IV using isoleucyl thiazolidine. More recently, one of the two 
2-cyanopyrrolidide compounds which are potent dipeptidyl peptidase IV inhibitors, 
NVP-DPP728 has been reported to increase plasma GLP-1 concentrations and 
improve oral glucose tolerance in obese zucker rats (Willand et al. 2002). In other 
physiological processes, degradation of neuropeptide Y and peptide YY was 
prevented in human serum by administration of lys-pyrrolidide (Mentiein et al. 1993).
O
Figure 1.13. The Chemical Structure of Inhibitor Val-Pyrrolidine
1.3.9. Physiological Relevance
Dipeptidyl peptidase IV is involved in a number of different physiological regulation 
processes. On one hand the enzyme is a peptidase, which can change the activity of a 
number of peptide hormones, neuropeptides and chemokines in a very specific 
manner (Mentlein, 1999), while also this enzyme exerts protein-protein interactions, 
so mediating the regulation of intracellular signalling cascades independent of its 
peptidase activity (De Meester et al. 1999)
Dipeptidyl peptidase IV is involved in peptide degradation and amino acid scavenging 
at the intestinal and renal brush border membranes. Using gliadin, a proline rich 
protein, in feeding rats that were normal and genetically deficient in dipeptidyl 
peptidase IV, the control group maintained their weight, whereas the deficient group 
experienced a significant weight loss. The expression of dipeptidyl peptidase IV in the 
intestinal brush border was also seen to increase dramatically by feeding with a high 
proline containing diet (Tiruppathi et al. 1990).
This enzyme is also well known to modulate the biological activity of several peptide 
hormones, chemokines and neuropeptides by specifically cleaving N-terminal 
dipeptides. Various genetic and pharmacological studies have revealed a prominent
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physiological role for this regulatory enzyme. Marguet et al. (2000) showed that mice 
lacking the gene for dipeptidyl peptidase IV show enhanced insulin secretion and 
improved clearance of blood glucose partly due to increased levels of active 
glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide 
(GIP). These two peptide hormones are known as incretins and both are involved in 
potent stimulation of insulin release. It is well established that dipeptidyl peptidase IV 
rapidly cleaves the N-terminal dipeptide from these incretins, yielding truncated, 
biologically inactive GIP3 .42 and GLP-19.36. Type II diabetes is a disease characterised 
by elevated blood glucose levels and an insufficiency of insulin. Inhibition of 
dipeptidyl peptidase IV activity increases insulin secretion and improves glucose 
control in diabetic animals and humans. Therefore, modulation of dipeptidyl peptidase 
IV activity using specific inhibitors could be a feasible approach to managing Type II 
diabetes (Hoffman and Demuth, 2002).
Dipeptidyl peptidase IV (CD 26) is considered to be an activation factor on the 
surface of human T lymphocytes, where it is considered to participate in regulation of 
proliferation and differentiation of the lymphocytes and in production of cytokines 
(Reinhold et al. 1994).
Adenosine deaminase, an enzyme that metabolises extracellular adenosine is a known 
ligand of cell surface and soluble dipeptidyl peptidase IV. As extracellular adenosine 
inhibits T-cell proliferation in a dose dependent manner, it is likely that this inhibition 
is relieved by localization of adenosine deaminase to the cell surface by binding to 
dipeptidyl peptidase IV, so therefore association of ADA with DPIV/CD26 is possibly 
importantly involved in the ability of DPIV/CD26 to promote proliferation and 
cytokine production. (Gorrell et al. 2001).
Dipeptidyl peptidase IV is also reported to bind to the extracellular matrix 
components collagen and fibronectin, potentially modifying cell adhesion, migration 
and metastatic behaviour (Drucker, 2003).
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Peptide N-terminus Amino acids
Neuropeptide Y Try-Pro-Ser-Lys 36
Peptide YY Try-Pro-Ile-Lys 36
RANTES Ser-Pro-Tyr-Ser 68
IP-10 Val-Pro-Leu-Ser 77
Eotaxin Gly-Pro-Ala-Ser 74
Substance P Arg-Pro-Lys-Pro 11
Endomorphin 2 Tyr-Pro-Phe-Phe-NH2 4
Enterostatin Val-Pro-Leu-Ser 5
P-Casomorphin Tyr-Pro-Phe-Pro-Gly-Pro-Ile 7
GRF (1-44) amide Tyr-Ala-Asp-Ala 44
GIP Tyr-Ala-Glu-Gly 42
GLP-1 (7-36) amide His-Ala-Glu-Gly 30
GLP-2 His Ala-Asp-Gly 33
Table 1.7. Some Peptides Cleaved By Dipeptidyl Peptidase IV
Abbreviations: IP-10, interferon-inducible protein; GRF, growth hormone-releasing 
factor; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagons-like 
peptide 1; RANTES, regulated on activation normal T-cell expressed and secreted.
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1.4. Seprase
Seprase (surface expressed protease) is an N-glycosylated, type II transmembrane 
protein belonging to the small family of serine integral membrane peptidases (SIMP). 
These peptidases are inducible, specific for proline-containing peptides and 
macromolecules and active on the cell surface (Chen et al. 2003). Seprase shows up to 
52% homology to dipeptidyl peptidase IV and its essentially identical to fibroblast 
activation protein a  (FAPa) (Goldstein et al. 1997). Seprase/FAPa is therefore a 
member of the DPIV-like gene family (Abbott and Gorrell, 2002) grouped in 
subfamily S9B of the peptidase family S9 (prolyl oligopeptidase family), clan SC 
(Barrett et al. 1998). Even though all SIMP members are known to cleave prolyl 
peptide (Pro-Xaa) bonds, there are conflicting reports on possible dipeptidyl peptidase 
activity by seprase but its main distinguishing feature is its gelatinase activity 
(Pineiro-Sanchez et al. 1997).
1.4.1. Distribution and Purification
Seprase is not expressed in most normal adult tissues but is expressed and localised on 
cell surface invadopodia of human melanoma and carcinoma cells (Monsky et al. 
1984; Pineiro-Sanchez et al. 1997). Seprase has been purified mainly from cell 
membranes and shed vesicles of LOX human melanoma cells. Size exclusion 
chromatography (S-200) and affinity chromatography using wheat germ agglutinin 
(WGA)-agarose are two of the most widely used resins for seprase purification 
(Aoyama and Chen, 1990; Pineiro-Sanchez et al. 1997). Soluble forms and isoforms 
of these membrane proteases are beginning to be found in biological fluids, but their 
roles are poorly understood (Chen et al. 2003).
1.4.2. Activity Detection and Specificity
The most sensitive assay available to date for seprase detection involves gelatin 
zymography due to the established gelatinase activity associated with seprase, though 
this is not a quantitative assay. Kelly (1999) developed an assay based on the 
degradation of radiolabelled gelatin substrate and subsequent qualitative measurement 
of the released fragments.
Substrate specificity studies using zymography have shown that seprase degrades 
gelatin (Aoyama and Chen, 1990). Pineiro-Sanchez et al. (1997) examined possible
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extracellular matrix substrates, such as type I collagen, type IV collagen, laminin and 
fibronectin. Native collagens were not degraded by seprase, whereas thermally 
denatured collagens were digested into smaller polypeptides. Seprase did not degrade 
fibronectin or laminin. Also, based possibly on such homology in the catalytic 
domains of seprase and DP IV, seprase is reported (Chen et al. 2003) to possess prolyl 
dipeptidyl peptidase activity. In this case Ala-Pro-AFC was seen as a sensitive 
fluorogenic substrate. Interestingly, conflicting reports still exist with Pineiro- 
Sanchez et al. (1997) and Ghersi et al. (2002) reporting no such prolyl dipeptidyl 
peptidase cleavage. Therefore, seprase is classified as a gelatinolytic endopeptidase 
due to its specific cleavage of gelatin.
1.4.3. Structural and Biochemical Aspects
Goldstein et al. (1997) reported the molecular cloning of a cDNA that encodes the 
97kDa subunit of seprase. As with dipeptidyl peptidase IV, seprase is a homodimer 
containing N-glycosylated subunits. Its deduced amino acid sequence predicts a type 
II integral membrane protein consisting of a cytoplasmic tail of six amino acids, 
followed by a twenty amino acid transmembrane domain at the N- terminus, an N- 
glycosylation and cysteine rich domain and a 200 amino acid region at the C-terminus 
that contains the catalytic region (Goldstein et al. 1997; Pineiro-Sanchez et al. 1997). 
Its catalytic triad residues Ser624, Asp702 and His734 are contained within this catalytic 
region at the carboxyl end of each subunit (Goldstein and Chen, 2000). This order of 
the catalytic triad members, similar to dipeptidyl peptidase IV and prolyl 
oligopeptidase is characteristic of the a/p hydrolase fold secondary structure. 
Dimerisation of its inactive subunits is an essential structural requirement for seprase 
activity (Goldstein et al. 1997; Pineiro-Sanchez et a l 1997).
Seprase is an active homodimeric 170kDa membrane protease composed of 
proteolytically inactive 97kDa subunits. An isoelectric point (pi) of 5 is reported for 
this enzyme with optimum assay temperature being 37°C (Pineiro-Sanchez et al.
1997).
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1.4.4. Catalytic Classification
Seprase is a gelatinolytic endopeptidase due to its ability to degrade gelatin, giving 
this enzyme its distinct gelatinase activity. As mentioned, many reports claim seprase 
to have exopeptidase (prolyl dipeptidase) activity due to its ability to cleave dipeptidyl 
peptidase IV substrates such as Gly-Pro-AMC and Ala-Pro-AFC and its similar 
sequence homology in the catalytic region with this enzyme, but these reports are still 
to be clarified for this enzyme (Chen et al. 2003).
Initial classification studies showed that seprase was a serine protease sensitive to 
PMSF and the sulfhydryl-modifying agent NEM (Aoyama and Chen, 1990). Pineiro- 
Sanchez et al. (1997) showed that seprase is a serine protease by virtue of its 
inhibition by the serine protease inhibitors DFP, PMSF, APSF, AEBSF and by 
affinity-labelling with [3H] DFP. Molecular cloning of seprase revealed Ser624 as its 
catalytic serine residue (Goldstein et al. 1997).
Analysis of the deduced amino acid sequence of the seprase monomer revealed 52% 
homology to dipeptidyl peptidase IV (68% in the catalytic domain) and also that 
seprase is actually identical to fibroblast activation protein a  (FAPa). The conserved 
serine pro tease motif G-X-S-X-G is present as G-W-S-Y-G. Since the orientation of 
the residues of the catalytic triad of seprase is similar to members of the prolyl 
oligopeptidase family, along with its structural organization similarity to dipeptidyl 
peptidase IV this enzyme is classified as a nonclassical serine protease and grouped 
along with other serine integral membrane peptidases in the subfamily S9B, known as 
the DPIV gene family (Abbott and Gorrell, 2002).
1.4.5. Catalytic and Structural Mechanism
The catalytic triad members of seprase play an important role in its possible 
dipeptidyl peptidase activity and more importantly its gelatinase activity. This 
suggests a single active site for various proteolytic activities (Park et al. 1999). Also, 
seprase requires dimérisation to exhibit its gelatinase activity thereby showing a 
structural regulation of its protease activity, already seen previously with dipeptidyl 
peptidase IV.
Apart from the proteolytic or gelatinolytic activity of seprase, these serine integral 
membrane proteases have glycosylation and cysteine rich domains present in their 
structures. These structural features may function in recognition and binding to their
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substrates, such as peptides, macromolecules, other enzymes or themselves (Chen et 
al,. 2003).
1.4.6. Inhibitors and Physiological Relevance
There is no specific inhibitor for seprase yet reported, but Chen et al. (2003) describe 
inhibitor profiling of seprase to be identical with that of dipeptidyl peptidase IV. 
Therefore, most work on seprase activity to date report the use of active site directed 
inhibitors such as DFP and PMSF for inactivation of its proteolytic activity (Aoyama 
and Chen, 1990; Pineiro-Sanchez el al. 1997).
The main function of serine integral membrane peptidases such as seprase resides in 
their proteolytic and adhesive abilities, thus influencing cellular activities, migration 
and invasion. Accumulation of these proteases and their complexes at cell surface 
protrusions, called invadopodia may play a prominent role in processing soluble 
factors (such as chemokines, hormones, bioactive peptides) in addition to the well- 
established role of invadopodia degrading components of the extracellular matrix 
(ECM) (Chen et al. 2003).
Due to the ability of seprase to degrade extracellular matrix components, which is 
essential to the cellular migration and matrix invasion that occurs during tumour 
invasion and metastasis (Ghersi et al. 2002), it is thought to have a role in facilitating 
tumour cell progression (Aoyama and Chen, 1990). This role of seprase is further 
enhanced by reports of its over expression by invasive tumour cells (Monsky et al.
1994) a feature also observed in pathologic specimens of human breast cancer tissue 
by immunohistochemistry (Kelly et al. 1998). Non-toxic inhibitors of seprase could 
be valuable for clarifying the role of this membrane protease in tumour cell invasion.
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1.5. Oligopeptidase B
The oligopeptidase B (OpdB; EC 3.4.21.83) subfamily of serine peptidases represents 
one of two branches of the prolyl oligopeptidase family of serine peptidases. 
Previously called protease II, it is homologous to prolyl oligopeptidase, indicating that 
the tertiary structures of the enzymes are similar (Kanatani et al. 1991; Barrett and 
Rawlings, 1992). Oligopeptidase B was first isolated with trypsin-like substrate 
specificity from Escherichia coli cells, cleaving peptides at lysine and arginine 
residues (Pacaud and Richaud, 1975). Due to the ability of oligopeptidase B to cleave 
seemingly only low molecular weight peptides with a preferential specificity for Basic 
amino acid residues led to the name oligopeptidase B. Initial examples of this enzyme 
was restricted to prokaryotes which led to them receiving little attention, but more 
recently oligopeptidase B has been isolated, cloned and studied in trypanosomatids 
(Burleigh et al. 1997).
1.5.1. Distribution and Purification
Oligopeptidase B is a cytosolic enzyme (Pacaud and Richaud, 1975) only found in 
unicellular eukaryotes (kinetoplastid protozoan parasites), gram-negative bacteria, 
spirochetes and plants. To date, no oligopeptidase B enzymes has been isolated or 
cloned from mammalian cells. All life stages of the parasite Trypanosoma cruzi 
express oligopeptidase B (Burleigh et al. 1997), with T.cruzi oligopeptidase B often 
isolated from epimastigotes, which are a good source of the parasite (Burleigh and 
Andrews, 1995). The enzyme has been purified from a number of sources such as 
E.coli, T.brucei, T.cruzi and soybean seed (Pacaud and Richaud, 1975; Troeberg et al. 
1996; Ashall, 1990; Nishikata, 1984). Utilizing expression of the recombinant enzyme 
in E.coli systems is the most convenient method for preparation of the enzyme. This 
procedure was used for isolation of oligopeptidase B from the following sources, 
E.coli, T.brucei, T.cruzi, Moraxella lacunata and Salmonella enterica (Juhasz et al. 
2002; Morty et al. 1999; Burleigh et al. 1997; Yoshimoto et al. 1995; Morty et al.
2002). Despite the wide distribution of oligopeptidase B in nature, the physiochemical 
properties of the enzyme differ between sources (Tsuru and Yoshimoto, 1994).
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1.5.2. Biochemical and Structural Aspects
Pachaud and Richaud (1975) first estimated a molecular weight of about 58-110kDa 
for E.coli oligopeptidase B. Subsequent reports (Kanatani et al. 1991; Komblatt et al. 
1992; Morty et al. 2002) have deduced oligopeptidase B to be a monomeric protein of 
about 80kDa, except for soybean seed oligopeptidase B which has a molecular weight 
of 59kDa (Nishikata, 1984). Studies on the T.cruzi oligopeptidase B enzyme that was 
formerly known as alkaline peptidase (Ashall et al. 1990; Burleigh et al. 1995) 
revealed a molecular mass of 120kDa when active enzyme was applied under non­
reducing conditions to an SDS PAGE gel (Burleigh et al. 1995). When this enzyme 
was fully denatured, SDS PAGE analysis revealed a molecular mass of 80kDa; this 
along with gel filtration results on native and recombinant enzyme possibly reveals 
dimerization (Burleigh et al. 1997).
The idea that the catalytic site of oligopeptidase B may be accessible only to 
unstructured oligopeptides similar to prolyl oligopeptidase, led to the construction of a 
three-dimensional homology model for Escherichia.coli oligopeptidase B based on 
the structure of prolyl oligopeptidase (Gerczei et al. 2000). This model showed that 
the S2 binding site-contained residues Asp460 and Asp462 thus implicating them in 
directing P2 specificity. Recent site-specific mutagenesis studies (Morty et al. 2002) 
identified a pair o f glutamic acid residues, Glu576 and Glu578 which define Pi 
specificity and also a second pair of residues Asp460 and Asp462 as proposed by the 3D 
model, involved in directing P2 specificity. It is noteworthy that residue Glu576 
occupies the same steric position as Trp595 in prolyl oligopeptidase, which is known to 
interact with the Pi proline ring (Polgar, 2002a).
The order of the catalytic serine and histidine of oligopeptidase B is reversed with 
respect to that in trypsin and subtilisin but similar to prolyl oligopeptidase, thus 
indicating an unrelated three-dimensional structure (Polgar, 1992a).
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Source MW
kDa
Pi pH
optima
Temp. optima
(°C)
Reference
Escherichia.coli 81.858 5.2 8.0 45 Kanatani et al. 1991
Moraxella, lacunata 80 4.3 6.5 35 Yoshimoto e ta l  1995
Trypanosoma, cruzi 120 4.8-5.0 ND ND Burleigh and Andrews, 1995
Trypanosoma, brucei 80 ND 8-9.5 25 Troeberg et al. 1996
Soyabean seed 59 ND 8.5 ND Nishikata, 1984
Table. 1.8. Biochemical Properties of Oligopeptidase B from Various Sources
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1.5.3. Activity Detection
Spectrophotometric assays using N-benzoyl-DL-arginine-p-nitroanilide (Bz-Arg-pNA) 
were the first described by Pachaud and Richaud (1975) for the identification of 
oligopeptidase B (Protease II) hydrolysing activity from E.coli. Other chromogenic 
substrates for the E.coli enzyme were N-benzoyl-arginine-P-naphthylamide (Bz-Arg- 
PNA), releasing pNA which can be measured at 550nm (Tsuru and Yoshimoto, 1994; 
Kanatani et al. 1991). In these substrates mentioned above, arginine can be replaced 
with lysine but these enzymes prefer arginine to lysine in the Pi position (Ashall, 
1990). The more sensitive fluorimetric assays where AMC replaces pNA or pNA 
have also been employed (Shannon et al. 1982; Tsuru and Yoshimoto, 1994). The 
discovery that oligopeptidase B cleaves much faster peptides with two adjacent basic 
residues (Ashall et al. 1990; Polgar, 1997) has led to the widespread use of the 
substrate Z-Arg-Arg-AMC for the detection of oligopeptidase B from T.brucei (Morty 
etal. 1999).
1.5.4. Catalytic Classification
Oligopeptidase B is a serine endopeptidase which catalyses the hydrolysis of 
oligopeptides at the carboxyl side of basic amino acids, but is only slightly active 
towards high molecular mass peptides (Tsuru and Yoshimoto, 1994). The enzyme is 
classified as a serine protease due to its inhibition by diisopropyl fluorophosphate 
(DFP), leupeptin, antipain and N-tosyl-L-lysyl-chloromethylketone (TLCK). Even 
though oligopeptidase B resembles trypsin in that it’s classified as a serine protease, 
which cleaves peptide bonds on the carboxyl side of basic amino acids, it is distinctly 
different with regards to its specificity for oligopeptides and insensitivity to protein 
inhibitors of trypsin. Interestingly, oligopeptidase B is not a member of the SI family 
of trypsin proteases but shares a high degree of homology with prolyl oligopeptidase 
and hence have been classified as a member of the S9 family of serine proteases 
(Rawlings and Barrett, 1994). Oligopeptidase B from E.coli shows about 25% 
homology with prolyl oligopeptidase from porcine brain (Kanatani et al. 1991), while 
T.cruzi oligopeptidase B shows only 18% homology with porcine brain prolyl 
oligopeptidase (Burleigh et al. 1997). It is also shown that the sequence homology is 
greater in the peptidase domain, especially around the catalytic groups, than in the 
propeller domain (Barrett and Rawlings, 1992).
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Barrett and Rawlings (1992) postulated that the S9 prolyl oligopeptidase family 
contain a consensus sequence GxSxGGzz (where x is any residue and z is a 
hydrophobic residue) that includes the active site serine residue. Oligopeptidase B 
contains this consensus sequence, where the active site serine (Ser532) was identified 
using radiolabelled DFP for E.coli (Kanatani et al. 1991). The catalytic triad of 
oligopeptidase B from E.coli was deduced to be ser , Asp and His (Tsuru,
1998).
S. enter ica OpdB 
H e a fi  OpdB 
T. brueti OpdB 
T. cntzi OpdB 
A t\)*Intphiid POP 
F  meningoseptictm POP 
Pofcuw POP
& oturica  OpdB 
F- c&li OpdB 
T. bntrei OpdB 
T. em zi OpdB 
A hydwphila POP 
F. iMtungoseplicum POP 
Porcine POP
S. mterica OpdB
E. cali OpdB 
T. bntcei OpdB 
r. cruzi OpdB
A hydrophila POP
F. mningoiefHicufH POP 
Porcirtc POP
S. tiUeriea OpdB 
F- cali OpdB 
T. bntcei OpdB 
F. crua  OpdB 
A ■ hydrophila POP 
F. mawgosrptiai/ft POP 
PoTL'inc POP
S. tnttrica  OpdB 
F coii OpdB 
T. bntcei OpdB 
T. c m d  OpdB 
A, ftydmpliifa POP 
F. menitttoftpiicum POP 
Porcini POP
Figure 1.14. Catalytic Domain Homology of Oligopeptidase B and Prolyl 
Oligopeptidase
Multiple sequence alignment of the amino acid sequences of the catalytic domains from representatives 
of the OpdB and POP branches of the prolyl oligpeptidase family of serine peptidases. Sources of 
sequences are given in the legend to Fig. 1.14. Asterisks indicate the active-site serine, histidine and 
aspartic acid residues that constitute the catalytic triad.
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1.5.5. Catalytic and Structural Mechanism
Active site and substrate binding
The catalytic triad amino acids play a significant role in the catalysis of oligopeptidase 
B. This serine protease catalysis is similar to that explained in sections 1.2.6. In order 
to understand substrate binding and specificity of the active site of oligopeptidase B 
Morty et al. (2002) performed site directed mutagenesis on acidic residues conserved 
in oligopeptidase B but absent from prolyl oligopeptidase. This studied identified 
Glu576 and Glu578 being critically involved in the interaction of oligopeptidase B with 
the Pi substrate residue and direct its cleavage C terminal to basic residues. They 
proposed that the carboxyl groups of Glu576 and Glu578 direct Pi substrate specificity 
by electrostatic interaction with the charged side chains of Pi arginine or lysine in 
substrates. Given their close proximity (Figure. 1.14.) separated by a single tryptophan 
in the sequence they speculated the formation of a carboxyl dyad by these two 
glutamic acid residues that binds the basic substrate side chains. As mentioned in 
section 1.3.2., this idea is reinforced by the fact that Glu576 corresponds to Trp595 
(Figure. 1.14.) of porcine prolyl oligopeptidase, which directs Pi specificity of prolyl 
oligopeptidase for proline residues (Fulop et al 1998). Morty et al. (2002) also 
identified Asp460 and Asp462 as possibly being involved in defining P2 specificity and 
so direct preferential cleavage by oligopeptidase B after a pair of basic residues. This 
proposing the presence of a second carboxyl dyad formed by the side chains of Asp460 
and Asp462. These results correspond exactly with the report by Gerczei et al. (2000) 
explained in section 1.3.2. on their three-dimensional structure of oligopeptidase B.
It is also reported (Juhasz et al. 2002) that Tyr452 of oligopeptidase B, which 
corresponds to Tyr473 of prolyl oligopeptidase is a member of the oligopeptidase B 
oxyanion binding site (Figure. 1.14.).
The observations that oligopeptidase B is unable to hydrolyse proteins (Polgar, 1997) 
could suggest a similar catalytic mechanism as shown in prolyl oligopeptidase (Fulop 
el al. 1998) where the catalytic triad is located in a tunnel like cavity, thus impeding 
the access of proteins to its catalytic site.
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Kinetic properties of catalysis
The reactions of oligopeptidase B are sensitive to ionic strength especially substrates 
containing arginines in positions Pi and P2. The rate is often seen to decrease by one 
order of magnitude by addition of 1M NaCl. The reactions are very sensitive in 
regions of low ionic strength and more reproducible rate constants can be measured at 
high ionic strength. The rate constant for Z-Arg-Arg-AMC one of the best substrates 
is 63|iM'1S"1 at low ionic strength. It is now known that the inhibition of hydrolysis at 
high ionic strength (decrease in rate constant) is caused by disruption of the 
electrostatic interactions between substrate arginines and enzyme carboxyl groups. 
This is caused by an elevation in Km due to reduced binding of substrate, which in 
turn decreases the specificity rate constant Kcat/Km (Polgar, 1997).
The importance of the positive charge of arginine was studied by using a neutral, 
structurally similar citrulline derivative. The very low rate constant observed while 
using this substrate indicated that the positive charge of arginine is essential for 
catalysis (Polgar, 1999).
In serine protease reactions the catalytic serine OH group attacks the substrate 
carbonyl carbon atom, with this process being assisted by general base catalysis 
afforded by the catalytic histidine side chain. The resulting tetrahedral intermediate 
then decomposes by general acid catalysis by the protonated histidine. These general 
acid/base catalysed reactions are commonly rate limiting in the classic serine 
proteases. General acid-base catalysed reactions proceed faster by a factor of 2-3 in 
water than in heavy water. The kinetic deuterium isotope effect indicated that general 
acid/base catalysis is not rate limiting in oligopeptidase B reactions. Therefore a rate- 
limiting conformational change induced by substrate binding as reported for prolyl 
oligopeptidase is also the rate-limiting step in oligopeptidase B catalysis (Polgar,
1997).
1.5.6. Substrate Specificity and Inhibitors
Oligopeptidase B of trypanosoma and prokaryotic organisms show both similar and 
strict specificity. Oligopeptidase B will only hydrolyse peptide substrates at the 
carboxyl end of basic amino acid residues (Arginine or Lysine) in the Pi position. No
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cleavage will occur with substrates of the general sequence H-Arg-Xaa or H-Lys-Xaa 
unless a blocking group (Cbz, Z) is placed at the N-terminus. Arginine appears to be 
the preferred Pi residue. Many different residues can be accommodated in the P2 
position such as aromatic (Phe), hydrophobic (Val), hydrophilic (Thr), small 
uncharged (Gly) and proline. Ultimately though there is a preference for cleavage of 
substrates with basic amino acids at the P2 position aswell as the Pi. It has actually 
been shown that oligopeptidase B hydrolyzes peptides with dibasic sites much faster 
than monobasic substrates with both argininie and lysine equally acceptable in the P2 
position (Polgar, 1997). An influence of the P3 residue on substrate hydrolysis is also 
reported (Ashall et al. 1990), while the Pi' position can accommodate all amino acids 
residues including proline (Tsuru, 1998).
The substrate size limitation of oligopeptidase B restricts its action to low-molecular 
mass (< 3kDa) peptides (Kanatani et al. 1991; Polgar, 1997; Troeberg et a l 1996; 
Yoshimoto et al. 1995). In addition to these oligopeptide substrates, restricted 
proteolysis of histone proteins was discovered, though no cleavage was detected at or 
near residues that had been posttranslationally modified or at defined secondary 
structures (Morty et al. 2002).
There are little reports available of specific and potent inhibitors of oligopeptidase B. 
Commonly used trypanocidal drugs inhibit oligopeptidase B from the African 
trypanosome, Trypanosoma brucei (Morty et al. 1998). These serine protease 
inhibitors namely pentamidine, diminazene and suramin reversibly inhibited 
oligopeptidase B in vitro. In the case of pentamidine and suramin the inhibition of 
oligopeptidase B in vivo may be of significant importance. Structurally, the 
pentamidine molecule represents two benzamidine molecules joined together, 
resembling a pair of basic amino acids (arginine residues) in a dipeptide, thus possibly 
mimicking potential oligopeptidase B substrates. Pentamidine resulted in competitive 
inhibition with a Ki of 3.4|jM for oligopeptidase B.
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1.5.7. Physiological Importance
Oligopeptidase B is well known to be actively present in protozoan parasites, such as 
Trypanosoma cruzi, the causative agent of chagas disease in humans (Burleigh and 
Andrews, 1998) and in the African trypanosomes that produce the diseases nagana 
and sleeping sickness in cattle and human respectively (Troeberg et al. 1996; 
Lonsdale et al. 2002).
It has been demonstrated that oligopeptidase B from Trypanosoma brucei is capable 
of cleaving biologically active peptides in vitro (Troeberg et al. 1996). Oligopeptidase 
B activity correlates with blood parasitemia levels and it was reported that live 
trypanosomes do not release oligopeptidase B in vitro but that it is released by dying 
parasites into the host bloodstream, where it remains stable and catalytically active. It 
may therefore contribute to the pathogenesis of nagana and sleeping sickness through 
degradation of biologically active peptides in the bloodstream of infected hosts 
(Morty et al. 2001). Also administration of irreversible oligopeptidase B inhibitors to 
trypanosome infected mice significantly impaired disease progression (Morty et al.
1998).
Mammalian cell invasion by the intracellular protozoan parasite Trypanosoma cruzi is 
mediated by recruitment and fusion of host cell lysosomes, an unusual process that 
has been proposed to be dependent on the ability of parasites to trigger intracellular 
free calcium concentration ([Ca2+]) transients in host cells (Caler et al. 1998; Burleigh 
and Woolsey, 2002). Oligopeptidase B has been proposed as the enzyme possibly 
responsible for the generation of a Ca2+ signalling agonist from a cytosolic precursor 
molecule for mammalian cells (Burleigh and Andrews, 1995; Burleigh et al. 1997; 
Caler et al. 1998). Inhibition of oligopeptidase B activity using protease inhibitors 
(Burleigh and Andrews, 1995) or by specific antibodies to recombinant oligopeptidase 
B (Burleigh et al. 1997) results in loss of Ca2+ signalling.
The role of oligopeptidase B in E.coli and other prokaryotic cells is still not known. It 
has been suggested by Polgar (1997) that oligopeptidase B in prokaryotic cells may be 
a specialized processing enzyme due to its extremely efficient cleavage of peptides at 
paired basic sites, but to date its natural substrate remain unknown.
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#
Figure 1.15. A Model for T. cruzi Oligopeptidase B-Mediated Signalling in 
Manunalian Cells
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1.6. Acylaminoacyl Peptidase
Acylaminoacyl peptidase (EC 3.4.19.1) is an omega-peptidase that catalyses the 
removal of an N-acylated amino acid from blocked peptides (Jones et al. 1994). It has 
also been referred to by the names acylpeptide hydrolase (Gade and Brown, 1978), 
acylaminoacid-releasing enzyme (Mitta et al. 1989) and as of now usually 
acylaminoacyl peptidase (Radhakrishna and Wold, 1989).
1.6.1. Distribution and Purification
Acylaminoacyl peptidase is a cytosolic enzyme that is present in all tissues but is 
absent from small cell lung carcinoma. Due to its wide distribution in tissues it has 
been isolated and subsequently purified to homogeneity from a number of sources. 
The enzyme has been purified from bovine liver (Gade and Brown, 1978), Rabbit 
muscle (Radhakrishna and Wold, 1989), human erythrocytes (Jones et al. 1994) and 
porcine intestine mucosa (Raphel et al. 1999).
Ammonium sulphate precipitation is widely used as the initial step in the isolation of 
acylaminoacyl peptidase from tissue source. It proved to be very effective in 
removing bulk-contaminating protein from the soluble extract with up to 85% 
recovery of applied peptidase activity (Gade and Brown, 1978; Radhakrishna and 
Wold, 1989). Conventional chromatographic techniques such as anion exchange and 
gel filtration chromatography are the two most widely used techniques reportedly 
employed for the purification of acylaminoacyl peptidase. Radhakrishna and Wold, 
(1989) obtained a 7000-fold purification using anion exchange and the gel filtration 
resin S-300 twice. Whereas Jones et al. (1994) employed a double anion exchange 
step along with S-300 gel filtration for the purification of acylaminoacyl peptidase 
from human erythrocytes. This use of a second anion exchange step during 
purification was also reported by Gade and Brown (1978).
Apart from isolation of acylaminoacyl peptidase from mammalian tissue, Ishikawa et 
al. (1998) purified the enzyme from the Archaeon Pyrococcus horikoshii and cloned 
and expressed it in Escherichia coli.
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1.6.2. Biochemical and Structural Aspects
The enzyme is a homotetramer composed of four identical subunits giving a total 
molecular mass of about 300kDa. The pi is reported to be acidic with a value of 4.0 
(Scaloni et al. 1994). The enzyme is active over a wide pH of ~ 4.5-9.0. Rabbit 
muscle acylaminoacyl peptidase was reported to have a pH optimum of 6.9 whereas 
the enzyme from bovine liver resulted in a pH optimum of 8.2.
The complete primary amino acid sequence of rat, porcine and human acylaminoacyl 
peptidase has been reported (Kobayashi et al. 1989; Mitta et al. 1989; Scaloni et al.
1999). They are all 732 amino acids in length and having over 90% homology with 
each other. The primary structure revealed that the N-terminus methionine is 
acetylated and that all cysteine residues are present in a reduced form (Miyagi et al.
1995). The crystal structure of this protein and preliminary x-ray studies has been 
reported (Feese et al. 1993) but to date no three-dimensional structure is available. 
The linear arrangement of the catalytic triad amino acids as nucleophile-acid-base in 
the secondary structural organization of the protease domain of this enzyme is 
consistent with a/p hydrolase fold (Scaloni et al. 1999). Durand et al. (2003) reported 
a three-dimensional model of porcine intestine acylaminoacyl peptidase consisting of 
a P-propeller in the N-terminus aswell as a C-terminal catalytic domain with an a/p 
hydrolase fold.
As well as isolation from eukaryotic cells, acylaminoacyl peptidase has been purified 
and cloned from the archaeon Pyrococcus horikoshii. This enzyme is only 632 amino 
acid residues in length and appears to be a dimer rather than a tetramer. A 
modification in the protein structure was seen to occur when incubated at 95°C for a 
few hours (Ishikawa et al. 1998).
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1.6.3. Substrate Specificity and Activity Detection
Acylaminoacyl peptidase catalyses the hydrolysis of N-terminus acylated peptide 
substrates of various sizes and containing different types of acyl groups (acetyl, 
chloroacetyl, formyl and carbamyl) to generate an acylamino acid and a peptide with 
a free NH2 terminus that is shortened by one amino acid as below (Radharishka and
Wold, 1989).
I
Acyl-xxi-xx2- ...xxn —» acyl-xxi + XX2- ... xxn
The rates of hydrolysis of different blocked peptides vary considerably, depending on 
the nature of the first (Pi) and second (Pi') amino acids. Thus acylaminoacyl 
peptidase cleaves primarily Ac-Ala, Ac-Met, Ac-Ser in peptides with neutral side 
chains. If the side chain of the Pi' or the P2' amino acid residues is charged the rate of 
cleavage is reduced. A proline residue at either side of the scissile bond abolishes 
activity (Jones and Manning, 1988; Radhakrishna and Wold, 1989; Sokolik et al. 
1994). It is well known that acylaminoacyl peptidase has a preference for hydrolysis 
of oligopeptides due to its inability to cleave N-blocked proteins. The optimum length 
of the blocked peptide substrate is 2-3 amino acids with a decrease in activity 
apparent with increasing chain length (Manning, 1998).
Acetylalanine-pnitroanilide is the most commonly used substrate for activity detection 
(Jones et al. 1994).
1.6.4. Catalytic Classification
Due to the ability of acylaminoacyl peptidase to remove N-acetylated N-terminal 
residues from oligopeptides, classifies it as an exopeptidase. This enzyme is a serine 
protease due to inactivation by modification of Ser587 by DFP (Scaloni et al. 1992). 
Further active site studies identified His707 using a radiolabelled chloromethyl ketone 
as a second active site residue. The third member of the triad was identified as Asp675 
by Mitta et al. (1998) using site directed mutagenesis. When the complete primary 
sequence of acylaminoacyl peptidase was discovered no resemblance to the known 
classic serine peptidase was noted. A similarity in the sequences around the active site 
serine residue and the order of the catalytic triad of this enzyme was evident with
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other oligopeptidases. It was classifed as a member of the prolyl oligopeptidase 
family of oligopeptidases (Rawlings et al. 1991; Barrett and Rawlings, 1992). It is 
highly likely there is an overall similarity in the three-dimensional structure of this 
enzyme to other known members of this family.
1.6.5. Catalytic Mechanism
The catalytic triad residues will govern catalysis of acylaminoacyl peptidase. The 
sensitivity of the catalytic activity of this peptidase to various thiol reagents is very 
similar to the role played by Cys255 in possibly regulating the activity of prolyl 
oligopeptidase (see section 1.2.6.). As with prolyl oligopeptidase this sensitivity to 
thiol reagents can be explained by their size. The larger p-hydroxymercuribenzoate 
(pHMB) or N-ethylmaleimide (NEM) can inhibit activity completely but the smaller 
iodoacetamide only partially under the same conditions. As with prolyl oligopeptidase 
it is postulated that the larger pHMB or NEM will react with a cysteine residue near 
the active site and block substrate entry, whereas the smaller iodoacetamide only 
partially blocks entry (Scaloni et al. 1994).
Kinetic properties
As mentioned the activity of acylaminoacyl peptidase can be assayed with 
acetylalanine-pnitroanilide as substrate (Jones el al. 1994). The enzyme exhibits 
different pH optima depending on the substrate used. For acetylglutamate- 
pnitroanilide the pH optima is 6.0, whereas for acetylalanine-pnitroanilide its 8.4. 
Also, Ac-Ala-Ala-OH and Ac-Ala-Ala-Ala-OH are better substrates than Ac-Ala- 
pNa, though pNa is a better leaving group than an amino acid. Ac-Ala-OH was 
reported to be a product like inhibitor (K of 0.4mM) being higher than Ac-D-Ala-OH 
(K  of 17mM) (Raphael et al. 1999).
1.6.6. Inhibitors and Physiological Relevance
Apart from active site directed inhibitors such as DFP and some chloromethyl 
ketones, very few specific acylaminoacyl peptidase inhibitors are reported. Scaloni et 
al. (1992) have used blocked amino acids to great effect for peptidase inhibition. They 
report one of their most efficient inhibitors was acetyl-L-valine giving an IC50 of 
100|jM. Transition state analog inhibitors are also very good competitive inhibitors of
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acylaminoacyl peptidase. Phenyl-n-butylborinic acid gave a Ki of 22\iM  for this 
enzyme (Scaloni etal. 1994).
The exact physiological role of this enzyme is still largely unknown. It possibly plays 
a role in the catabolism of N-acetylated proteins, which are abundant in living cells, 
after action of possible endopeptidases in the release of N-acetylated peptides 
(Richards et al. 2000). The blocked 13-residue peptide a-melanocyte stimulating 
hormone (aMSH) is a substrate of acylaminoacyl peptidase. It may play a role in the 
regulation of this peptide hormone (Manning, 1998).
Deficiency in expression of acylaminoacyl peptidase is reported in small-cell lung 
carcinomas and renal carcinomas. It is still unknown the potential role, if  any, the 
peptidase plays in the malignant state of these cell lines (Jones et al. 1991; Polgar, 
2002a).
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MATERIALS and METHODS
2.1. Materials
Sigma Chemical Company (Poole, Dorset.
2-Mercapto ethanol 
7-Amino-4-Methylcoumarin 
Acetic Acid (HPLC grade)
Acetonitrile (HPLC grade)
Acetonitrile (Spectranal grade) 
Acrylamide/bis-Acrylamide solution 
Ala-AMC
Ammonium Acetate (HPLC grade)
Ammonium Persulphate
Ammonium Sulphate
Arg-AMC
Biuret Reagent
Blotting Paper
Bovine Serum Albumin
CAPS
Cellulose Dialysis Tubing 
Cellulose Type 50 
Cibacron Blue 3 GA 
Colorburst Electrophoresis Markers 
DFP
Dithiothreitol
EDTA
Formaldehyde
England):
Formic Acid 
Glacial Acetic Acid 
Glycine
High Range MW Markers 
Hydrochloric Acid 
Methanol (HPLC grade)
Phenyl Sepharose CL-4B 
Potassium Phosphate (dibasic) 
Potassium Phosphate (monobasic) 
Protein G agarose 
Pro-AMC
Sample Buffer, Laemmeli 
SDS
Silver Nitrate
Sodium Carbonate
Sodium Chloride
Sodium Phosphate (Dibasic)
Sodium Phosphate (Monobasic)
Sodium Thiosulfate
TEMED
Thioglycolic Acid 
Trifluoroacetic Acid 
Trizma Base
BDH Chemicals Ltd. (Poole, Dorset, England):
Bromophenol Blue Glycerol
Calcium Chloride
66
Bio-Rad Laboratories (Hercules, California, USA):
Coomassie Blue Stain PVDF Membrane
Coomassie Destain
Bachem AG (Bebendorf, Switzerland):
Z-Gly-Pro-AMC 
Z-Phe-Arg-AMC 
Z-Arg-Arg-AMC 
Pyr-His-Pro-AMC 
Gly-Pro-AMC 
Lys-Ala-AMC 
Z-Arg-AMC 
Leu-AMC
Pierce Chemical Company (Illinois, USA):
BCA Reagent Gelcode Blue Stain
Coomassie Plus Assay Reagent
Merck Chemical Company (Frankfurt, Germany):
Sodium Hydroxide
Pharmacia-Biotech (Uppsala, Sweden):
Hiprep 16/16 Sephacryl S300 Gelatin Sepharose
Keypaks Meats (Clonee, Co. Meath, Ireland):
Bovine Whole Blood
School of Biotechnology, Dublin City University:
Ethanol
Central Pharmaceutical Research Institute (Japan, Courtesy of Dr. K. Toide):
JTP-4819
Lys-AMC
Pyr-AMC
Glu-Phe-AMC
Z-Gly-Pro-Ala
Gly-Gly-Pro-Ala
Z-Pro-Phe
Z-Gly-Pro
Z-Gly-Leu
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(Dublin, Ireland):
Z-Gly-Pro-Phe-His
Z-Gly-Pro-Phe-His-Arg
Z-Gly-Pro-Phe-His-Arg-Ser
Z-Gly-Pro-Met-His
Z-Gly-Pro-Met-His-Arg
The Royal College of Surgeons
Z-Gly-Pro-Phe 
Z-Gly-Pro-Met 
Z-GIy-Pro-Ser 
Z-Gly-Pro-Tyr 
Z-Gly-Pro-Leu 
Z-Gly-Pro-Glu 
Z-Gly-Pro-His
Probiodrug AG (Halle, Gennany):
Anti-human PEP antibody (S449) 
Anti-actin antibody 
Human glioma cell line U343 
Neuroblastoma cell line SH-SY5Y 
Rat Cortex
Z-Gly-Pro-Met-His-Arg-Ser
Z-Gly-Leu-Phe-His
Fmoc-Ala-PyrrCN 
Z-Phe-Pro-BT 
SR 063298 
SR 063125
68
2.2. Protein Standard Curves
2.2.1. Biuret Assay
The Biuret assay was used to monitor protein in post column chromatography 
fractions and also to quantify protein in crude serum and post chromatography active 
enzyme pooled sample containing greater than 2mg/ml protein. For protein 
quantification, all samples were dialysed into ultra-pure water and diluted 
appropriately to achieve a concentration suitably determinable by the assay. Bovine 
serum albumin (BSA) standards (2-10mg/ml) were prepared and assayed in triplicate 
along with the pooled active enzyme samples as above. Absorbances were determined 
at 540nm using a Techan Spectra Plate Reader.
2.2.2. Standard BCA Assay
The standard bicinchoninic acid (BCA) assay was used for protein monitoring and 
quantification in post column chromatography fractions and pooled samples 
containing less than 2mg/ml of protein. Samples were prepared as outlined in section
2.2.1 and BSA standards in the range 0-2mg/ml were included. 25jxl of standard or 
sample was added in triplicate with 200|il of BCA reagent at 37°C for 30 minutes. 
Absorbances were read at 570nm.
2.2.3. Coomassie Plus Assay
The coomassie plus protein assay was used to monitor and quantify protein 
concentration in post column chromatography fractions and pooled samples 
containing between 2.5 and 25[ig/ml. Samples were prepared as outlined in section
2.2.1 and BSA standards in the range 2.5-25|a.g/ml were included. 150(4,1 of standard 
or sample was added in triplicate to 150(j,l of coomassie plus reagent, allowed stand at 
room temperature for 5 minutes and finally read at 595nm.
2.3. Fluorescence Spectrometry using 7-Amino-4-Methyl-Coumarin (AMC)
2.3.1. AMC Standard Curves
lOOfiM stock AMC solution containing 4%v/v methanol was prepared in lOOmM 
potassium phosphate, pH 7.4. All lower AMC concentrations were obtained using
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lOOmM potassium phosphate, pH 7.4 containing 4%v/v methanol as diluent. Stock 
solution and standards were stored in the dark at 4°C for up to one month. Standard 
curves in the range 0-5 (jM and 0-20pM AMC were prepared in triplicate by 
combining 100(0.1 of lOOmM potassium phosphate pH 7.4, 400(il of appropriate AMC 
concentration and 1ml of 1.5M acetic acid. Fluorimetric analysis of these samples was 
achieved using a Perkin Elmer LS50 Fluoresence Spectrophotometer at excitation and 
emission wavelengths of 370nm and 440nm respectively. Excitation slit widths were 
maintained at lOnm while emission slit widths were adjusted accordingly for the 
range being analysed.
2.3.2. Inner Filter Effect
The inner filter or quenching effect of enzyme samples was determined by combining 
100(il of enzyme sample, 400jal appropriate AMC dilution and finally 1.5M acetic 
acid. The filtering effect of crude serum samples was assessed in the presence and 
absence of 2.5xl0'4M JTP-4819* in 10%v/v MeOH. The samples were all assayed in 
triplicate as described in section 2.3.1.
Note: Even though the peptidase under study is named ZIP (Z-Pro-prolinal 
Insensitive Peptidase), JTP-4819, which is also a potent and specific inhibitor of 
prolyl oligopeptidase, is used throughout this work for distinguishing between these 
peptidases. This is due to the unavailability of Z-Pro-prolinal.
2.4. Enzyme Assays
2.4.1. Substrate Preparation
Both Prolyl Oligopeptidase (PO) and Z-Pro-prolinal Insensitive Peptidase (ZIP) 
activities were determined using the fluorimetric substrate Z-Gly-Pro-AMC, with 
modification of the original protocol of Yoshimoto et al. (1979). lOmM Z-Gly-Pro- 
AMC stock was prepared in 100% methanol, aliquoted and stored at -20°C. 100|jM 
substrate containing 4%v/v MeOH was prepared by adding slowly 300 ,^1 MeOH and 
100(4.1 Z-Gly-Pro-AMC stock to 9.6mls of lOOmM potassium phosphate, pH 7.4 at 
37°C. Prolyl Oligopeptidase activity was determined with lOmM DTT in the above 
substrate, while for determination of ZIP activity 500mM NaCl was included.
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2.4.2. Quantitative Z-Gly-Pro-AMC Degrading Activity Measurements.
400(0.1 of the lOOjjM substrate was added to 1 OOp.1 enzyme sample in triplicate and 
incubated at 37°C for 60mins. Both samples and substrate were preincubated at 37°C 
to allow them reach thermal equilibrium. Reactions were terminated by the addition 
of 1ml of 1.5M acetic acid. Blanks or negative controls were prepared by adding 1ml 
of 1.5M acetic acid to 100^1 of enzyme sample prior to substrate addition and 
incubation at 37°C for 60mins. Formation of AMC was measured as described in 
section 2.3.1. End point measurements were allowed, as the enzyme assay was linear 
with respect to time and enzyme concentration up to 60mins. Fluorimetrie intensities 
observed were converted to nanomoles AMC released per minute per ml using the 
appropriate standard curve as outlined in section 2.3.2. Enzyme units were defined as 
nanomoles of AMC released per minute at 37°C.
2.4.3. Quantitative Z-Pro-prolinal Insensitive Z-GIy-Pro-AMC Degrading 
Activity Measurement.
Section 2.4.2 describes the determination of ZIP activity in situations where it was 
most certainly separated from prolyl oligopeptidase activity. In crude bovine serum, 
ZIP activity had to be distinguished from PO activity so the following assay 
modifications were necessary. 100fa,l of enzyme sample was pre-incubated for 15 
minutes at 37°C with 20(j,l of 2.5x10“4M JTP-4819 in 10%v/v MeOH prior to 
substrate addition. Negative controls were also included as in section 2.4.2 
incorporating JTP-4819 and determinations were carried out in triplicate. AMC 
released was determined fluorimetrically as in section 2.3.1. with end point 
measurements taken as in section 2.4.2. Fluorimetrie intensities obtained for each 
sample were converted to nanomoles of AMC released per minute per ml using the 
standard curves incorporating JTP-4819, prepared as outlined in section 2.3.2. 
Enzyme units were defined as nanomoles of AMC released per minute at 37°C.
2.4.4. Non-Quantitative Z-GLy-Pro-AMC Degrading Activity Measurements.
A non-quantitative fluorimetrie microtitre plate assay was developed to assist in the 
rapid identification of Z-Gly-Pro-AMC degrading activities in post-column 
chromatography fractions. 200^1 of lOO^M Z-Gly-Pro-AMC in 4% MeOH containing 
500mM NaCl or lOmM DTT, at 37°C was added to 100^1 of sample in each well.
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Post phenyl sepharose fractions were assayed in the presence and absence of 20ial 
2.5x10'4M JTP 4819 in 10% MeOH. The microtitre plate was incubated at 37°C for 
30 minutes. AMC released was determined fluorimetrically as outlined in section
2.3.1. using the Perkin Elmer LS-50B plate reader attachment.
2.5. An Optimised Purification Procedure for Bovine Serum ZIP.
Purification steps were all carried out at 4°C apart from the final size exclusion 
column, which was performed using FPLC at room temperature.
2.5.1. Bovine Serum Preparation.
Bovine whole blood was collected from a freshly slaughtered animal and stored at 
4°C over 24 hours to allow clot formation. The remaining un-clotted whole blood was 
decanted and centrifuged at 6000rpm for 1 hour at 4°C using a Beckman J2-MC 
centrifuge fitted with JL-10.5 rotor. The supernatant and loose cellular debris was 
decanted and re-centrifuged at 20,000rpm for 15mins using a JL-20 rotor. The final 
serum was collected and stored at -17°C in 20ml aliquots.
2.5.2. Phenyl Sepharose Hydrophobic Interaction Chromatography.
A 20ml Phenyl Sepharose CL-4B hydrophobic interaction column (2.5cm x 7cm) was 
equilibrated with 100ml of lOOmM potassium phosphate containing 200mM 
ammonium sulphate, pH 7.4. Solid ammonium sulphate was dissolved in 20ml of 
bovine serum to give a final concentration of 200mM. This sample was then applied 
to the equilibrated column followed by a 100ml wash with lOOmM potassium 
phosphate containing 200mM ammonium sulphate, pH 7.4. The column was then 
washed with 100ml of lOOmM potassium phosphate containing 50mM ammonium 
sulphate, pH 7.4. Bound protein was eluted isocratically with a lOOml ultra-pure 
water wash. Equilibration of the column was carried out at a flow rate of lml/min, 
while all other steps were performed at 2ml/min. 5 ml fractions were collected 
throughout the procedure and were assayed for ZIP activity according to section 2.4.4. 
Protein content in each fraction was determined using the biuret assay according to 
section 2.2.1. Fractions containing ZIP activity were pooled to yield post phenyl 
sepharose ZIP and enzyme activity and protein content was quantified using the
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fluorimetric assay as outlined in section 2.4.2 and the biuret assay as in section 2.2.1. 
The phenyl sepharose resin was regenerated with a 100ml wash of pure ethanol at 
0.5ml/min, followed by 150ml of equilibration buffer.
2.5.3 Calcium Phosphate Cellulose Chromatography.
2.5.3.1. Resin Preparation
11 of 500mM sodium hydrogen phosphate was added (at 6.4ml/min) to 1.51 of 
constantly stirred 500mM calcium chloride at room temperature. Following a 15min 
agitation, 1.5ml of concentrated ammonia solution was added and stirred for a further 
10min. The precipitated gel was allowed to settle and the supernatant decanted and 
discarded. 11 of ultra-pure water was added and the stirring continued for 5min. 
Settling and decanting was performed and this procedure was repeated until the gel 
was washed with 101 of ultra-pure water. The washed calcium phosphate gel was 
stored in 11 of ultra-pure water at 4°C. 10g Sigma cellulose type 50 was soaked 
overnight in 200ml 500mM potassium phosphate containing 150mM potassium 
chloride, pH 6.8. The cellulose was washed eight times with ultra-pure water and 
dried overnight at 70°C. 2g washed and dried cellulose was dissolved in 20ml 20mM 
potassium phosphate, pH 7.5 and added to 24ml of evenly suspended calcium 
phosphate gel. The calcium phosphate cellulose was poured into a column (2.5 x 
7.0cm) and allowed to settle yielding 15ml of packed resin.
2.5.3.2. Column Chromatography
The column was equilibrated at lml/min with lOmM potassium phosphate, pH 7.4. 
The post phenyl sepharose ZIP was concentrated to 10ml and applied to the column 
followed by a 100ml wash with 1 OmM potassium phosphate, pH 7.4. The column was 
then washed with 100ml of 170mM potassium phosphate, pH 7.4. Bound protein was 
eluted with 100ml of 500mM potassium phosphate, pH 7.4. Loading and washing 
steps were performed at lml/min, while elution was performed at 2ml/min. 5ml 
fractions were collected throughout the procedure, and again were assayed for ZIP 
activity according to section 2.4.4. Protein content in each fraction was determined 
using the standard BCA assay as outlined in section 2.2.2. Fractions containing ZIP
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activity were pooled to yield post calcium phosphate cellulose ZIP. En/.yme activity 
and protein content were then quantified as outlined in section 2.4.2. and 2.2.2.
2.5.4. Cibacron Blue 3GA Chromatography.
100ml of 20mM potassium phosphate, pH 7.4 was used to equilibrate a 20ml 
Cibacron blue 3GA resin. The post calcium phosphate cellulose ZIP was concentrated 
and then dialysed overnight against 21 of 20mM potassium phosphate, pH 7.4. After 
sample application the column was washed with 100ml of 20mM potassium 
phosphate, pH 7.4 to remove any unbound protein. Elution was performed using a 
100ml linear 0-2M NaCl gradient in 20mM potassium phosphate, pH 7.4. Loading, 
washing and elution were all performed at lml/min. 5ml fractions were collected and 
assayed for ZIP activity according to section 2.4.4. Protein content in each fraction 
was determined using coomassie plus protein reagent as in section 2.2.3. Fractions 
containing ZIP activity were pooled and enzyme activity and protein content were 
quantified as outlined in section 2.4.2. and 2.2.3.
2.5.5. Sephacryl S-300 Size Exclusion Chromatography.
A 16/60 S-300 size exclusion chromatography column was attached to a fast protein 
liquid chromatography system. The column was equilibrated at 0.8ml/min with 250ml 
of lOOmM potassium phosphate containing 150mM NaCl, pH 7.4. The post cibacron 
blue 3GA ZIP pool was concentrated to 2ml and applied to the column followed by a 
150ml wash with equilibration buffer at 0.8ml/min. 5ml fractions were collected and 
assayed for ZIP activity as outlined in section 2.4.4. Protein content in each fraction 
was monitored online at 280nm and also using coomassie plus protein reagent as 
outlined in section 2.2.3. Fractions containing ZIP activity were pooled and enzyme 
activity and protein content were quantified as in section 2.4.2 and 2.2.3.
2.6. Assessment of Purity of Purified Bovine Serum ZIP.
2.6.1. Fluorimetric Assays
Purified ZIP activity was assayed in the presence of various fluorimetric substrates to 
assess the enzymatic purity of the sample. The substrates used and the peptidase 
activity they are most commonly used to detect are outlined in Table 2.1. 1ml of each
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substrate was prepared as a lOmM stock in 100% MeOH. 50/al of each substrate and 
150(0.1 MeOH was added to lOOmM potassium phosphate, pH 7.4 at 37°C to a final 
volume of 5ml. This yielded a final substrate concentration of 100|jM in 4%v/v 
MeOH. As a positive control, ZIP activity was assayed in the presence of lOOpM Z- 
Gly-Pro-AMC in 4%v/v MeOH containing no NaCl. Assays were performed 
according to section 2.4.2.
Fluorimetric Substrate Cleavage Detected by
Z-Phe-Arg-AMC Plasma Kallikrein, Cathepsin B 
Cathepsin L, Papain 
Oligopeptidase B
Z-Arg-AMC Trypsin, Papain
Z-Gly-Pro-AMC Prolyl oligopeptidase, ZIP
Ala-AMC Alanine aminopeptidase
Arg-AMC Arginine aminopeptidase
Leu-AMC Leucine aminopeptidase
Lys-AMC Aminopeptidase B
Pro-AMC Proline aminopeptidase
Gly-Pro-AMC Dipeptidyl Peptidase IV
Glu-Phe-AMC Chymotrypsin
Pyr-AMC Pyroglutamyl aminopeptidase I
Pyr-His-Pro-AMC Prolyl oligopeptidase 
Pyroglutamyl aminopeptidase II
Lys-Ala-AMC Dipeptidyl Peptidase II
Z-Arg- Arg-AMC Cathepsin B
Table 2.1. Fluorimetric Substrates Tested for the Presence or Absence of 
Contaminating Peptidase Activity.
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2.6.2. Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis based on the method of Laemmli (1970) was 
employed to determine the effectiveness of the purification procedure.
2.6.2.I. Preparation of SDS Gels
10% resolving and 4.5% stacking gels were prepared as in Table 2.2. from the 
following stock solutions which were all prepared using ultra-pure water.
Gels were cast using an ATTO vertical mini electrophoresis system. The resolving gel 
solution (Table 2.2.) was degassed and filtered, TEMED added, mixed and the gel 
poured immediately. An overlay of ethanol/water was placed over the resolving gel. 
After polymerisation, the overlay was removed. The stacking gel solution (Table 2.2.) 
was degassed and filtered, TEMED added, mixed and the gel poured immediately. A 
comb was placed into the top of the gel liquid and the gel was allowed polymerise.
Solution 10%v/v Resolving Gel 4.5%v/v Stacking Gel
Acrylamide/Bisacryl soln. 5 ml 1.5ml
Ultra-pure water 7.225ml 5.4ml
Ammonium Persulphate 750^1 500p.l
SDS 150^1 100(J-1
Resolving Gel Buffer 1.875ml -
Stacking Gel Buffer - 2.5ml
TEMED 7.5 |xl 7.5^1
Table 2.2. SDS PAGE Gel Preparation
Solution Composition
1.5M Tris/HCl, pH 8.8
0.5M Tris/HCl, pH 6.8
30% w/v Acrylamide, 0.8% Bisacryl
10% w/v SDS
1.5% Ammonium Persulphate
25mM Tris/HCl, 192mM glycine, 0.1% SDS
Resolving Gel Buffer 
Stacking Gel Buffer 
Acryl/Bisacryl Stock
SDS
Ammonium Persulphate 
Running Buffer
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2.6.2.2. Sample Preparation
Samples generated over the purification of bovine serum ZIP (Post phenyl sepharose, 
post calcium phosphate cellulose, post cibacron blue 3GA and post S-300 gel 
filtration) were extensively dialysed overnight into ultra-pure water. Each dialysed 
sample was added to an equal volume of 2x solubilisation buffer which consisted of 
20% v/v glycerol, 4% w/v SDS, 10% v/v 2-mercaptoethanol, 0.004% w/v 
bromophenol blue and 125mM Tris/HCl, pH 6.8. Samples were boiled for 2 minutes 
and stored on ice until application.
2.6.2.3. Sample Application
20(j.l of each prepared sample from section 2.6 2.2. was applied to the 10% SDS 
PAGE gel. The high molecular weight standards used consisted of Myosin (205kDa), 
P-Galactosidase (116kDa), Phosphorylase B (97kDa), Fructose-6-phosphate kinase 
(84kDa), BSA (66kDa), Glutamic dehydrogenase (55kDa), Ovalbumin (45kDa) and 
Glyceraldehyde-3-phosphate dehydrogenase (36kDa). 20p.1 of the standards solution 
was also applied to the gel, which was then run at 20mA for 2hrs at room temperature.
2.6.2.4. SDS PAGE Gel Staining
Polyacrylamide gels were stained using gelcode blue (a coomassie based product) and 
silver stained based on the method by Blum et al., (1987). Gels stained using gelcode 
blue were removed from the electrophoresis chamber, washed 3 x 5mins in ultra-pure 
water and then placed in gelcode blue stain for at least an hour. After the hour, 
washing in ultra-pure water enhances band visibility. Table 2.3. outlines the stages for 
silver staining. An image of each stained gel was scanned or captured using a Kodak 
digital camera coupled to Kodak software.
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Step Reagent Time
Fix 50% ethanol, 12% acetic acid, 0.05% 
formaldehyde (37% stock)
1 hour at least
Wash 50% ethanol 3 x 20 min
Pretreat 200pl of a 5% Na2 S2 0 3  x H20  stock 
soln. in 100mlH20
lmin
Rinse h 2o 2 x 20 sec
Impregnate O.lg AgN03, 70pi formaldehyde in 
100ml H20
20 min
Rinse h 2o 2 x 20sec
Development 3g Na2C0 3 , 50pl formaldehyde, 4|xl 
Na2S20 3 x H20  stock soln. in 100ml
h 2o
Max. 10min
Stop 0.1MEDTA 5 min at least
Table 2.3. Silver Staining Procedure
2.7. Substrate Specificity Studies
2.7.1. Kinetic Analysis
Substrate specificity studies on bovine serum ZIP, based on kinetic analysis were 
performed.
2.7.1.1. Km Determination For Z-Gly-Pro-AMC
A 300(jM  stock solution of Z-Gly-Pro-AMC in 5%v/v MeOH containing 500mM 
NaCl was prepared. A range of concentrations (0-300p,M) was prepared from this 
stock using lOOmM potassium phosphate, pH 7.4, containing 5%v/v MeOH and 
500mM NaCl as diluant. Purified ZIP was assayed with each concentration in 
triplicate as outlined in section 2.4.2. The Km of ZIP for the substrate Z-Gly-Pro- 
AMC was estimated when the data obtained was applied to various kinetic models 
(section 6.4.1.).
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2.7.1.2. Kj (app) Determination Using Selected Synthetic Peptides
The effect of a variety of selected synthetic peptides on the kinetic interaction 
between ZIP and the substrate Z-Gly-Pro-AMC was determined. Substrate 
concentrations in the range 100-300|xM Z-Gly-Pro-AMC in 5%v/v MeOH containing 
500mM NaCl was prepared in the presence of 200(jM  peptide, each in a final volume 
of 2ml. The assay MeOH concentration was maintained at 5%. The peptides studied 
and their preparation is outlined in Table 2.3. ZIP activity was assayed in triplicate 
using these substrate mixtures as outlined in section 2.4.2. The data obtained was 
applied to the Lineweaver-Burk analysis model, where the inhibition constant (Kj (app)) 
and the type of inhibition observed were determined as outlined in sections 6.4.2. and
6,4.3. respectively.
Peptide Stock Cone. 
(Mm)
Solubility Assay Cone. 
(HM)
Z-Gly-Pro-Phe 5 10%v/v MeOH * 200
Z-Gly-Pro-Met 5 10%v/v MeOH* 200
Z-Gly-Pro-Ser 5 Ultra-pure water 200
Z-Gly-Pro-Tyr 5 10%v/v MeOH 200
Z-Gly-Pro-Leu 5 10%v/v MeOH * 200
Z-Gly-Pro-Ala 5 Ultra-pure water 200
Z-Gly-Pro-Glu 5 Ultra-pure water 200
Z-Gly-Pro-His 5 10%v/v MeOH * 200
Z-Gly-Pro-Phe-His 5 Ultra-pure water 200
Z-Gly-Pro-Phe-His-Arg 5 Ultra-pure water 200
Z-Gly-Pro-Phe-His-Arg-Ser 5 Ultra-pure water 200
Z-Gly-Pro-Met-His 5 10%v/v MeOH * 200
Z-Gly-Pro-Met-His-Arg 5 Ultra-pure water 200
Z-Gly-Pro-Met-His-Arg-Ser 5 Ultra-pure water 200
Z-Gly-Leu-Phe-His 5 Ultra-pure water 200
Table 2.4. Peptide Preparation for Kj (app) Determinations
* Sonication using an ultrasonic water bath was required for complete dissolution.
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2.7.2. Reverse Phase High Performance Liquid Chromatography
The formation of products upon digestion of the NH2-terminal protected peptides by 
ZIP were analysed on a Beckman Chromatographic system incorporating a dual 
pump, a 526 Photo-Diode array detector and a 507 autosampler served by Beckman 
32 Karat HPLC software. A Waters Spherisorb ODS-2 C-18 analytical column 
(250mm x 4.6mm) and a Supelguard LC-18 guard column were used for all analysis. 
All solvents and buffers used in sample preparation and chromatography were 
prepared from ultra-pure water and then filtered and degassed.
2.7.2.1. Preparation of Substrates and Standards
lml of ImM substrate/standard was prepared as outlined in Table 2.4. Stock substrate 
concentrations as outlined in Table 2.3 were diluted using 50mM ammonium acetate, 
pH 7.2. The ImM standard Z-Gly-Pro was diluted using 50mM ammonium acetate, 
pH 7.2 giving concentrations from 0.1-lmM for the construction of a standard curve.
2.1.2.2. Hydrolysis of the Peptide Substrates by ZIP
Purified ZIP (post S-300 gel filtration) was concentrated 10-fold and dialysed 
extensively overnight against 50mM ammonium acetate, pH 7.2. 50[xl of ZIP in 
50mM ammonium acetate, pH 7.2, was added to 200fxl of each peptide substrate 
(ImM) in 50mM ammonium acetate, pH 7.2 containing 2%v/v methanol. Hydrolysis 
of the peptides was performed at 37°C over a 24hr period. Enzyme control was 50|o.l 
ZIP added to 200 .^1 50mM ammonium acetate, pH 7.2 containing 2%v/v methanol. 
Peptide control was 200pl of each peptide solution added to 50|j.l ammonium acetate, 
pH 7.2. All controls were incubated under the same conditions. Reactions were 
terminated with 25/il of 50mM ammonium acetate containing 50%v/v acetonitrile and 
5%v/v acetic acid.
2.1.2.3. Reverse Phase HPLC of Incubates and Standards
Mobile phases for the HPLC system consisted of solvent A; 80% (v/v) Acetonitrile, 
0.2% (v/v) TFA and solvent B; 5% (v/v) Acetonitrile, 0.2% (v/v) TFA. The reverse 
phase C-18 column was equilibrated for ten minutes with 100% solvent B. 20|ol of 
sample and controls were injected onto the column followed by a four-minute wash 
with 100% solvent B. A linear gradient from 100% solvent B to 100% solvent A over
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a twenty-one minute period was then applied. Finally, a five-minute wash with 100% 
solvent A was applied. A flow rate of 0.7ml/min was used throughout. The 
absorbance of the eluent was monitored at 214nm
Peptide Concentration Preparation
Z-Pro-Phe ImM 2 %v/v MeOH
Gly-Gly-Pro-Ala 1 niM 2%v/v MeOH
Z-Gly-Pro-Phe ImM 2 %v/v MeOH
Z-Gly-Pro-Met ImM 2%v/v MeOH
Z-Gly-Pro-Ser ImM 2 %v/v MeOH
Z-Gly-Pro-Tyr ImM 2 %v/v MeOH
Z-Gly-Pro-Leu ImM 2%v/v MeOH
Z-Gly-Pro-Ala ImM 2 %v/v MeOH
Z-Gly-Pro-Glu ImM 2%v/v MeOH
Z-Gly-Pro-His ImM 2%v/v MeOH
Z-Gly-Pro-Phe-His ImM 2 %v/v MeOH
Z-Gly-Pro-Phe-His-Arg ImM 2%v/v MeOH
Z-Gly-Pro-Phe-His-Arg-Ser ImM 2%v/v MeOH
Z-Gly-Pro-Met-His ImM 2%v/v MeOH
Z-Gly-Pro-Met-His-Arg ImM 2 %v/v MeOH
Z-Gly-Pro-Met-His-Arg-Ser ImM 2%v/v MeOH
Z-Gly-Leu-Phe-His ImM 2%v/v MeOH
Z-Gly-Leu ImM 2%v/v MeOH
Z-Gly-Pro 0.1-lmM 2%v/v MeOH
Table 2.5. Preparation of the Peptide Substrates and Standards for Substrate 
Specificity studies using HPLC and Mass Spectrometry.
2.7.3. Identification of Hydrolysis Products Using Mass Spectrometry
Mass Spectrometry data was acquired to identify the digest products been formed. 
Sample preparation and hydrolysis of the peptide substrates were as according to 
Table 2.4. and section 2.7.2.2. respectively.
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2.7.3.1. Direct Infusion MS Analysis
Initially, incubate samples were directly infused into the MS source but some 
components of the mixtures were preferentially ionised over others which led to 
ambiguous results. Thus, it was decided to use LC-MS but the direct infusion analysis 
did aid in the development of the MS experimental conditions.
2.7.3.2. LC-MS Analysis of Incubates
The instrument used was the Bruker/Hewlett-Packard Esquire LC - a Bruker mass 
spectrometer linked to a HP liquid chromatograph. The LC module of the instrument 
was a HP 1100 with a variable wavelength detector, a low-volume pump, an in-line 
degasser and an autosampler. This LC system generally uses low flow rates, narrow 
bore columns and a micro flow cell in the UV detector. The MS module of the 
instrument comprised the ionisation chamber, the ion-trap to collect the ions and then 
to release them according to mass, and the ion detector to generate the spectrum. The 
Esquire-LC is capable of two types of ionisation - electrospray ionisation (ESI) and 
atmospheric pressure chemical ionisation, although in this work, we used only ESI. 
With ESI, samples are subjected to ‘gentle’ ionisation such that in-source 
fragmentation generally does not occur to any great extent. The LC isocratic method 
used aZorbax RX-C18, 150 x 2.1mm, 5(j.M column with amobile phase of 78/22/0.1 
v/v/v water/ACN/formic acid at a flowrate of 0.15ml/min. The monitoring wavelength 
was 205nm and an injection volume of 4|nl was used. After passing through the UV 
detector, the samples were introduced directly into the mass spectrometer, with the 
ESI source in the positive mode, enabling simultaneous UV and TIC (Total Ion 
Current) traces to be obtained. The nebulisation gas and drying gas (both nitrogen) 
were set to 30psi and 81/min respectively. The temperature of the source was 
maintained at 340°C. Depending on the chosen target mass, the octopole voltage, 
skimmer 1 voltage and the trap drive voltage changed, but for mass 329 (sodiated Z- 
gly-pro) for example, these values were 2.48V, 34.4V and 32.5V respectively. Mass 
spectral data was generally collected in the scan range 50-1000 m/z.
82
2.8. Partial Purification Procedure for Bovine Serum Prolyl Oli go peptidase
2.8.1. Phenyl Sepharose Hydrophobic Interaction Chromatography I
A 20ml Phenyl Sepharose CL-4B hydrophobic interaction column (2.5 x 7cm) was 
equilibrated with 100ml of lOOmM potassium phosphate containing 20mM 
ammonium sulphate, pH 7.4. Solid ammonium sulphate was dissolved in 20ml of 
bovine serum to give a final concentration of 200mM. This sample was then applied 
to the equilibrated column followed by a 100ml wash with lOOmM potassium 
phosphate containing 200mM ammonium sulphate, pH 7.4. The column was then 
washed with 100ml of lOOmM potassium phosphate containing 50mM ammonium 
sulphate, pH 7.4. Bound protein was eluted with a distilled water wash. Equilibration 
of the column was carried out at a flow rate of lml/min, while all other steps were 
performed at 2ml/min. 5ml fractions were collected throughout the procedure and 
were assayed for PO activity according to section 2.4.4. Protein content in each 
fraction was determined using the biuret assay according to section 2.2.1. Fractions 
containing PO were pooled to yield post phenyl sepharose I PO and enzyme activity 
and protein content were quantified using the fluorimetric assay as outlined in section
2.4.2. and the biuret assay as in section 2.2.1.
2.8.2. Phenyl Sepharose Hydrophobic Interaction Chromatography II
The 20ml resin used in section 2.8.1. was regenerated with a 100ml wash of pure 
ethanol at 0.5ml/min. The column was then equilibrated with 100ml of lOOmM 
potassium phosphate containing 1M ammonium sulphate, pH 7.4. Solid ammonium 
sulphate was dissolved in the concentrated post phenyl sepharose I pool (pH was 
maintained at 7.4 using 1M NaOH), to give a final concentration of 1M. The sample 
was then applied to the column followed by a 100ml wash of equilibration buffer. 
Bound protein was eluted with a 100ml linear gradient of 1-0M ammonium sulphate, 
lOO-OmM potassium phosphate, pH 7.4. The column was then washed with 25ml of 
ultra-pure water. All steps were performed at a flow rate of 2ml/min. 5ml fractions 
were collected throughout the procedure, and again were assayed for PO activity 
according to section 2.4.4. Protein content in each fraction was determined using the 
standard BCA assay as outlined in section 2.2.2. Fractions containing PO activity 
were pooled to yield post phenyl sepharose II PO. Enzyme activity and protein 
content were then quantified as outlined in section 2.4.2. and 2.2.2.
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2.8.3 Cibacron Blue 3GA Chromatography
The post phenyl sepharose II pool was concentrated and dialysed overnight against 21 
of 20mM potassium phosphate. 100 ml of 20mM potassium phosphate, pH 7.4. was 
used to equilibrate a 20ml cibacron blue 3GA resin. After sample application the 
column was washed with 100ml of 20mM potassium phosphate, pH 7.4. to remove 
any unbound protein. Elution was performed using a 100ml linear 0-2M NaCl 
gradient in 20mM potassium phosphate, pH 7.4. Loading, washing and elution were 
all performed at lml/min. 5ml fractions were collected and assayed for PO activity 
according to section 2.4.4. Protein content in each fraction was determined using 
coomassie plus protein reagent as in section 2.2.3. Fractions containing PO activity 
were pooled and enzyme activity and protein content were quantified as outlined in 
section 2.4.2. and 2.2.3.
2.9. Inhibitor Studies
2.9.1. Catalytic Classification Using Diisopropylfluorophosphate
A range of concentrations of DFP was prepared from a stock concentration of 20mM 
using 100m M potassium phosphate containing 500mM NaCl as diluant. A stock 
substrate of 200^M Z-Gly-Pro-AMC in 8% v/v MeOH and containing 500mM NaCl 
was prepared using lOOmM potassium phosphate, pH 7.4. This stock was 
preincubated at 37°C until completely dissolved and thermal equilibrium was reached, 
lml of substrate stock was added to 1ml of appropriate DFP concentration to give a 
final substrate concentration of lOOpM Z-Gly-Pro-AMC in 4%v/v MeOH containing 
500mM NaCl. ZIP activity using these substrate: inhibitor mixtures was assayed in 
triplicate as outlined in section 2.4.2. Suitable negative and positive controls were 
prepared. The IC50 value of DFP for ZIP was determined as explained in section 6.4.4.
2.9.2. Effect of Specific Prolyl Oligopeptidase Inhibitors
The potency of some specific Prolyl Oligopeptidase inhibitors towards purified ZIP 
and partially purified PO from bovine serum was assessed. IC50 values were evaluated 
using steady-state enzyme-substrate reaction. Reactions were initiated by the addition 
of lOOfjl enzyme to 1.9ml 20pM Z-Gly-Pro-AMC containing l%v/v MeOH, giving a
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final volume of 2ml. The reaction was constantly monitored for 15 minutes until a 
constant rate was observed. 2pl of each inhibitor concentration was then added and 
the reaction allowed to proceed for 45 minutes at 37°C. Reaction buffer for purified 
ZIP was lOOmM potassium phosphate containing 500mM NaCl, pH 7.4 and for PO 
was lOOmM potassium phosphate containing lOmM DTT, pH 7.4. Suitable positive 
and negative controls were also prepared. Enzyme activity was continuously 
monitored on a Kontron spectrofluorimeter SFM 25 (excitation wavelength 370nm, 
emission wavelength 440nm) equipped with a thermostated four-cell changer and 
controlled by an IBM-compatible computer.
Inhibitor Stock Cone.
(M)
Preparation Assay Cone. 
(M)
F moc-Ala-PyrrCN lxlO^-lxlO"3 10% DMSO Ixl0 '9-lx l0 ‘6
Z-Phe-Pro-BT 1x10'5-2x1 O'3 10% DMSO Ix l0 ‘8-2xl0"6
SR 063298 1x10‘7-2x10’2 Ultra-pure water lxlO‘10-2xlO'5
SR 063125 1x10"7-2x10‘2 10% DMSO lxlO '10-2xlO‘5
JTP-4819 5x10'5-1x10"8 10% MeOH Ix l0 'n -5xl0'8
Table 2.6. Preparation of Specific Inhibitors 
2.10. Immunological Studies
Using a polyclonal antibody against human prolyl oligopeptidase, studies were 
performed to check for any cross reactivity with bovine serum PO and ZIP. The 
polyclonal antibody (S449) against human PO/PEP was generated when rabbits were 
immunized with a peptide containing the N-terminal PO/PEP sequence of amino acids
10-25.
2.10.1. SDS PAGE and Immunoblotting
Separating gels containing 10% acrylamide were prepared according to Table 2.2. and 
section 2.6.2.1. except the system used was a mini Biorad vertical electrophoresis 
unit. Two cell lines expressing PEP activity were used as positive controls. They were 
the human glioma cell line U343 and the neuroblastoma cell line SH-SY5Y. Also Rat
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cortex was used as a positive control. 15fag of the prepared positive controls were 
loaded per lane along with 140ng purified ZIP and 2.9fig partially purified PO from 
bovine serum. Coloured makers were also loaded, to aid visualising electrophoresis 
and electrotransfer.
After SDS-gel electrophoresis for 45 minutes at 200V the following procedure was 
performed. A blotting sandwich was constructed as follows, 5 layers of filter paper 
(What. Nr.3) Soaked in anode buffer 1, 3 layers filter paper (What. Nr.3) Soaked in 
anode buffer 2, nitrocellulose soaked in water, gel and finally 5 layers filter paper 
(What. Nr.3) Soaked in cathode buffer 3. Electroblotting transfer time was 1-1.5hr at 
a constant current of 0.8mA/cm2. The blot was carefully removed and blocked for lhr 
with 30ml of 3% dry milk in PBS-Tween. Primary anti-PEP antibody (1:400 dilution) 
and monoclonal antibody anti-actin (1:1000 dilution) in PBS-Tween with 5% dry 
milk were prepared and placed on the blot overnight in cold room. The blot was then 
washed 3 x 1 0  min with PBS. It was then placed shaking for lhr in HRP conjugated 
secondary antibody (1:10,000 dilution) in PBS-Tween with 5% dry milk. The blot 
was then washed again 3 x lOmin with PBS.
The chemiluminescence substrate was prepared by mixing 2.5ml of each Biorad 
solution, added to the blot and shook by hand for 5 mins. The substrate solution was 
decanted off and clingfilm bound carefully around the blot. Air bubbles were 
removed, excess clingfilm removed from the edges and the blot dried. It was then 
placed in the x-ray chamber. In the dark room, an x-ray film was removed and placed 
firmly on the blot in the x-ray chamber, closed and exposure allowed for up to 60 
seconds. The film was then placed in developer solution for 5 mins, briefly washed in 
water and fixed for up to 2 mins. The developed film was then washed with water and 
allowed air dry.
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2.11. Identification of this Z-Pro-prolinal Insensitive Peptidase
2.11.1. Determination of N-Terminal Protein Sequence
Bryan Dunbar performed N-terminal sequencing of ZIP commercially at the 
University of Aberdeen, Scotland. The enzyme sample had to be firstly separated by 
SDS PAGE, then electroblotted onto polyvinylidene difluoride (PVDF) membrane 
and stained.
2.11.1.1. SDS Polyacrylamide Gel Electrophoresis
An SDS PAGE gel was precast according to Table 2.2. and section 2.6.2.1. and stored 
overnight at 4°C to prevent N-terminal blocking by free amines. 50ml of bovine 
serum was purified as in section 2.5. and the final purified ZIP sample was dialysed 
extensively overnight against ultra-pure water and concentrated to 500p.l using a 
speedvac. An equal volume of sample was added to an equal volume of solubilisation 
buffer (see section 2.6.2.2.) and boiled for 2 minutes. Coloured markers were 
employed as in section 2.10.1. The gel was pre-run at 50V for 30min with 200p,M 
thioglycolic acid in the upper reservoir in order to provide a scavenger for free 
radicals. The chamber was emptied, rinsed with reservoir buffer and further 
electrophoresis was performed at a constant current of 20mA for 2hr.
2.11.1.2. PVDF Electroblotting
11 of lOx CAPS buffer was prepared and adjusted to pH 11 using sodium hydroxide, 
lx  electroblotting buffer in 10% MeOH was prepared and stored at 4°C. On removal 
of the gel it was placed in electroblotting buffer for lhr, while the PVDF membrane 
was dipped in MeOH for lOsec and also equilibrated in electroblotting buffer for lhr. 
A transblotting sandwich was made using 8 layers of pre-soaked filter paper, cut to 
the exact size of the gel. The PVDF membrane was placed on top of the filter paper 
followed by the gel. Eight more layers of equilibrated filter paper were added to 
complete the sandwich. Electroblotting was performed at 0.8mA/cm2 for lhr lOmin. 
Removal of the membrane was followed by a rapid membrane wash in ultra-pure 
water. It was then saturated in 100% MeOH for lOsec and stained with coomassie 
blue for 3min. Destaining in 1% acetic acid was repeated twice, then the blot was
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extensively washed with ultra-pure water and finally allowed to air dry. The blot was 
wrapped in clingfilm and transported for sequencing.
2.11.2. UV Zymogram Development
2.11.2.1. Native Polyacrylamide Gel Electrophoresis
A 10% native polyacrylamide gel was prepared as in section 2.6.2.1. except that no 
SDS was present in the gel and the gels in this case were cast in the large ATTO 
electrophoresis system. The cast gels were stored overnight at 4°C. Purified ZIP 
sample was dialysed extensively overnight into ultra-pure water and concentrated to 
500(0,1 using a speedvac.
lOx (non-denaturing) solubilisation buffer was prepared as follows: 3.2ml 10% SDS, 
2ml 0.5M Tris/HCl pH 6.8, 1.6ml glycerol, 0.05%(w/v) bromophenol blue and 1.2ml 
of ultra-pure water, in a final volume of 8ml. This solution was stable for 4-6 weeks at 
4°C, or for months if stored at -20°C.
Running buffer was prepared as in section 2.6,2.1. without SDS present. 54|j.l of 
concentrated ZIP sample was added to 6|j,l lOx (non-denaturing) solubilisation buffer 
and applied directly to the gel. The gel was run at a constant voltage of 125V at 4°C 
for up to 2.5hrs.
2.11.2.2. U.V. Zymogram Assessment
After native page electrophoresis, the gel was rapidly removed and placed in 50ml of 
100fiM Z-Gly-Pro-AMC in lOOmM potassium phosphate pH 7.4 containing 4%v/v 
MeOH and 500mM NaCl. It was incubated with shaking for 10-15mins at 37°C, after 
this excess substrate was removed and the gel placed under ultraviolet light in an 
image analyser for visualisation.
2.11.2.3. Protein G Affinity Chromatography
2.5ml of protein G resin was equilibrated with 10ml of lOOmM potassium phosphate 
containing 200mM NaCl, pH 7.4. l-2ml of concentrated purified ZIP sample was 
applied to the affinity resin and allowed to shake slowly for 30mins at 4°C (Batch 
bind). The resin was allowed to settle and the supernatant removed. The resin was
8 8
then washed with 10ml of equilibration buffer, allowed settle and the supernatant 
removed. A second 10ml wash of lOOmM potassium phosphate containing 500mM 
NaCl, pH 7.4. was then performed, with the resin again allowed to settle and the 
supernatant removed. Each supernatant was pooled and assayed for ZIP activity 
according to section 2.4.2. Bound protein was eluted using a 10ml wash with 0.1M 
glycine/HCl, pH 2.2.
2.11.2.4. Gelatin Sepharose Chromatography
5ml of gelatin sepharose was equilibrated with 15ml lOOmM potassium phosphate 
containing 200mM NaCl, pH 7.4. The post protein G ZIP sample was concentrated, 
applied to the resin and allowed to batch bind slowly at 4°C. The resin was allowed to 
settle and the supernatant removed. This was followed by a wash with 15ml of 
equilibration buffer, resin allowed to settle and the supernatant removed. A second 
15ml wash of lOOmM potassium phosphate containing 1M NaCl, pH 7.4 was 
performed, with the resin again allowed to settle and the supernatant removed. Each 
supernatant was pooled and assayed for ZIP activity according to section 2.4.2. Bound 
protein was eluted with a 15ml wash of 4M urea, pH 7.0.
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RESULTS
3.0 Results
3.1. Protein Determination
Protein standard curves incorporating BSA were prepared as outlined in sections
2.2.1. , 2.2.2. and 2.2.3. Plots o f protein absorbance versus BSA concentration are 
presented in Figures 3.1.1. , 3.1.2. and 3.1.3. for the Biuret, standard BCA and 
coomassie plus assays respectively.
C o n c e n t r a t i o n  B S A  ( m g / m l )
Figure 3.1.1. BSA Standard Curve
Plot of absorbance at 540nm versus BSA concentration obtained using the Biuret 
assay procedure as outlined in section 2.2.1. Error bars represent the SEM of triplicate 
readings.
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C o n c e n t r a t i o n  B S A  ( u çj / ni I )
Figure 3.1.2. BSA Standard Curve
Plot o f Absorbance at 570nm versus BSA concentration obtained using the standard 
BCA assay procedure as outlined in section 2.2.2. Error bars represent the SEM of 
triplicate readings.
C o n c e n t r a t i o n  B S A  ( u g / m l )
Figure 3.13. BSA Standard Curve
Plot of Absorbance at 595nm versus BSA concentration obtained using the coomassie 
plus assay procedure as outlined in section 2,2.3. Error bars represent the SEM of 
triplicate readings.
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3.2. AMC Standard Curves and the Inner Filter Effect
AMC standard curves were prepared as outlined in section 2.3.1. Plots of fluorescent 
intensity versus AMC concentration are presented in Figures 3.2.1. and 3.2.2. The 
inner filter effect (quenching) was also performed according to section 2.3.2. This was 
performed to see the effect on fluorescence of including crude serum or post column 
pooled fractions in the assay mixture. Figures 3.2.3. and 3.2.4. are plots of fluorescent 
intensity versus AMC concentration for crude serum and post phenyl sepharose pool. 
Plots for the remaining post column pools are not included, as the inner filter effect 
was not observed for these samples. Table 3.1. shows the degree of filtering observed 
and the slopes obtained for each sample.
A M C  C o n c e n t r a t i o n  ( nM)
Figures 3.2.1. and 3.2.2. AMC Standard Curves
Plots of fluorescent intensity versus AMC concentration. Excitation slit width was 
maintained at lOnm, while emission slit widths were lOnmand 5nm for Figures 3.2.1. 
and 3.2.2, respectively.
AMC  C o n c e n t r a t i o n  (uM)
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A M C  C o n c e n t r a t i o n  ( u M)
Figures 3.2.3. and 3.2.4. Quenched AMC Standard Curves
Plots of fluorescent intensity versus AMC concentration. Figure 3.2.3. illustrates the 
filter eifect for serum (•) in comparison to unfiltered for buffer (o). Figure 3.2.4. 
shows the filter effect for post phenyl sepharose ZIP (•) in comparison to buffer (o).
Sample R2 Slope % Filtering
lOnm, 5nm
Buffer 0.997 47.93 0.0
Serum 0.999 44.38 7.41
Post-phenyl sepharose 0.997 45.91 4.21
lOnm, lOnm
Buffer 0.998 230.42 0.0
Table 3.1. Slopes and the Percentage Filtering of Quenched Standard Curves
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3.3. Purification of ZIP Activity From Bovine Serum
3.3.1. Serum Preparation
51 of fresh bovine whole blood was collected, which resulted in 11 of serum post 
clotting and centrifugation at 4°C.
3.3.2. Phenyl Sepharose Hydrophobic Interaction Chromatography
Figure 3.3.2.1. illustrates the elution profile of ZIP activity from a phenyl sepharose 
column, which was prepared and run according to section 2.5.2. The profile shows the 
presence of two Z-Gly-Pro-AMC degrading activity peaks, measured as in section 
2.4.4. The first activity peak is present in the run through wash, while the second 
major activity peak elutes with the ultra-pure water wash. These activities are 
distinguished according to their sensitivity to JTP-4819 (a potent and specific 
inhibitor of prolyl oligopeptidase), which is seen in Figure 3.3.2.2. Fractions 53-57 
were combined yielding 25ml post phenyl sepharose ZIP sample. 1.5ml of this pooled 
sample was retained for quantitative ZIP activity (section 2.4.2.) and quantitative 
protein (section 2.2.1.) determinations.
3.3.3. Calcium Phosphate Cellulose Chromatography
After concentration of the post phenyl sepharose pool to 10ml, the sample was further 
purified using calcium phosphate cellulose as outlined in section 2.5.3. Figure 3.3.3. 
shows the elution profile of ZIP activity and protein, measured according to sections
2.4.4. and 2.2.2. ZIP bound to the column at a low phosphate concentration and eluted 
on application of 500mM phosphate. Fractions 46-47 were pooled yielding 10ml post 
calcium phosphate cellulose ZIP sample. 1.5ml of this pool was retained for 
quantitative ZIP activity (section 2.4.2.) and quantitative protein (section 2.2.2.) 
determinations.
3.3.4. Cibacron Blue 3GA Chromatography
Concentrated and dialysed post calcium phosphate cellulose ZIP was applied to a 
Cibacron blue 3GA column and further purified as outlined in section 2.5.4. ZIP 
bound to the resin and was eluted using an increasing linear gradient of sodium 
chloride. Figure 3.3.4. illustrates the elution profile from the column. Fractions 28-31
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were combined yielding 20ml post Cibacron blue 3GA ZIP sample. 1,5ml of this pool 
was retained for quantitative ZIP activity (section 2.4.2.) and quantitative protein 
(section 2.2.3.) measurements.
3.3.5. Sephacryl S-300 Size Exclusion Chromatography
2ml of concentrated post cibacron blue 3GA ZIP was applied to the S-300 column as 
outlined in section 2.5.4. Figure 3.3.5. shows the purification of ZIP on the gel 
filtration resin. Fractions 12-14, which contained activity, were combined to form 
15ml post S-300 ZIP sample. 1.5ml of this pool was again retained for quantitative 
ZIP activity (section 2.4.2.) and quantitative protein (section 2.2.3.) determinations.
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Figure 3.3.2.I. Fractionation of the Two Z-Gly-Pro-AMC Hydrolysing Activities 
in Bovine Serum by Phenyl Sepharose Hydrophobic Interaction 
Chromatography.
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Figure 3.3.2.2. Differentiation of the Two Distinct Z-Gly-Pro-AMC Degrading 
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Figure 3.3.3. Elution Profile of ZIP During Calcium Phosphate Cellulose 
Chromatography.
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Figure 3.3.4. Cibacron Blue 3GA Chromatography of ZIP
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Figure 3.3.5. Elution Profile of ZIP Activity During S-300 Gel Filtration 
Chromatography.
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Purification Step Volume
ml
Total Activity “
Units
Total Protein
mg
Specific Activity
Units/mg
Purification Factor Recovery
%
Crude Serum 2 0 16.12 1766 0.00913 1 1 0 0
Phenyl Sepharose 25 15.02 37.15 0.404 44.3 93.18
CPC 1 0 8.62 1.52 5.67 621 53.47
Cibacron Blue 2 0 3.25 0.019 171.05 18,735 20.16
S-300 15 1.93 0.007 275.7 30,197 11.97
Table 3.2. Representative Purification of ZIP from Bovine Serum
The representative purification table was constructed to assess the overall effectiveness of the purification procedure.
“ Based on the enzymatic activity using lOOpM Z-Gly-Pro-AMC, where Units = nmoles.min1 i.e. Units are expressed as nanomoles of AMC 
released per minute at 37°C.
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3.4. Purity Assessment of ZIP
3.4.1. The Activity of Purified ZIP Sample Against Fluorimetric Substrates
The presence of contaminating peptidase activities in purified ZIP sample was 
assessed by monitoring for hydrolysis a number of fluorimetric substrates. These 
substrates were prepared and assayed as outlined in section 2.6.1. Table 3.4. illustrates 
that no cleavage of these substrates was detected in the presence of purified ZIP 
sample.
Substrate Hydrolysis Substrate Hydrolysis
Z-Phe-Arg-AMC No Pro-AMC No
Z-Arg-Arg-AMC No Gly-AMC No
Z-Gly-Pro-AMC Yes Pyr-AMC No
Pyr-His-Pro-AMC No Arg-AMC No
Glu-Phe-AMC No Ala-AMC No
Gly-Pro-AMC No Leu-AMC No
Lys-Ala-AMC No Lys-AMC No
Table 3.3. Cleavage of Fluorimetric Substrates by Contaminating Peptidases.
3.4.2. SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed as outlined in section 2.6.2. 
Figure 3.4.2.1. illustrates a gelcode blue stained gel image of the purification 
procedure, including post column ZIP samples and molecular weight markers. Figure
3.4.2.2. shows a silver stained image of lanes 4,5,6 & 7 of the gelcode stained gel.
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Figure 3.4.2.I. 10% SDS PAGE for Bovine Serum ZIP Purification
4 5 6
ZIP
Figure 3.4.2.2. Silver Stained Image-Showing Part of the Gel in Fig. 3.4.2.I.
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3.5. Substrate Specificity Studies
Substrate specificity studies on purified ZIP were performed as outlined in section
2.7. Kinetic analysis of residues located NEh-terminally and at the COOH- terminal 
site of the scissile bond of proline-containing peptides was investigated. Reverse 
Phase (RP) HPLC was used to separate and quantify peptide digest products of some 
of the proline-containing peptides. LC-MS was then performed on these complex 
digest products for identification.
3.5.1. Effect of Residues Located NH2-Tenninally from the Scissile Bond of 
Proline-Containing Peptides
The effect of increasing the peptide chain length from the Pro-X (Pi-Pi') bond to 
include P2  and P3 is shown in Table 3.4. Figure 3.5.1.1. and 3.5.1.2. show the 
chromatograms for the peptide Z-Pro-Phe-OH before and after incubation with ZIP as 
outlined in section 2.7.2.
Peptide
P3 P2 Pi I  Pi'
[Peptide]
(mM)
Hydrolysis
Pro-AMC 0 . 1 No
Gly-Pro-AMC 0 . 1 No
Z-Gly-Pro-AMC 0 . 1 Yes
pGlu-His-Pro-AMC 0 . 1 No
Z-Gly-Pro-Ala 1 Yes
Gly-Gly-Pro-Ala 1 No
Z-Pro-Phe 1 No
Table 3.4. The Effect on Hydrolysis of Proline-Containing Peptides Extended 
NH2-Terminally from the Scissile Bond.
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Figures 3.5.1.1. and 3.5.1.2. HPLC chromatograms for Z-Pro-Phe incubation 
with ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig. 3.5.1.1.) 
and for peptide and ZIP incubate (Fig. 3.5.1.2.). Figure 3.5.1.2. illustrates the failure 
of ZIP to cleave the peptide Z-Pro-Phe-OH.
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3.5.2. Km Determination for Z-Gly-Pro-AMC
The kinetic behaviour of purified ZIP was investigated using Z-Gly-Pro-AMC. Km 
values for the hydrolysis of the substrate Z-Gly-Pro-AMC were determined according 
to section 2.7.1.1. Data obtained was applied to the Lineweaver-Burk, Eadie-Hofstee 
and Hanes-Woolf kinetic models for analysis (section 6.4.1.). Table 3.5. represents 
the Km values deduced using these models. Figures 3.5.2.1. through to 3.5.2.3. 
illustrate Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf plots for ZIP assayed 
with Z-Gly-Pro-AMC.
l/[Z -G ly-P ro-A M C ] (oM *)
Figure 3.5.2.I. Km determination using the Lineweaver-Burk kinetic model
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Figure 3.5.2.2. Km determination using the Eadie-Hofstee kinetic model
P-Qly-Pro-AMC] (uM)
Figure 3.5.23. K,n determination using the Hanes-Woolf kinetic model
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Kinetic Model Km (pM)
Lineweaver-Burk 323.47
Eadie-Hofstee 225.20
Hanes-Woolf 261.67
Average 270
Table 3.5. Km Value (|JM) Obtained for the Substrate Z-Gly-Pro-AMC
3.5.3. Effect of Residues Located at the COOH-Terminal Site of the Scissile 
Bond of Proline-Containing Peptides
3.5.3.1. Amino Acid Preference at the C-Terminal End of the Scissile Bond (Pi' 
Position)
While keeping the Z-Gly-Pro (P3 , P2 , Pi) sequence constant, a range of N-blocked 
tripeptides with variable amino acids in the Pi' position were synthesised and then 
prepared according to Table 2.3.
3.5.3.L1. Determination of K  (app) Values for Proline-Containing Peptides
Determination of K; (app) values in the ZIP-catalysed hydrolysis of Z-Gly-Pro-AMC 
using proline-containing peptides was performed according to section 2.7.1.2. Km and 
VmaX values were determined for ZIP using the Lineweaver-Burk kinetic model 
described in section 3.5.2. Kmlpp and Vm,,app values were determined graphically for 
each of the peptides using the Lineweaver-Burk kinetic plot. K; (app) values and the 
nature of inhibition were estimated for each peptide (sections 6.4.2. & 6.4.3.). Figures
3.5.3.1.1.1. to 3.5.3.1.1.8. represent Lineweaver-Burk plots for each peptide studied. 
Table 3.6. lists the K; (app) values and the type of inhibition obtained.
110
0 010
0  00 8
I  0 .0 0 6
1/[2-Gly-Pro-AMC] (uM ')
Figure 3.5.3.I.I.I. Kinetic analysis of the effect of Z-Gly-Pro-Phe (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-Phe.
1/[Z-G ly-Pro-AMC] (uM'1)
Figure 3.5.3.I.I.2. Kinetic analysis of the effect of Z-GIy-Pro-Met (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the non-competitive 
inhibition of ZIP by Z-Gly-Pro-Met.
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Figure 3.5.3.1.13. Kinetic analysis of the effect of Z-Gly-Pro-Tyr (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the non-competitive 
inhibition of ZIP by Z-Gly-Pro-Tyr.
1/[Z-Gly-Pro-AMC] (uM ’)
Figure 3.5.3.1.1.4. Kinetic analysis of the effect of Z-Gly-Pro-Ser (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-Ser.
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Figure 3.5.3.1.1.5. Kinetic analysis of the effect of Z-Gly-Pro-Glu (♦ ) on ZIP 
catalysed hydrolysis of Z-GIy-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-Glu.
1/[Z-G ly-Pro-AMC] (uM 1)
Figure 3.5.3.1.1.6. Kinetic analysis of the effect of Z-Gly-Pro-His (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-His.
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Figure 3.5.3.1.1.7. Kinetic analysis of the effect of Z-Gly-Pro-Leu (4 ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-Leu.
1 f[Z-G ly-Pro-AMC] [u M '|
Figure 3.5.3.1.1.8. Kinetic analysis of the effect of Z-Gly-Pro-Ala (4 ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the non-competitive 
inhibition of ZIP by Z-Gly-Pro-Ala.
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Peptide
P3 P2 P i^  Pi'
Assay Cone.
G*M)
Kj (app) (M'M) Inhibition Type
Z-Gly-Pro-Phe 200 461.53 Mixed
Z-Gly-Pro-Met 200 554.72 Non-competitive
Z-Gly-Pro-Tyr 200 632.76 Non-competitive
Z-Gly-Pro-Ser 200 672.80 Mixed
Z-Gly-Pro-Leu 200 687.97 Mixed
Z-Gly-Pro-Glu 200 748.90 Mixed
Z-Gly-Pro-His 200 769.07 Mixed
Z-Gly-Pro-Ala 200 862.65 Non-competitive
Table 3.6. Ki (app) Values Obtained for Proline-Containing N-blocked Tripeptides
3.5.3.1.2. Reverse Phase HPLC of Proline-Containing N-blocked Tripeptides
To determine the ability of ZIP to hydrolyse a variety of N-blocked tripeptides, the 
products of hydrolysis were separated by reverse phase HPLC. Reaction of peptides 
with ZIP and reverse phase HPLC were performed according to sections 2.7.2.2. and
2.7.2.3. respectively. Figures 3.5.3.1.2.1 to 3.5.3.1.2.16 represent chromatograms of 
each of the peptides tested. Figure 3.5.3.1.2.18 shows a standard curve of the peptide 
standard Z-Gly-Pro, prepared according to section 2.7.2.1. Table 3.7. gives a 
summary of the peptides studied, whether hydrolysis was detected and if so, a 
quantified product value. The optimum wavelength for detection of peptides was 
found to be at 214nm.
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Figures 3.5.3.I.2.I. and 3.5.3.I.2.2. HPLC chromatogram of Z-Gly-Pro-Phe 
hydrolysis by ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.1.2.1.) and for peptide and ZIP incubate (Fig. 3.5.3.1.2.2.). Figure 3.5.3.1.2.2. 
clearly shows the cleavage ofZ-Gly-Pro-Phe by ZIP.
116
Figures 3.5.3.I.2.3. and 3.5.3.I.2.4. HPLC chromatogram of Z-GIy-Pro-Met 
hydrolysis by ZIP, Plots of absorbance at 2l4nm versus time for peptide only (Fig.
3.5.3.1.2.3.) and for peptide and ZIP incubate (Fig. 3.5.3.1.2.4.). Figure 3.5.3.1.2.4. 
shows the slight cleavage of Z-Gly-Pro-Met by ZIP.
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Figures 3.5.3.1.2.5. and 3.53.1.2.6. HPLC chromatogram of Z-Gly-Pro-Tyr 
hydrolysis by ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.2.1.5.) and for peptide and ZIP incubate (Fig. 3.5.3.2.I.6.). Figure 3.5.3.2.1.6. 
shows the cleavage of Z-Gly-Pro-Tyr by ZIP.
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Figures 3.53.1.2.7. and 3.53.1.2.8. HPLC chromatogram of Z-Gly-Pro-Ser 
hydrolysis by ZIP. Plot of absorbance at 214nm versus time for peptide only (Fig,
3.53.1,2.7.) and for peptide and ZIP incubate (Fig. 3.5.3.1.2.8.), Figure 3,53,1.2.8. 
illustrates the hydrolysis of Z-Gly-Pro-Ser by ZIP.
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Figures 3.53.1.2.9. and 3.5.3.1.2.10 HPLC chromatogram of Z-Gly-Pro-Glu 
hydrolysis by ZIP. Plots o f absorbance at 214nm versus time for peptide only (Fig.
3.5.3.1.2.9.) and for peptide and ZIP incubate (Fig. 3.5.3.1.2.10). Figure 3.5.3.1.2.10 
illustrates the negligible hydrolysis o f  Z-Gly-Pro-Glu by ZIP.
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Figures 3.53.1.2.11. and 3.53.1.2.12. HPLC chromatograms of Z-GIy-Pro-His 
hydrolysis by ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.1.2.11.) and for peptide and ZIP incubate (Fig. 3.5.3.1.2,12.). Figure
3.5.3.1.2.12. illustrates the cleavage of Z-Gly-Pro-His by ZIP.
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Figures 3 .5 .3 .1 .2 .1 3 . and 3.53.1.2.14. HPLC chromatograms of Z-Gly-Pro-Leu 
hydrolysis by ZIP. Plot of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.1.2.13.) and for peptide and ZIP incubate (Fig. 3.5.3.1,2.14.). Figure
3.5.3.1.2.14. illustrates the cleavage of Z-Gly-Pro-Leu by ZIP.
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Figures 3.5.3.1.2.15. and 3.5.3.1.2.16. HPLC chromatograms of Z-Gly-Pro-Ala 
hydrolysis by ZIP, Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.1.2.15.) and for peptide and ZIP incubate (Fig 3.5.3.1,2.16.). Figure
3.5.3.1.2.16. shows the hydrolysis o f Z-Gly-Pro-Ala by ZIP.
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Figure 3.53.1.2.17. HPLC chromatogram of the standard Z-Gly-Pro
Plot of absorbance at 214nm versus time for the peptide standard Z-Gly-Pro. The plot 
illustrates a retention time of 20.983 minutes for ImM Z-Gly-Pro standard. This 
correlates well with the major product formed in figures 3.5.3.1.2.1. to 3.5.3.1.2.16.
0 0 2 0.4 0 .6  0 8 1.0
[Z-Gly-Pro] (mM)
Figure 3.53.1.2.18. Z-Gly-Pro standard curve
Plot of peak area (absorbance) at 214nm versus Z-Gly-Pro concentration obtained 
using reverse phase HPLC as outlined in section 2.7.2.3. Errors bars represent the 
SEM of duplicate readings.
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Peptide Hydrolysis [Z-Gly-Pro] (mM)
Z-Gly-Pro-Phe Yes 0.096
Z-Gly-Pro-Tyr Yes 0.057
Z-Gly-Pro-Ser Yes 0.056
Z-Gly-Pro-Met Yes 0.025
Z-Gly-Pro-His Yes 0.029
Z-Gly-Pro-Glu Negligible -
Z-Gly-Pro-Leu Yes 0.031
Z-Gly-Pro-Ala Yes 0.037
Table 3.7. Quantification of Z-Gly-Pro after hydrolysis by ZIP
3.5.3.13. Identification of the Hydrolysis Products Separated by Reverse Phase 
HPLC using LC-MS.
As outlined in section 2.7.3.1. direct infusion MS analysis was initially used to 
identify the hydrolysis products. This led to some components of the reaction been 
preferentially ionised over others, thus leading to inaccurate results. LC-MS analysis 
was then employed to first separate the products of hydrolysis and then identify them 
individually using ion spray mass spectrometry according to section 2.13.2. This also 
enabled the confirmation of cleavage post proline in each of the peptides analysed. 
Figures 3.5.3.1.3.1. to 3.5.3.1.3.7. represent the LC-MS spectra obtained for some of 
the peptides analysed for Pi' specificity.
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Figure 3.5.3.1.3.1. LC-MS spectra of Z-Gly-Pro-Phe digestion
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Figure 3 .5 .3 .0 .2 . LC-MS spectra of Z-Gly-Pro-Met digestion
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Figur« 3.5.3.13.3. LC-MS spectra of Z-Gly-Pro-Tyr digestion
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Figure 3.53.13.4. LC-MS spectra of Z-Gly-Pro-Ser digestion
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Figure 3.5.3.1.3.5. LC-MS spectra of Z-GIy-Pro-Glu digestion
130
----— T--r-----T-«------- ---T-'---------- ----- - ----- - ---*-t-•----' ‘ ‘ ~ ■ ' ' '
100 200 300 400 500 600 700 800 900 m Iz
Figure 3.5.3.13.6. LC-MS spectra of Z-Gly-Pro-His digestion
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Figure 3.53.1.3.7. LC-MS spectra of Z-Gly-Pro-Ala digestion
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3.5.3.2. Chain Length Elongation at the Carboxyl Terminal Site
The chain length of substrates was increased at the carboxyl terminal site while again 
keeping the Z-Gly-Pro sequence constant. With the lowest Ki(app) values (Table 3.6.) 
obtained with Methionine and Phenylalanine in the Pi' position, peptides were 
elongated to include P2 ', P3 ' and P4 '. The peptides sequence and preparation is as 
according to Table 2.3.
3.5.3.2.1. Determination of Kj (app) Values for Proline-Containing Peptides 
Elongated in the COOH-Terminal Direction.
Determination of Kj (app) values in the ZIP catalysed hydrolysis of Z-Gly-Pro-AMC 
using proline-containing peptides of increasing chain length was performed as in 
section 2.7.1.2. Kinetic parameters were determined as according to section 3.5.3.1.1. 
Figures 3.5.3.2.1.1. to 3.5.3.2.1.6. represent Lineweaver-Burk reciprocal plots of each 
of the peptides tested. Table 3.8. lists the K  (app) values obtained and the type of 
inhibition observed.
Peptide
P3 P2 PiJ' Pi' P2' P3' P4'
Assay Cone. 
(HM)
Ki (app) (flM) Inhibition Type
Z-Gly-Pro-Phe * 200 461.53 Mixed
Z-Gly-Pro-Phe-His 200 206.88 Mixed
Z-Gly-Pro-Phe-His-Arg 200 309.40 Competitive
Z-Gly-Pro-Phe-His-Arg-Ser 200 401.72 Mixed
Z-Gly-Pro-Met * 200 554.72 Non-competitive
Z-Gly-Pro-Met-His 200 270.28 Mixed
Z-Gly-Pro-Met-His-Arg 200 333.90 Mixed
Z-Gly-Pro-Met-His-Arg-Ser 200 474.07 Mixed
Table 3.8. Kinetic parameters for the inhibition of ZIP catalysed hydrolysis of 
Z-Gly-Pro-AMC by peptides extended COOH-terminally from the scissile bond.
* See Table 3.6.
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Figure 3.53.2.1.1. Kinetic analysis of the effect of Z-Gly-Pro-Phe-His (♦ ) on ZIP 
catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot of 
fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the mixed inhibition of 
ZIP by Z-Gly-Pro-Phe-His.
1/[Z-Gly-Pro-AMC] (uM 1)
Figure 3.53.2.1.2. Kinetic analysis of the effect of Z-Gly-Pro-Phe-His-Arg (♦) on 
ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot 
of fluorescent intensity versus [Z-Gly-Pro-AMC], Plot illustrates the competitive 
inhibition of ZIP by Z-Gly-Pro-Phe-His-Arg.
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Figure 3.53.2.1.3. Kinetic analysis of the effect of Z-Gly-Pro-Phe-His-Arg-Ser 
(♦ ) on ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk 
reciprocal plot of fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot illustrates the 
mixed inhibition of ZIP by Z-Gly-Pro-Phe-His-Arg-Ser.
1 /[Z-G ly-Pro-A MC] (uM'1)
Figure 3.5.3.2.1.4. Kinetic analysis of the effect of Z-Gly-Pro-Met-His (♦ ) on the 
ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot 
of fluorescent intensity versus [Z-Gly-Pro-AMC], Plot shows the mixed inhibition of 
ZIP by Z-Gly-Pro-Met-His.
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Figure 3.5.3.2.1.5. Kinetic analysis o f the effect of Z-Gly-Pro-Met-His-Arg (♦) 
on ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal 
plot of fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot illustrates the mixed 
inhibition of ZIP by Z-Gly-Pro-Met-His-Arg.
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Figure 3.5.3.2.I.6. Kinetic analysis of the effect of Z-Gly-Pro-Met-His-Arg-Ser
(♦ ) on ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk 
reciprocal plot of fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot shows the 
mixed inhibition of ZIP by Z-Gly-Pro-Met-His-Arg-Ser.
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3.5.3.2.2. Reverse Phase HPLC of COOH-Terminally Elongated Proline- 
Containing Peptides.
Reverse phase HPLC was performed to determine effect of chain length on ZIP 
hydrolysis of proline-containing peptides. Reaction of peptides with ZIP and reverse 
phase HPLC of the resulting digests was performed as outlined in sections 2.7.2.2. 
and 2.7.2.3. respectively. Figures 3.5.3.2.2.1. to 3.5.3.2.2.6. represent chromatograms 
of the peptides studied. Table 3.9. illustrates the peptides tested, detection of cleavage 
and a quantified Z-Gly-Pro value. Only peptides with phenylalanine in the Pi' position 
were quantified in this study. This was basically due to the enhanced hydrolysis of the 
peptides with a phenylalanine in the Pi' position compared with methionine for 
quantification purposes and ease of separation of these peptides digest products post 
hydrolysis using the method outlined in section 2.7.2.3. Digest products of peptides 
with a Pi' methionine residue were separated and analysed using LC-MS only.
Peptide Hydrolysis [Z-Gly-Pro] (mM)
Z-Gly-Pro-Phe Yes 0.096
Z-Gly-Pro-Phe-His Yes 0.655
Z-Gly-Pro-Phe-His-Arg Yes 0.579
Z-Gly-Pro-Phe-His-Arg-Ser Yes 0.548
Table 3.9. Reverse phase HPLC of proline-containing peptides elongated at the 
carboxyl terminal site.
3.5.3.23. Identification of Hydrolysis Products Using Mass Spectrometry
LC-MS was again employed to identify the products of hydrolysis of peptides 
elongated COOH-terminally from the scissile bond. Reaction of peptides with ZIP 
and LC-MS analysis of the resulting digests were performed as outlined in sections
2.7.2.2. and 2.7.3.2. respectively. Figures 3.5 3.2.3.1. to 3.5.3.2.3.6. represent the LC- 
MS spectra of the peptides analysed.
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Figures 3.5.3.2.2.1. and 3.5.3.2.2.2. HPLC chromatogram of Z-Gly-Pro-Phe-His 
hydrolysis by ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.3.2.2.1.) and for peptide and ZIP incubate (Fig. 3.5.3.2.2.2.). Figure 3.5.3.2.2.2. 
illustrates the hydrolysis of Z-Gly-Pro-Phe-His by ZIP.
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Figures 3.53.2.2.3. and 333.2.2.4. HPLC chromatogram of Z-GJy-Pro-Phe-His- 
Arg hydrolysis by ZIP. Plots of absorbance at 214nm versus time for peptide only 
(Fig. 3.5.3.2.2.3.) and for peptide and ZIP incubate (Fig. 3.5.3.2.2.4.). Figure
3.5.3.2.2.4. illustrates the cleavage of Z-Gly-Pro-Phe-His-Arg by ZIP.
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Figures 3.53.2.2.5. and 3.5.3.2.2.6. HPLC chromatogram for Z-Gly-Pro-Phe- 
His-Arg-Ser hydrolysis by ZIP. Plots of absorbance at 214nm versus time for 
peptide only (Fig. 3.5.3.2.2.5.) and for peptide aid  ZIP incubate (Fig 3,5.3.2.2.6.). 
Figure 3.5.3.2.2.6. illustrates the hydrolysis of Z-Gly-Pro-Phe-His-Arg-Ser by ZIP.
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Figure 3.S.3.2J.1. LC-MS spectra for Z-Gly-Pro-Phe-His digestion
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Figure 3.5.3.23.2. LC-MS spectra for Z-GIy-Pro-Phe-His-Arg digestion
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Figure 3.5.3.23.3. LC-MS spectra for Z-Gly-Pro-Phe-His-Arg-Ser digestion
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Figure 3.5.3.23.4. LC-MS spectra for Z-Gly-Pro-Met-His digestion
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Figure 3.5.3.2.3.5. LC-MS spectra for Z-GIy-Pro-Met-His-Arg digestion
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Figure 3.5.3.23.6. LC-MS spectra for Z-Gly-Pro-Met-His-Arg-Ser digestion
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3.5.4. Specificity Studies Involving the Pi Proline Position
The importance of a proline residue in the Pi position was investigated using Z-Gly- 
Leu-Phe-His as substrate. Kinetic analysis and reverse phase HPLC was performed to 
determine the effect of replacing proline in the primary specificity position (Pi) with a 
leucine residue.
3.5.4.1. Kinetic Effect of Introducing Leucine in the Pi Position
The kinetic effect of the peptide Z-Gly-Leu-Phe-His in the ZIP catalysed hydrolysis 
of Z-Gly-Pro-AMC was determined as outlined in section 2.7.1.2. Kinetic parameters 
were determined as explained in section 3.5.3.1.1. Figure 3.5.4.1 represents a 
Lineweaver-Burk reciprocal plot for the peptide using purified ZIP activity. Table 4.0 
lists the K  (app) value and type of inhibition obtained compared to the values 
determined for the peptide Z-Gly-Pro-Phe-His.
Peptide Assay Cone. (jiM) K| (app) (p.M) Inhibition Type
P3 P2 Pi i  Pi' P2'
Z-Gly-Leu-Phe-His 200 1473.74 Mixed
Z-Gly-Pro-Phe-His * 200 206.88 Mixed
Table 3.10. Importance of a Proline Residue in the Pt Position
‘ See Table 3.8.
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Figure 3.5.4.I. Kinetic analysis of the effect of Z-Gly-Leu-Phe-His (♦ ) on the 
ZIP catalysed hydrolysis of Z-Gly-Pro-AMC (o). Lineweaver-Burk reciprocal plot 
of fluorescent intensity versus [Z-Gly-Pro-AMC]. Plot illustrates the mixed inhibition 
of ZIP by Z-Gly-Leu-Phe-His.
3.5.4.2. Analysis of Hydrolysis by ZIP of Z-Gly-Lcu-Phe-His using Reverse 
Phase HPLC
Reverse phase HPLC was performed to determine if replacing the Pi proline residue 
with leucine would have an effect on the peptides hydrolysis by ZIP. Reaction of the 
peptide with ZIP and reverse phase HPLC was performed as outlined in sections
2.7.2.2. and 2.1.23. respectively. Figures 3.5.4.2.I. and 3.5.4.2.2. represent 
chromatograms of the resulting digests post hydrolysis. Figure 3.5.4.2.3. shows the 
retention time of the standard Z-Gly-Leu.
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Figures 3.5.4.2.1. and 3.5.4.2.2. HPLC chromatogram post hydrolysis of Z-Gly- 
Leu-Phe-His by ZIP. Plots of absorbance at 214nm versus time for peptide only (Fig.
3.5.4.2.I.) and for peptide and ZIP incubate (Fig. 3.5.4.2.2.). Figure 3.5.4.2.2. 
illustrates the possible negligible amount of Z-Gly-Leu formed.
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Figure 3.5.4.23. HPLC chromatogram of the standard Z-Gly-Leu.
Plot of absorbance at 214nm versus time for the peptide standard Z-Gly-Leu. The 
chromatogram shows a retention time of 23.317 minutes for the standard, which 
correlates well with the appearance (Fig. 3.5.4.2.2.) of a slight digest product at 
23.333 after the reaction of Z-Gly-Leu-Phe-His with ZIP.
3.5.43. LC-MS Analysis of Peptide Digest
LC-MS was employed to determine if cleavage of the peptide Z-Gly-Leu-Phe-His had 
occurred as shown by reverse phase HPLC and to identify the digest products as 
before. Figure 3.5.4.3. illustrates the LC-MS spectra obtained.
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1Figure 3,5.43. LC-MS spectra of Z-Gly-Leu-Phe-His digestion
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Substrate/Peptide
P3 P2 P i i  Pi' P2' P3' P4'
Hydrolysis + K, (app) (JJ.M) K m (jxM)
Pro-AMC - ND
Gly-Pro-AMC - ND
Z-Gly-Pro-AMC + 270
pGlu-His-Pro-AMC - ND
Z-Pro-Phe - ND
Gly-Gly-Pro-Ala - ND
Z-Gly-Pro-Ala + 862.65
Z-Gly-Pro-Met + 554.72
Z-Gly-Pro-Tyr + 632.76
Z-Gly-Pro-Ser + 672.80
Z-Gly-Pro-Leu + 687.97
Z-Gly-Pro-Glu + (Negligible) 748.90
Z-Gly-Pro-His + 769.07
Z-Gly-Pro-Phe + 461.53
Z-Gly-Pro-Phe-His + 206.88
Z-Gly-Pro-Phe-His-Arg + 309.40
Z-Gly-Pro-Phe-His-Arg-Ser + 401.72
Z-Gly-Pro-Met-His + 270.28
Z-Gly-Pro-Met-His-Arg + 333.90
Z-Gly-Pro-Met-His-Arg-Ser + 474.07
Z-Gly-Leu-Phe-His + (Negligible) 1473.74
Table 3.11. Overall Substrate Specificity Studies on ZIP from Bovine Serum
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3.6. Partial Purification of Prolyl Oligopeptidase From Bovine Serum
3.6.1. Phenyl Sepharose Hydrophobic Interaction Chromatography I
Figure 3.6.1. shows the elution profile of PO activity from a phenyl sepharose 
column, prepared and run according to section 2.8.1. This purification column is the 
exact same as that used for the isolation of ZIP activity (see section 3.3.2.). The first 
activity peak, which is present in the run through and inhibited by JTP-4819, is prolyl 
oligopeptidase activity (see Figure 3.3.2.2). Fractions 5-9 were pooled yielding 25ml 
post phenyl sepharose I PO sample. 1.5ml was retained for quantitative PO (section
2.4.2.) and quantitative protein (section 2.2.1.) determinations.
3.6.2. Phenyl Sepharose Hydrophobic Interaction Chromatography n
After concentration and salting of the post phenyl sepharose I PO pool, the sample 
was further purified by application to a second phenyl sepharose column as outlined 
in section 2.8.2. Figure 3.6.2. illustrates the elution profile of PO activity and protein, 
measured according to sections 2.4.4. and 2.2.2. Fractions 35-38 were combined to 
give 20ml post phenyl sepharose chromatography II PO pool. 1.5ml of this pool was 
retained for quantitative PO activity (section 2.4.2.) and quantitative protein (section 
2.2.2) measurements.
3.6.3. Cibacron Blue 3GA Chromatography
Concentrated and dialysed post phenyl sepharose II PO was applied to a cibacron blue 
3GA column and further purified as outlined in section 2.8.3. PO activity failed to 
bind to the resin and was collected in the run through. Figure 3.6.3. illustrates the 
elution profile of PO activity and protein, measured according to sections 2.4.4. and
2.2.3. Fractions 4-6 were combined to yield 15ml post cibacron blue PO sample. 
1.5ml of this pool was retained for quantitative PO activity (section 2.4.2.) and 
quantitative (section 2.2.2.) determinations.
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Figure 3.6.1. Elution Profile of PO Activity During Phenyl Sepharose 
Hydrophobic Interaction Chromatography I.
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Figure 3.6.2. Elution Profile of PO Activity During Purification using Phenyl 
Sepharose Hydrophobic Interaction Chromatography II.
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Purification Step Volume
ml
Total Activity
Units
Total Protein
mg
Crude Serum 20 12.64 1766
Phenyl Sepharose I 25 12.42 534.44
Phenyl Sepharose II 20 2.55 24.82
Cibacron Blue 15 1.13 4.33
Table 3.12. Purification of PO from Bovine Serum
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Specific Activity Purification Factor Recovery
Units/mg %
0.00716 1 100
0.023 3.2 98.26
0.103 14.39 20.17
0.261 36.45 8.94
3.7. Inhibitor Studies
3.7.1. Effect of Diisopropylfluorophosphate (DFP) on Purified ZIP Activity
Previous studies on the catalytic classification of ZIP from bovine serum only 
possibly confirmed it as a serine protease (Bimey and O’Connor, 2001). This was due 
to 58% inhibition by AEBSF at 22.5mM concentration. To finally catalytically 
classify ZIP as a serine protease, the irreversible and classic serine protease 
inactivator DFP (Barrett, 1994) was used. The effect of DFP on purified ZIP activity 
was investigated as outlined in section 2.9.1. Figure 3.7.1. illustrates the inactivation 
of purified ZIP activity from bovine serum by DFP.
Figure 3.7.1. Inhibitor Profile Effect of DFP
Log plot of enzyme activity versus DFP concentration. Plot shows the concentration 
of DFP required to reduce the activity by 50%. The IC50 value of DFP for purified 
bovine serum ZIP was deduced to be 0.1 pM. Enzyme activities are expressed as a 
percentage of uninhibited enzyme.
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3.7.2. Effect of Specific Prolyl Oligopeptidase Inhibitors
The potency of specific Prolyl oligopeptidase inhibitors towards purified ZIP and 
partially purified PO activities from bovine serum was assessed.
3.7.2.I. Determination of ICso Values
The effect of four potent and specific inhibitors on bovine serum ZIP and PO 
activities was investigated as outlined in section 2.9.2. Figures 3.7.2.1. to 3.7.2.10. 
illustrate the effect each inhibitor has on both serum activities. Interestingly, all five 
inhibitors had little or no effect on ZIP activity even at high concentrations of 
inhibitor. JTP-4819 and Fmoc-Ala-PyrrCN with IC50 values of 0.8nM and 1.5nM 
respectively, were the most potent towards PO activity. Table 4.2. summarises the 
IC50 values determined for ZIP and PO activities.
Inhibitor IC50 for ZIP (M) IC50 for PO(M)
Fmoc-Ala-PyrrCN ND 1.5xl0'9
Z-Phe-Pro-Benzothiazol ND 4.5xl0'8
SR 063298 ND lxlO'7
SR 063125 ND 9x1 O'8
JTP-4819 ND 8x1 O'10
Table 3.13. IC50 Values Determined for Prolyl Oligopeptidase Inhibitors
Results are expressed as IC50 (M), which were taken as the concentration of inhibitor 
required to inhibit enzyme activity by 50% (section 6.4.4.).
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Fmoc-Ala-PyrrCN concentration (M)
Figures 3.7.2.1. and 5.1.2.2. Inhibitor Profile Effects of Fmoc-Ala-PyrrCN
Log plots of enzyme activity versus specific inhibitor concentrations. Figure 3.7.2.1. 
shows the effect of Fmoc-Ala-PyrrCN on PO activity, whereas Figure 3.7.2.2. 
illustrates the failure o f Fmoc-Ala-PyrrCN to have any effect on ZIP activity. Enzyme 
activities are expressed as a percentage of uninhibited enzyme.
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Z-Phe-Pro-Benzothiazol concentration (M)
Z-Phe-Pro-Benzothlazol concentration (M)
Figures 3.72 3 .  and 3.72.4. Inhibitor Profile Effects of Z-Phe-Pro-BT
Log plots of enzyme activity versus specific inhibitor concentrations. Figure 3.7.2.3. 
illustrates the inhibition of PO activity with Z-Phe-Pro-BT, whereas Figure 3.7.2.4. 
shows the failure of Z-Phe-Pro-BT to inhibit ZIP activity. Enzyme acti vity expressed 
as a percentage of uninhibited enzyme.
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Figures 3.7.2.5. and 3.7.2.6. Inhibitor Profile Effects of SR 063298
Log plots of enzyme activity versus specific inhibitor concentrations. Figure 3.7.2.5. 
illustrates the inhibition of PO activity with SR 063298. Figure 3.7.2.6. shows the 
failure of SR 063298 to inhibit ZIP even at high concentrations.
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SR 063125 concentration (M)
Figures 3.1.2.1. and 3.7.2.8. Inhibitor Profile Effects of SR 063125
Log plots of enzyme activity versus specific inhibitor concentrations. Figure 3.1.2.7. 
illustrates the inhibition of PO activity by SR 063125. Figure 3.7.2.8. shows almost 
30% inhibition but at an inhibitor concentration of 20jjM,
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J TP-4819 concentration (M)
Figures 3.7.2.9. and 3.7.2.10. Inhibitor Profile Effects of JTP-4819
Log plots of enzyme activity versus specific inhibitor concentrations. Figure 3.7.2.9. 
illustrates the inhibition of PO activity by JTP-4819. Figure 3.7.2.10. shows the 
failure of JTP-4819 to inhibit ZIP activity.
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3.8. Immunological Studies
Western blot analysis was performed as outlined in section 2.10.1. to determine if a 
polyclonal antibody (anti-human prolyl oligopeptidase) would show any 
immunological cross reactivity with purified ZIP protein and partial purified PO from 
bovine serum. Figures 3.8.1.1. and 3.8.1.2. represent westem-blot analysis of the 
proteins.
PO/PEP (80kDa)
Actin (40kDa)
SY5Y ZIP U343 PO U343
Figure 3.8.I.I. Westem-Blot Analysis of Bovine ZIP and PO
(A) U343 PO U343 (B) Rat cortex
PO/PEP
<- Actin
Figure 3.8.I.2. Westem-Blot Analysis
(A) A more concentrated PO sample applied with possible cross reactivity. (B) The 
ability of the anti-human PO/PEP antibody to immunoreact with rat cortex PO.
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3.9. Identification of this Z-Pro-prolinal Insensitive Peptidase
3.9.1. TV-Terminal and Internal Sequencing
50ml o f bovine serum was purified to obtain sufficient ZIP sample for sequence 
analysis. SDS PAGE was performed as outlined in section 2.11.1.1. and followed by 
electroblotting to a PVDF membrane (section 2.11.1.2.). Figure 3.9.1. is an image of 
the coomassie-stained blot. This blot was sent to Dr. Bryan Dunbar, Protein 
Sequencing Department, University of Dundee, Scotland for N-terminal sequencing. 
The molecular weight reported previously for ZIP was 95kDa (Bimey, 2000). The 
blot showed a possible faint band close to this location but also a number of other 
bands possibly due to purifying up to 50ml starting material.
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Figure 3.9.1.1. Coomassie-Stained PVDF Membrane Blot
The N-terminal sequence of the faint band visible just below the 98kDa marker in 
Figure 3.9.1.1. failed to be successfully determined after many attempts. This was 
reported to be due to an inadequate amount of protein present in this band. The strong 
band above the 52kDa was determined to be BSA from sequencing, while the band 
just below was N-terminally blocked, resulting in no sequence data. Due to failing to 
obtain any sequence data that may be of interest with regards to our activity, another 
larger sample was prepared. 60ml of bovine serum was purified over the first three 
columns in the purification procedure and this partial purified concentrated ZIP
1 6 6
sample was sent to the Proteomics Department, University of Dundee for internal 
sequencing.
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Figure 3.9.I.2. SDS PAGE Gel of Partial Purified ZIP Sample
It is obvious from Figure 3.9.1.2. that using such a large volume of starting material 
and only performing partial purification of the sample caused many more contaminant 
bands to be present. The reason for removing a step in the purification procedure was 
the hope that there would be more of our target protein present to obtain sequence 
data from. Internal sequencing of the major band below the 55kDa marker, which 
corresponds to the N-blocked protein in Figure 3.9.1.1. resulted in identification of up 
to seven proteins with the major protein identified being bovine heavy chain IgG. No 
other protein identified was of any interest to our protease activity.
It was obvious from these results that without knowledge of the exact location of the 
ZIP band under denaturing conditions it was impossible to sequence and identify the 
protein of interest. This was made more difficult when trying to purify up to 60ml of 
serum using the optimised protocol in order to obtain enough target protein and the 
unavailability of an antibody towards ZIP.
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3.9.2. In Gel (Zymogram) Assay
The only alternative remaining, in order to be sure that the correct protein of interest 
was being sequenced was an in gel (zymogram) assay for ZIP. There was no reports 
of this technique been performed previously using this enzyme. A 10% native 
polyacrylamide gel was prepared and run according to section 2.11.2.1. Figure
3.9.2.1. illustrates a zymogram showing the presence of native ZIP hydrolysing the 
substrate Z-Gly-Pro-AMC, viewed under ultraviolet light.
Z I P - >
Figure 3.9.2.I. Native PAGE Analysis of ZIP Proteolytic Activity.
The zymogram clearly shows fluorescent bands (-»), which appear in the region of substrate 
hydrolysis after visualisation under ultraviolet light.
The fluorescent bands above were excised and placed in ultra-pure water overnight at 
4°C. This was performed so that the protein present in the bands would diffuse out of 
the bands into solution. Due to the small amount of protein present in each band this 
technique didn’t seem to work to any great extent. A fluorescent band, which was also 
excised from the same gel, was then sent to the University of Dundee for internal 
sequence analysis. Again, due to such a low level of protein present within this gel 
piece it was rather difficult to identify the protein/s present. The two proteins that 
were identified by internal sequence analysis were IgG and fibronectin. Fibronectin 
was interesting at first, as its plasma form is known to have potential proteolytic 
activity. Therefore, it was important to remove these two proteins from the sample if 
they are contaminants, but if the activity is being caused by fibronectin to try and 
remove this activity by gelatin chromatography.
80ml of bovine serum was purified, but this time in 20ml batches as described as 
always in section 2.5. The pooled activity from each purification was concentrated
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and chromatography performed using protein G affinity resin as outlined in section
2.11.2.3. This resin failed to bind ZIP and any IgG present in the sample was 
successfully removed. The next step as outlined in section 2.11.2.4. involved running 
this post protein G ZIP sample on a gelatin sepharose resin. The ZIP activity failed to 
bind to this resin also, thus eliminating any involvement of fibronectin in our protease 
activity. The final sample was prepared and run on a native page gel and finally 
analysed using ultraviolet zymography and silver staining as outlined in sections
2.11.2. and 2.6.2.4.
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Figure 3.9.2.2. In Gel Assay (Zymogram) and Silver Staining of Native ZIP
The fluorescent band in Figure 3.9.2.2. was excised and sent to the Harvard 
Microchemistry Facility where sequence analysis was performed by microcapillary 
reverse-phase HPLC nano-electrospray tandem mass spectrometry ((J.LC/MS/MS) on 
a Finnigan LCQ DEÇA XP Plus quadrupole ion trap mass spectrometer.
The procedure used as mentioned identified the ZIP protein as Seprase, which is a 
known serine protease, associated with the small group of serine integral membrane 
peptidases. The peptides sequenced and identified are shown below.
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Oil 15933540 MS/HS Spectra: 12 Sum TIC: 4.1*8 Avfl TIC 34e7
fibroblast activation protein, alpha siibunit; integ-al membrane serine prowase; s«irase [Homo sapiens] gi|l924982|gb|AAC5l668.1| integral 
membrane serine pretease Seprase [Homo sapiensl 0|2OO728ll|gb|AAH262SO.L| fibroblast activation protein, alpha [Homo sapiens]
Sequence Reference TIC lone Scan
(-> KLGVYEVEDQITAVR gi|l6933W0 13 5.4e7 22/28 899
(-) KLGWEVEDQUAVR gi 116933WO 13 l.le8 35/56 897
C-> layvyqnniylx gl 116933540 tS 3.1e7 17/22 858
t-) IFHG1P0WVYSEM*LATK gi 116933W0 13 1.7«7 20/34 1243
[-) FIEM'GFIDEKR yi 116933W0 13 6.6e6 16/20 734
(-> NVDYIUHGTADDHVHFQNSAQIAK gl|16933W0 »6 1.2e6 25/96 1260
H  YALWWSPNGK nil 16933WO 12 3.2e6 14/18 1019
(-) U.YAVYR gi 116933540 +3 7.5e7 11/12 713
(-) F1EM*GFIDEK $116933540 +3 2.7e6 13/18 769
(-) WEAINIFR gi|16933540 +2 1.0C8 13/14 1052
(-) T1NIPYPK 0116933540 +5 3.3e6 10/14 733
Figure 3.9.23. The Peptides Sequenced and Identification of the Serine Protease 
Seprase.
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DISCUSSION
4.0. Discussion
4.1. Fluorescence Spectrometry using 7-Amino-4-Methyl-Coumarin
This work presented focused mainly on the study of ZIP (Z-Pro-prolinal Insensitive 
Peptidase), a possibly novel proline specific peptidase activity from bovine serum. 
The uniqueness of this peptidase was its ability to cleave the supposedly specific 
prolyl oligopeptidase substrate Z-Gly-Pro-AMC, but being completely distinct to this 
serine peptidase (Cunningham and O’Connor, 1997a).
A method capable of detecting low-levels of these peptidase in biological systems is 
essential. The selection of substrates for the enzyme of interest has evolved over the 
years when when the properties and functionality become clearer like, Walter et al. 
(1971) identifying prolyl oligopeptidase using radiolabelled oxytocin. In recent years 
synthetic substrates have been specifically designed for enzyme detection. The main 
parameters ruling substrate selection are enzyme specificity and the flurophore or 
chromophore employed. Generally, fluorescence spectroscopy offers increased safety, 
sensitivity and specificity over colorimetric, spectrometric and radiometric assays. 
The high sensitivity results from the wavelength difference between the exciting and 
fluorescence radiation, resulting in minimal background, while the high specificity is 
due to the dependence on both an excitation and emission spectra (Willard et al. 
1988).
The substrate used for ZIP detection was Z-Gly-Pro-AMC. This substrate was first 
synthesised and applied in the detection of prolyl oligopeptidase by Yoshimoto et al. 
(1979) who determined a Km value of 20^M and noticed increased sensitivity over 
other substrates. This externally quenched fluorimetric substrate is suitable for 
endopeptidase mediated peptide bond cleavage on the carboxyl side of the proline 
residue leading to the liberation of the fluorophore, AMC. Excitation to a higher 
energy state occurs at 370nm due to the absorption of electromagnetic radiation by 
AMC, followed by the return of the molecule to a lower state and re-emission of 
radiation at 440nm. The sensitivity of fluorimetric assays may be improved by 
expansion of the emission slit width, which consequently broadens the bandwidth 
over which light is integrated. Therefore, for samples with low enzyme activity
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resulting in low fluorescence, adaptation of the emission slit width ensures improved 
sensitivity.
The major disadvantage of fluorimetric assays is the occurrence of quenching and the 
inner filter effect. With regard to fluorescence a variety of forms of quenching can 
affect sensitivity resulting in misleadingly low fluorescence. Quenching mostly 
involves the removal of energy from a molecule in the excited state by another 
molecule. The most common form is collisional impurity quenching caused by 
molecular collisions. It is the form of quenching that is a result of the presence of 
impurities that absorb either the exciting or emitted radiation, leading to the reduction 
in fluorescence that is particularly problematic when using crude biological samples 
such as serum. This form of quenching is better known as the inner filter effect.
4.1.1. AMC Standard C u r v e s  and the Inner Filter Effect
Enzyme activity was quantified (section 6.1.) from liberated AMC, as a result of 
peptide cleavage, by reference to standard curves. Free AMC standard were prepared 
according to section 2.2.1. and the linear relationship between AMC concentration 
and fluorescence intensity at excitation and emission wavelengths of 370nm and 
440nm is clearly exhibited in Figures 3.2.1. and 3.2.2. The slope of each standard 
curve is reported in Table 3.1.
To compensate for the inner filter effect it was necessary to prepare AMC standard 
curves in the presence of serum. Section 2.3.2. described the preparation of these 
standard curves and from Figure 3.2.3. a notable reduction in fluorescence was 
obvious on incorporation of serum This decrease is obvious from the reduced slope 
(Table 3 .1.), which is indicative of a reduced sensitivity. Bovine serum accounted for 
up to 7.4% filtering at excitation and emission slit widths of lOnm and 5nm 
respectively. All post column chromatography samples were checked for possible 
inner filter interference. As shown in Figure 3.2.4. and reported in Table 3.1. post 
phenyl sepharose showed 4.2% filtering but further purification of the sample resulted 
in no apparent effect of filtering.
These results are very important when assessing a purification procedure. Starting 
material for such procedures usually constitute a crude sample, like serum, highly 
susceptible to inner filtering. When using such crude, highly coloured, high protein
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samples failure to consider effect of filtering would reveal a lower activity than 
actually present. It is evident that filtered AMC standard curves are essential for 
accurate enzyme quantification using fluorimetric assays.
The inner filter effect was also investigated during characterisation studies using 
inhibitors, functional reagents and even buffers to be certain the compound is 
affecting the enzyme and not the liberated fluorescence.
4.2. Protein Determinations
As described earlier the fluorimetric enzyme assay was essential for activity 
determination in a particular sample. It is also equally essential to determine total 
protein content, which in relation to the purification of ZIP was evident when 
calculation of specific activity relied heavily on accurate determination of the protein 
content. Determination of protein content is also essential for estimating the degree of 
purification obtained by a particular fractionation step.
Many protein assays have evolved each with their own advantages and disadvantages 
(Dunn, 1989). The most non-specific, rapid and inexpensive method utilises 
ultraviolet spectrometry commonly at a wavelength of 280nm for protein detection. 
This assay exploits the ability of the aromatic amino acids, tyrosine and tryptophan to 
absorb at 280nm. Unfortunately, it is well known that serum has a great variety of 
nonproteinaceous, uv-absorbing compounds (Schlabach, 1984).
The biuret assay (section 2.2.1.) was employed for protein detection in crude samples. 
It is not reliant on amino acid composition of the protein and less prone to 
interference than ultraviolet spectrometry at 280nm. Under alkaline conditions copper 
ions readily complex adjacent peptide bonds, producing a purple colour with an 
adsorption maximum at 540nm. The linear relationship observed between protein 
concentration and absorbance at 540nm up to lOmg/ml (Figure 3.1.1.) for this assay 
allowed for total protein estimation in enzyme samples. This assay was performed in a 
microtitre plate, using only 50[il of sample.
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Samples containing less than 2mg/ml of protein were assayed using the bicinchoninic 
acid (BCA) assay, first developed by Smith et al. (1985). It combines the biuret 
reaction of the reduction of Cu2+ by protein to Cu1+, with the highly sensitive and 
selective colorimetric detection of the cuprous cation (Cu1+) by BCA. The assay is 
generally linear up to 2mg/ml (Figure 3.1.2.) and only 25 .^1 of sample is required for 
analysis.
The Coomassie Plus protein assay was used for detection of low levels of protein, 
typical values between 2.5 and 25(j.g/ml. The coomassie molecule binds to protein in 
an acidic medium causing a colour change from brown to blue, maximally absorbing 
at 595nm. This assay is linear up to 25^g/ml (Figure 3.1.3.). A disadvantage of this 
reagent is batch to batch variation and the need for up to 150fxl of sample for analysis.
Method and Detection 
Range
Interférants Comments
A 280
(0.05-2mg/ml)
Nucleic acids, Haem 
containing compounds
Relatively insensitive, 
non-specific, Rapid
Biuret
(l-10mg/ml)
Ammonia, Bile pigments Low sensitivity, unaffected 
by amino acid composition
BCA
(0.02-2mg/ml)
Reducing agents, Sugars Little interférants, 
Extremely sensitive
Coomassie Plus
(2.5-25|xg/ml)
High concentrations of DTT Batch to batch variation 
Very sensitive
Table 4.1. Comparison of some protein determination assays
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4.3. Enzyme Assays
The activity of ZIP studied in this work was determined fluorimetrically using AMC 
release. The linear relationship between fluorescence and AMC concentration allows 
for the accurate quantification of enzyme activity (see appendix, section 6.1.).
Z-Gly-Pro-AMC was the synthetic substrate used for the detection of ZIP activity. 
Enzyme assays were performed as outlined in sections 2.4.2., 2.4.3. and 2.4.4. 
showing a slight modification of the assay system employed previously by Bimey and 
O’Connor (2001). When designing the assays it had to be carefully considered that 
Yoshimoto etal. (1979) described Z-Gly-Pro-AMC as a specific prolyl oligopeptidase 
substrate. So as outlined in section 2.4.3. a specific prolyl oligopeptidase inhibitor, in 
this case JTP-4819 instead of Z-Pro-prolinal, was incorporated into the assay. This 
enabled the identification of ZIP activity alone in samples such as serum also 
containing prolyl oligopeptidase activity. The procedure described in section 2.4.2. 
was therefore employed for the detection of either ZIP or PO activity once they were 
separated. In this case the assay was used for ZIP activity detection in samples, which 
were known to be free of prolyl oligopeptidase activity (e.g. post column pools).
Figure 4.1. Chemical Structure of Inhibitor JTP-4819
The cuvette based assays were ideal in that they proved specific for ZIP or PO 
activity, were sensitive, quantifiable, rapid and simple so meeting the requirements of 
any enzyme assay. The third assay described in section 2.4.4. is a microtitre plate 
assay, developed to enable rapid identification of enzyme activity in post column 
chromatography fractions. The microtitre plate assay proved ideal for non-quantitative 
enzyme detection, using less sample, substrate and acid volumes than the cuvette and 
only half the incubation period before analysis.
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In order to express the activity of an enzyme quantitatively it is necessary to ensure 
that the assay procedure used is measuring the true initial velocity and that this is 
proportional to the enzyme concentration. When the time-course of product 
formation, or substrate utilisation, is determined a curve such as that shown in Figure
4.2. is usually obtained. The time-course is initially linear but the rate of product 
formation starts to decline at longer times. There are several possible reasons for 
departure from linearity such as substrate depletion, product inhibition, enzyme or 
substrate instability, time-dependant inhibition or a change in assay conditions. 
Therefore, due to these potential problems it is desirable, if possible to adjust assay 
conditions such that a linear response is maintained for a sufficient time to allow 
direct measurement of initial rate/velocity.
IProtJucil
T im e
Figure 4.2. A Typical Progress Curve of an Enzyme-Catalysed Reaction
Due to using a discontinuous assay (section 2.4.2.), quantification of ZIP or PO 
activity could not be relied upon unless linearity of the assay had previously been 
assured using a continuous assay system. Purified ZIP and partial purified PO were 
linear using lOOfiM substrate with respect to time, over a 60-minute period, and with 
respect to enzyme concentration. These assay conditions for ZIP activity was also 
used previously by Bimey and O’Connor (2001). Overall, the linearity of these assays 
with respect to time and enzyme concentration permitted quantitative expression of 
enzyme activity using a fluorescent reading (section 6.1.).
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4.4. Protein Purification
The purification of a protein from a mixture that may only constitute 1% of the 
species of interest incorporates the exploitation o f a number of physical, chemical and 
biological characteristics of the target protein. The purification of a protein is 
frequently not the end point itself, but the means of obtaining a pure protein for 
further studies. These studies may be on the activity of the protein, on its structure or 
on its structure-function relationships. Overall, these studies will dictate the necessary 
purity, activity and quantity of the protein required. It is these parameters that play a 
considerable role in the selection of the purification process for the target protein.
4.4.1. Purification of ZIP from Bovine Serum
The isolation of ZIP for characterisation studies required the production of relatively 
large quantities of highly purified active enzyme. The most important factor to be 
taken into consideration was the conservation of biological activity throughout the 
purification process. The purification of ZIP from bovine serum was performed 
according to section 2.5. showing significant modification of the original procedure 
reported by Bimey and O’Connor (2001). These modifications were deemed 
necessary in order to obtain an increased level of purity. Overall, a highly effective 
purification procedure was established.
4.4.1.1. Serum Preparation
Due to the optimisation of the purification protocol for ZIP and subsequent 
characterisation studies, a relatively large volume of purified enzyme was necessary, 
which in turn necessitates a large amount of starting material. Therefore, a reliable 
commercially available, inexpensive source that was high in ZIP content was 
essential. Bovine serum fulfilled these criteria and was thus selected as the ideal 
source for the isolation of ZIP. Bovine serum was prepared as outlined in section
2.5.1. by centrifugation of the non-clotted portion of bovine whole blood thus 
generating a large volume of serum. Storage at -17°C had no effect on the stability of 
ZIP activity over a long period of time.
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4.4.1.2. Phenyl Sepharose Hydrophobic Interaction Chromatography
Protein surface hydrophobicity occurs due to the presence at the surface, of the side 
chains of non-polar amino acids such as alanine, methionine, tryptophan and 
phenylalanine. These surface hydrophobic amino acids are usually arranged in 
patches. The number, size and distribution of these non-ionic regions is a 
characteristic of each individual protein, which can therefore be exploited as a basis 
for their separation. In solution a protein molecule holds a film of water in an ordered 
structure at its surface, which must be removed from non-ionic domains so 
hydrophobic interaction can occur. Salting-out ions decrease the availability of water 
molecules in solution, increase the surface tension and enhance hydrophobic 
interaction (Roe, 1989). Phenyl sepharose is classified as a high capacity resin (20mg 
protein/ml), therefore with serum as the enzyme source this resin was chosen as the 
initial column for the purification procedure.
Before application to the phenyl sepharose resin solid ammonium sulphate to a final 
concentration of 200mM was added to serum as outlined in section 2.5.2, This method 
of salting avoided dilution and dialysis, which were shown to substantially decrease 
biological activity. The most interesting observation from the elution profile in Figure
3.3.2.2. of the HIC column was the presence of the two distinct Z-Gly-Pro-AMC 
hydrolysing activities. Knowing of the existence of ZIP and from previous 
fractionation of these activities by HIC chromatography, it was assumed that the first 
peak was prolyl oligopeptidase activity, while the second showed the presence of ZIP 
in bovine serum. Figure 3.3.2.2. confirmed this when the run through peak was totally 
inhibited by JTP-4819, with the elution peak, hence deduced ZIP, showing no effect 
by the specific inhibitor.
On the purification of ZIP, this resin was very successful in separating ZIP from bulk 
contaminating protein. A large protein peak (Figure 3.3.2.1.) is evident in the column 
run through with a smaller peak observed during the second wash. ZIP activity co­
eluted with the third peak in the final wash in the complete absence of salt. The 
substantial loss of protein, 1766mg to 37.15mg, along with only a 6.8% loss of ZIP 
activity resulted in a 44-fold purification using HIC.
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4.4.1.3. Calcium Phosphate Cellulose Chromatography
The resin for this purification step was produced in the laboratory (section 2.5.3.1.) 
according to modifications of the methods described by Tiselius et a I. (1956) and 
Donlon and Kaufman (1980). Bulk preparation of calcium phosphate cellulose resin 
in the laboratory eliminates any concerns of possible batch to batch variation. The 
difficulty in predicting the precise mechanism of action of this resin in column 
chromatography has limited its use as a purification tool. It is thought that the 
mechanism of protein adsorption onto calcium phosphate cellulose involves both Ca2+ 
and PO43' groups on the crystal surface (Bemardi et al. 1972).
The elution profile of ZIP on this resin is presented in Figure 3.3 .3. with resolution of 
ZIP activity from contaminating protein being observed. The inclusion of the 170mM 
wash (section 2.5.3.2.) was essential for removal of contaminating protein but more 
importantly was responsible for separating ZIP from Gly-Pro-AMC and Z-Phe-Arg- 
AMC degrading peptidases.
The effectiveness of this resin is seen by the 96% reduction in protein applied to the 
column but as shown in Table 3.2. this is coupled with only a 57% recovery of 
applied activity. There was still a 621-fold purification factor achieved using this 
resin. It was therefore apparent that the calcium phosphate cellulose resin proved 
successful for the further purification of ZIP.
4.4.1.4. Cibacron Blue 3GA Chromatography
The use of an anion exchange resin as employed by Bimey and O’Connor (2001) 
failed in this case to further resolve ZIP activity from contaminating protein. Cibacron 
blue 3GA is a reactive dye, which is used in affinity chromatography protein 
purification. This resin is ideal for removing bovine serum albumin contamination 
from serum samples, so it was employed in this case for the removal of possible 
bovine serum contamination and hence further purify ZIP.
Figure 3.3.4. presents the elution profile, which clearly shows that ZIP activity 
actually bound to the resin and eluted during the increasing salt gradient applied. The 
initial reason for this resin was in the hope that ZIP would run through and thus be 
separated from any contaminating bovine serum albumin present in the sample. Even
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though this failed to be the case, the chromatography step proved incredibly effective 
with a 80-fold decrease in total protein content. The recovery of applied activity was 
only 37% but it still enabled a 18,735-fold purification to be obtained along with 20% 
overall recovery of biological activity after three chromatographic steps (Table 3.2.). 
This 18,735-fold purification factor compares to the 4023-fold obtained previously for 
a three step purification of ZIP from bovine serum (Bimey and O’Connor, 2001).
4.4.I.5. S-300 HR Gel Filtration Chromatography
Proteins have a characteristic molecular size and shape when dealing with gel 
filtration chromatography. This is based on their molecular weight due to the number 
and size of their amino acids and the folding of the protein. The seperation 
mechanism of gel filtration chromatography involves both molecular shape and mass 
of the protein. It is a very popular non-binding technique employed for protein 
purification. When a mixture of differing molecular weights is applied to the resin, 
large molecules fail to enter the pore beads and move through the column rapidly, 
while small sized molecules become retarded as they become trapped in the pore 
beads. The rate of movement is directly proportional to the size of the molecule and 
on this basis protein separation occurs.
S-300 gel filtration chromatography was chosen as the final column in the purification 
procedure. It is ideal at this stage due to its relatively low capacity and ability to aid in 
assessing the purity of a preparation. The elution profile is presented in Figure 3.3.5. 
The resin was very effective in removing some large molecular weight contaminants 
as shown by the protein peak prior to the activity peak of ZIP. It also removed any of 
the remaining Z-Phe-Arg-AMC degrading peptidase activity present in the sample. 
Overall, it was an ideal clean up step for the preparation only losing about 40% of 
applied activity while still reducing protein from 19|a.g to 7|ig.
During the purification of ZIP, appropriate precautions and considerations were taken 
throughout. Even though concentration steps were involved throughout the procedure 
extensive dialysis was only performed once, as this step is known to be detrimental to 
activity at times during protein purification. All steps were carried out at 4°C except 
the final column, which was at room temperature, but this change didn’t affect
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activity to any large extent. All steps were performed consecutively leading to the 
specific activity of purified ZIP being 30,197-fold higher compared to that in crude 
serum. A 12% conservation of biological activity after the reduction of protein from 
1766mg to 0.007mg was considered very successful. Defining the purity of the 
protein for enzymic studies in terms of the percentage of total protein shows that the 
ZIP sample is possibly up to 99% pure.
4.5. Purity Assessment
Purity of the protein of interest after purification can simply be defined in terms of the 
percentage of total protein as mentioned in section 4.4.1.5. though other contaminants, 
which are important, must be considered. Typically for enzymic studies a purity of 
80-90% is adequate, though the presence of active proteases or other enzymes that 
could interfere with activity are unacceptable. Therefore, it is unnecessary and almost 
unattainable to try and obtain a pure protein i.e. one population of molecules all with 
identical covalent and three-dimensional structures in solution. For the purpose of this 
study, purity was assumed if the sample was shown not to contain any contaminants 
that would interfere with intended experiments with ZIP. Assessment of a suitable 
purity level was achieved using fluorimetry-based analysis and SDS PAGE.
To detect for the presence of contaminating peptidases in the purified (post S-300) 
ZIP sample a number of fluorimetric assays were performed. The substrates employed 
are shown in Table 2.1. with the presence of the peptidase being determined by a 
measure of AMC release (section 2.6.1.). As highlighted in Table 3.3. no hydrolysis 
of any substrate other than Z-Gly-Pro-AMC was detected. The absence of 
contaminating peptidases such as prolyl oligopeptidase and dipeptidyl peptidase IV 
was essential since they would have interfered with subsequent physiochemical 
analysis such as substrate specificity studies further on.
Figures 3.4.2.1. and 3.4.2.2. represent images of gelcode blue and silver stained 
polyacrylamide gels respectively. Figure 3.4.2.1. illustrates that as the purification 
procedure progressed (lanes 2-4) there was a reduction of the bands present. The final 
step in the purification, post S-300 (lane 5) clearly shows no visible band present 
when stained with this coomassie based reagent. Silver staining (Figure 3.4.2.2.) of 
lanes 4-7 show the presence of a faint band with a molecular weight of about 95-
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96kDa present in lane 5 i.e. purified sample. This band is relatively faint with no other 
bands apparently visible in this lane. Bimey (2000) also reported a molecular weight 
of 95kDa for ZIP based on silver stained SDS PAGE analysis.
Based on fluorimetric and SDS PAGE analysis, post S-300 gel filtration ZIP sample 
was deemed acceptably pure for further studies.
4.6. Substrate Specificity
The substrate specificity of ZIP is potentially the most important study that can be 
undertaken to ultimately understand the possible function of this enzyme. Previous 
work on the specificity of ZIP studied proline containing bioactive peptides as 
potential substrates (Bimey and O’Connor, 2001). It is known that the specificity of a 
protease is determined not only by the two amino acid residues at either side of the 
scissile bond of a peptide substrate, but also by amino acid residues more distant from 
the point of hydrolysis. Therefore, this work was performed in order to investigate the 
secondary specificity of ZIP using peptide substrates of various structural 
conformation and length (Table 3.11.). These studies involved, (i) chain elongation at 
the amino side of the primary specificity proline residue, (ii) amino acid preference at 
the carboxyl side of the scissile bond, (iii) chain elongation at the carboxyl side of the 
primary specificity proline residue and, (iv) a final study was undertaken to 
investigate the importance of the primary specificity proline residue in ZIP catalysed 
hydrolysis. These studies were performed using kinetic analysis, RP-HPLC and LC- 
MS. Prolyl oligopeptidase is the only other proline specific endopeptidase known and 
its substrate specificity is thoroughly documented. Thus all results discussed will be 
directly compared to the specificity of prolyl oligopeptidase.
The effect of a range of proline containing peptides on the ZIP catalysed hydrolysis of 
Z-Gly-Pro-AMC enabled Ki (app) values to be obtained for each peptide according to 
section 6.4.1. The complex situation arises when one questions whether a substrate 
can be classified as an actual inhibitor. Rahfeld el a I. (1991) explained the situation 
where one enzyme hydrolyses two substrates simultaneously that one substrate (S2) 
formally acts as the inhibitor for the other substrate (SI) (e.g. SI = Z-Gly-Pro-AMC; 
S2 = Z-Gly-Pro-Phe). The K; value in this case is not the true thermodynamic 
dissociation constant of the E-S2-complex but the Km value for the substrate S2.
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Therefore Kj (app) values obtained in this study will be regarded as the affinity 
constants of the enzyme ZIP for that particular peptide.
The high resolving power, speed and efficiencies typically achieved using reverse 
phase high performance liquid chromatography (RP HPLC) makes it the predominant 
technique for peptide separation. In this study RP HPLC was performed (section
2.7.2.) to detect hydrolysis and the subsequent cleavage products following incubation 
of certain peptides with purified ZIP. A silica based analytical column containing 
octadecyl ligands (C]g) was employed as the non-polar stationary phase. The polar 
mobile phase of acetonitrile and water contained the hydrophobic ion-pairing reagent 
trifluoroacetic acid (TFA). TFA is a weak hydrophobic ion-pairing reagent that also 
serves to maintain a low pH (~2), thereby minimizing ionic interactions between 
peptide and the stationary phase. Thus, RP HPLC was chosen as the optimum 
analytical tool for substrate specificity studies on ZIP.
Due to the formation of complex standards after hydrolysis of the peptides by ZIP, 
LC-MS analysis was used to give exact identification of each product formed. As 
mentioned in section 3.5.3.1.3. direct infusion MS analysis, which was initially used 
preferentially ionised some components over others that led to the failure to identify 
any product formation post incubation. LC-MS analysis was then chosen to identify 
each product of hydrolysis (section 2.7.3.2.). Mass spectrometry using electrospray 
ionisation was used. This enabled the compounds of interest to only become singly 
charged and so their molecular weight being readily obtained (McMahon et al. 2003).
( i )  Effects resulting from an increase of the number of residues of the substrate in the 
NH2-terminal direction from the scissile bond are shown in Table 3.4. The enzyme 
was completely inert towards Pro-AMC and Gly-Pro-AMC. Further elongation at the 
amino terminal by placing an N-benzyloxycarbonyl (Z) group in the P3 position 
resulted in hydrolysis. These results are the same for prolyl oligopeptidase where 
cleavage will not occur if a free a-amine exists in the N-terminal sequence Yaa-Pro- 
Xaa or Pro-Xaa (Cunningham and O’Connor, 1997b). Figure 3.5.1.2. clearly shows 
that ZIP failed to cleave Z-Pro-Phe, a similar trait of prolyl oligopeptidase (Wilk, 
1983). Therefore it seems a strong interaction in the substrate-ZIP complex at the 
level P3-S3 in addition to P1-S1 and P2-S2 occurs. Interestingly, replacement of the Z 
group in the peptide Z-Gly-Pro-Ala with a glycine residue seems to prevent
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hydrolysis. A bulky hydrophobic residue (Z-group) may be a preference for ZIP in the 
P3 position. This interaction at the P3-S3 level may also be the reason for the failure of 
ZIP to cleave pGlu-His-Pro-AMC, a known substrate of prolyl oligopeptidase. 
Overall, analysis of substrates with increasing chain length in the NH2-terminal 
direction from residue Pi reveals that binding of the peptides to ZIP involves 
interactions between P1-S1, P2-S2 and P3-S3 and that the minimum hydrolysable 
peptide size is an N-blocked tripeptide. Initial investigations seem to suggest that the 
P3-S3 interaction may be a lot more specific in ZIP than prolyl oligopeptidase.
The affinity constant Km, for the ZIP catalysed hydrolysis of Z-Gly-Pro-AMC was 
determined according to section 2.7.1.1. The hydrolysis followed the normal 
Michaelis-Menten kinetics allowing Lineweaver-Burk, Eadie-Hofstee and Hanes- 
Woolf kinetic models to be applied to the data. Figures 3.5.2.1. to 3.5.2.3. shows the 
results obtained when the kinetic data was applied to each model as detailed in section
6.4.1. Table 3.5. presents the calculated constants for ZIP. The Km value obtained of 
270|aM shows the high affinity ZIP has for the substrate Z-Gly-Pro-AMC. This value 
is much higher though than the Km value of 54(a.M reported previously for ZIP by 
Bimey and O’Connor (2001). Though interestingly Cunningham (1996) reported a 
Km of 267 (iM for bovine serum ZIP hydrolysis of Z-Gly-Pro-AMC, almost identical 
to the value obtained in this work.
(ii) It is well established that the specificity of a protease is determined by the nature 
of the amino acid residues at both sides of the peptide bond subject to hydrolysis. The 
effect on the ZIP catalysed hydrolysis of Z-Gly-Pro-AMC of proline-containing 
substrates (section 2.7.1.2.) with variations of amino acid residues located at the 
carboxyl-terminal site of the scissile bond (position Pi'), but with a constant sequence 
of Z-Gly-Pro are shown in Figures 3.5.3.1 .1 ,1 . to 3.5.3.1 .1 .8 . and their K  (app) values 
presented in Table 3.6. All peptides inhibited ZIP either in a mixed or non­
competitive mode. The lowest IQ (app) values were obtained for peptides Z-Gly-Pro- 
Phe and Z-Gly-Pro-Met. The highest K, (app) values originated when the charged 
residues histidine and glutamic acid along with the small hydrophobic alanine residue 
were in the Pi' position. Kinetic analysis would therefore seem to show that ZIP has 
greatest affinity for large hydrophobic residues in the P f  position with less affinity for
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acidic, basic and small amino acids in this position. These results are rather similar to 
the preference of prolyl oligopeptidase for a hydrophobic residue in the Pi' position 
with lower specificities for basic and acidic (Koida and Walter, 1976).
As outlined in section 2.7.2. RP HPLC was performed for peptide digest separations 
in order to evaluate the ability of ZIP to hydrolyse the peptides outlined in Table 3 .7., 
determination of the cleavage point and the effect, as discussed for the kinetic 
analysis, of the amino acid variation in the P f position on hydrolysis. Figures
3.5.3.1.2.1. to 3.5.3.1.2.16. are chromatograms showing the hydrolysis of each peptide 
by ZIP. A common product peak is obvious for each peptide except in the case of the 
hydrolysis of Z-Gly-Pro-Glu. This common product peak corresponds to the peak for 
the standard Z-Gly-Pro shown in Figure 3.5.3.1.2.17. The definite identification of 
this product peak as Z-Gly-Pro for each peptide hydrolysed is shown by LC-MS 
analysis in Figures 3.5.3.1.3.1. to 3.5.3.1.3.7. Quantification of the amount of Z-Gly- 
Pro formed in each case is evaluated in Table 3.7. The most hydrolysis seemed to take 
place with phenylalanine in the Pi' position, whereas it is obvious as shown in Figure 
3.5.3.1.2.10. that when glutamic acid occupied the P f position, hydrolysis took place 
at a negligible rate making quantification impossible, though LC-MS analysis (Figure 
3.5.3.1.3.5.) did show hydrolysis took place.
(iii) Taking peptides with phenylalanine and methionine in the Pi' position as 
explained, the effect of further chain elongation on the carboxyl-terminal site to 
include P2', P3' and P4' on the ZIP catalysed hydrolysis of Z-Gly-Pro-AMC was 
evaluated as outlined in section 3.5.3.2.1. Table 3.8. presents the Kj (app) values 
obtained and the mode of inhibition observed. A 2-fold increase in affinity was 
observed in going from Z-Gly-Pro-Phe to Z-Gly-Pro-Phe-His i.e. to include P2' 
position. An affinity constant of 206^M obtained for Z-Gly-Pro-Phe-His is even 
greater than the Km of 270fj,M obtained for ZIP using Z-Gly-Pro-AMC. Quantification 
of Z-Gly-Pro formed after hydrolysis of Z-Gly-Pro-Phe-His by ZIP (Figure
3.5.3.2.2.2.), identified according to Figure 3.5.3.2.3.1, is shown in Table 3.9. There is 
almost a 7-fold increase in the amount of Z-Gly-Pro formed when the P2' position is 
occupied. However, addition of residues in locations P3' and P4' caused an increase in 
Ki (app) values (Table 3.6.), therefore showing a decrease in affinity of ZIP for 
elongated peptides beyond P2' position. Table 3.9. also shows a decrease in the
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amount of Z-Gly-Pro formed with peptide elongation beyond the P2 ' position. An 
interesting feature showed that ZIP seemed to have a better affinity and hydrolysed 
peptides to a greater extent when multiple substrate-binding sites are occupied. So 
overall the important interactions in the substrate-ZIP complex at the carboxyl site of 
the substrate cleavage point seems to involve Pi'-Si' and P2f-S2 '.
(iv) Extensive studies on the importance of the Pi proline residue in catalysis by 
prolyl oligopeptidase are well reported. These studies conclude that the Si subsite is 
designed specifically to fit proline but tolerates other residues carrying substituent 
groups provided they do not exceed the size of prolines pyrrolidine ring (Nomura, 
1986; Makinen et al. 1994; Kreig and Wolfe, 1995). Therefore it was paramount to 
study the importance of the P1-S1 interaction in ZIP catalysis. It was decided due to 
the high affinity of ZIP for Z-Gly-Pro-Phe-His, to replace the Pi proline residue with 
leucine in this peptide. Replacement of the proline residue with leucine in the primary 
specificity position (Pi) caused a 7-fold decrease in affinity of ZIP for this peptide as 
shown in Table 4.0. Analysis of hydrolysis of Z-Gly-Leu-Phe-His by RP HPLC 
described in section 3.5.4.2. is presented in Figure 3.5.4.2.2. There seems to be the 
slightest formation of a Z-Gly-Leu product peak after incubation but as shown in 
Figure 3.5.4.3., LC-MS analysis failed to detect any peak with mass corresponding to 
the formation of a Z-Gly-Leu product. Therefore, it is evident that the Si subsite of 
ZIP, like prolyl oligopeptidase, is more than likely also designed to specifically fit a 
proline residue.
In summary, these results suggest that ZIP has an extended substrate-binding region 
in addition to the primary specificity site, Si. Its possible it is comprised of three sites 
located at the amino-terminal site (Si, S2, S3) and two sites at the carboxyl site from 
the scissile bond (Sf and S2'). Regarding these subsites the Si' position has a 
preference for a bulky hydrophobic residue along with the S3 subsite. An imino acid 
residue (proline) in the Pi position is absolutely necessary and a tetrapeptide P3P2PiPi' 
is the minimum hydrolysable peptide size. Further increase in substrate chain length 
beyond the P2' position causes a continuous decrease in ZIP affinity and hydrolysis 
ability for substrates. The kinetic, RP HPLC and LC-MS data on the substrate 
specificity of ZIP suggests it’s extremely similar to that of prolyl oligopeptidase.
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4.7. Partial Purification of Prolyl Oligopeptidase From Bovine Serum
Prolyl oligopeptidase from bovine serum was partially purified as outlined in section
2.8. This enabled comparative work to be completed in inhibitor and immunological 
studies with ZIP. Enzyme assays for prolyl oligopeptidase were performed, as for the 
determination of ZIP activity, explained in section 2.4.2. The only difference was the 
addition of DTT in substrate preparation as outlined in section 2.4.1.
4.7.1. Phenyl Sepharose Hydrophobic Interaction Chromatography I
The first step in prolyl oligopeptidase purification from bovine serum is the exact step 
discussed in section 4.4.1. for the isolation of ZIP. Indeed this step is extremely 
important in the purification of both peptidases in that it separates both activities from 
each other in crude serum along with purifying each to some extent.
The elution profile of prolyl oligopeptidase during hydrophobic interaction 
chromatography I is shown in Figure 3.6.1. The first activity peak shown, which runs 
through the column is prolyl oligopeptidase, shown in Figure 3.3.2.2. It is likely that 
the retention of over 98% activity is due to the enzyme not binding to the column but 
running through, but only a 3.2-fold purification factor resulted due to up to 534mg of 
protein also running through with the prolyl oligopeptidase activity.
4.7.2. Phenyl Sepharose Hydrophobic Interaction Chromatography II
As the first chromatography step in the purification of prolyl oligopeptidase was 
basically applied to separate both ZIP and PO activities, a second hydrophobic 
interaction chromatography column was used for further purification. The higher 
ammonium sulphate concentration (1M) during the running of this second 
hydrophobic interaction chromatography column allowed for binding of prolyl 
oligopeptidase. Prolyl oligopeptidase activity eluted during a linear decreasing 
ammonium sulphate concentration gradient as shown in Figure 3.6.2. Compared to 
ZIP the instability of prolyl oligopeptidase was a huge factor during the purification.
As shown in Table 4.2. a loss of almost 80% applied activity occurred during this 
purification step alone. This was extremely significant considering the loss of only 
2% for the first hydrophobic interaction chromatography step. The 95% decrease in 
protein was significant in obtaining a 14.4-fold purification factor for this step. The
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concentration and addition of ammonium sulphate to the sample prior to 
chromatography and the removal of that amount of contaminating protein were 
possibly detrimental to activity leading to only 20.17% overall biological activity 
remaining after only two purification steps. It is interesting to note that serum prolyl 
oligopeptidase has been reported to be rather unstable during purification (Cunning 
ham and O’Connor, 1998; Dowling, 1998).
4.7.3. Cibacron Blue 3GA Chromatography
Preliminary investigation of the post phenyl sepharose n  sample on SDS PAGE gels 
showed the presence of a major band corresponding to BSA. The employment of this 
resin was hoped to remove any BSA present in the sample and purify prolyl 
oligopeptidase to a greater extent. Prolyl oligopeptidase failed to bind to the cibacron 
blue resin, which is the direct opposite to ZIP, as shown in Figure 3.6.3. Up to 44% 
applied activity was retained and even though the enzyme failed to bind it was 
removed from contaminating protein substantially with an 83% reduction in protein 
achieved.
An overall 36.45-fold purification factor along with almost 9% retention of biological 
activity was deemed rather effective for only a partial purification of prolyl 
oligopeptidase from bovine serum.
4.8. Inhibitor Studies
4.8.1. Catalytic Classification
Sensitivity to specific active site directed inhibitors along with amino acid sequence 
analysis is frequently investigated to determine the catalytic class of an enzyme. ZIP 
has been previously classified as a serine protease due to inhibition by the classic 
serine protease inhibitors, 4-(2-aminoethyl)-benzenesulphonylfluoride (AEBSF) and 
aprotinin. Interestingly, AEBSF even at a concentration of 22.5mM only gave 58% 
inhibition. It was also reported that 4-amidino-phenylmethanesulphonyl fluoride 
(APMSF), a reportedly specific, irreversible serine protease inhibitor and the 
reversible serine protease inhibitor phenylmethyl-sulphonyl fluoride (PMSF) failed to 
inhibit ZIP (Bimey and O’Connor, 2001). It is known that enzymes are often 
classified as serine proteases despite not exhibiting sensitivity towards all of the
189
possible active site directed serine protease inhibitors. Many factors may contribute to 
this with one reason possibly due to active site serine being the target for these studies 
and inaccessibility by steric hindrance may prevent inhibition.
Prolyl oligopeptidase is classified as a serine protease based on its sensitivity towards 
inhibitors such as DFP and PMSF (Rennex et al. 1991). Goosens et al. (1995) 
reported inhibition of prolyl oligopeptidase by DFP and PMSF but resistance to 
aprotinin, whereas Yoshimoto et al. (1983) reported complete inhibition of prolyl 
oligopeptidase by DFP yet none by PMSF. To finally catalytically classify ZIP as a 
serine protease, the irreversible and classic serine protease inactivator DFP (Barrett, 
1994) was employed as outlined in section 2.9.1. Figure 3.7.1. illustrates the 
inhibition of ZIP by DFP with an IC50 value of lOOnM being obtained. This shows the 
high specificity of DFP for the catalytic serine of ZIP, thus catalytically classifying 
this enzyme as a possible serine protease.
4.8.2. Effect of Specific Prolyl Oligopeptidase Inhibitors
Prolyl oligopeptidase specific inhibitors are commonly used to investigate the 
enzymes physiological effect in the body. Several studies have pointed out the 
potential therapeutic relevance of prolyl oligopeptidase inhibitors as memory 
promoting drugs, which is possibly attributable to the protection of various 
neuropeptides against degradation by prolyl oligopeptidase (Shinoda et al 1996 and 
1999; Marighetto etal. 2000; Bellemere et al. 2003).
In general, specific inhibitors are synthesised to bind to the enzymes active site, so 
these inhibitors interact with the enzyme in a substrate-like manner and restrict 
changes to the active site. Therefore, prolyl oligopeptidase inhibitors are in general 
very specific because of the proline residue in the Pi position and the substrate-like 
peptide structure (e.g. Z-Pro-prolinal). Due to the near identical substrate specificity 
requirements of both enzymes, it is most intriguing that ZIP is totally insensitive to 
the prolyl oligopeptidase inhibitor Z-Pro-prolinal (Cunningham and O’Connor, 
1997a).
A number of prolyl oligopeptidase specific inhibitors were incubated with purified 
ZIP to determine any possible inhibitory effect; partial purified prolyl oligopeptidase 
was also assayed for comparison (section 2.9.2.). As highlighted in Table 3.13. all 
inhibitors tested had little or no inhibitory effect on ZIP activity. On the other hand,
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partial purified prolyl oligopeptidase was extremely sensitive to all inhibitors; IC50 
values are listed in Table 3.13. JTP-4819 and Fmoc-Ala-PyrrCN were the most potent 
inhibitors tested towards prolyl oligopeptidase with IC50 values of 0.8nM and 1.5nM 
respectively.
Fmoc-Ala-PyrrCN interacts with prolyl oligopeptidase in a substrate-like manner and 
restricts changes to its active site. This inhibitor is cell permeable, has no inhibitory 
effect towards dipeptidyl peptidase IV and a K; value of 5nM is reported for brain 
prolyl oligopeptidase (Li et al. 1996). This inhibitor was seen to potently inhibit 
serum prolyl oligopeptidase with an IC50 of 1.5nM (Figure 3.7.2.1.), which is greater 
than the lOnM obtained by Dowling (1998). As illustrated in Figure 3.7.2.2. this 
inhibitor had no effect whatsoever on ZIP activity.
Z-Phe-Pro-Benzothiazol, SR 063125 and SR 063298 are all Z-Pro-prolinal 
derivatives. The structures of the latter two are shown in Figure 4.3. They were all 
found to be relatively potent inhibitors of prolyl oligopeptidase with Z-Phe-Pro- 
Benzothiazol giving an IC50 of 45nM. Figures 3.7.2.5. and 3.7.2.7. show the inhibition 
of prolyl oligopeptidase with SR 063298 and SR 063125, resulting in similar IC50 
values of 90nM and lOOnM respectively. Again no significant inhibition was 
observed by each of these three inhibitors towards ZIP activity.
Figure 4.3. Chemical Structures of SR 063125 and 063298
Toide et al. (1995a) reported JTP-4819 as a potent and highly specific inhibitor of 
prolyl oligopeptidase, with no effect on other related proline specific enzymes. The 
therapeutic potential of JTP-4819 has been investigated due to its known 
pharmacological actions. One of these main actions is its inhibition of prolyl 
oligopeptidase mediated degradation of neuropeptides in rat brain thus linking it
191
possibly to ameliorating memory impairment in rats (Toide et al. 1995b and 1997b; 
Shinoda et al. 1996 and 1999). An IC50 value of 0.8nM was achieved towards partial 
purified prolyl oligopeptidase as outlined in Table 3.13 and shown in Figure 3.7.2.9. 
This shows the potency of this inhibitor towards prolyl oligopeptidase from bovine 
serum, the 0.8nM obtained being remarkedly similar to the IC50 value of 0.83nM 
reported by Toide et al. (1995a) towards rat brain supernatant prolyl oligopeptidase. 
More importantly, as shown in Figure 3.7.2.10. ZIP remained completely resistant to 
inhibition by JTP-4819. This shows the advantage of using JTP-4819 as the optimum 
inhibitor for detection of ZIP alone in crude samples, like serum as explained in 
section 2.4.3. Also, as discussed (section 4.6.) ZIP and prolyl oligopeptidase seem to 
share very similar substrate specificity, so the total prevention of neuropeptide 
degradation using JTP-4819 may be futile due to the total resistance of ZIP towards 
this specific prolyl oligopeptidase inhibitor.
4.9. Immunological Studies
An anti-human prolyl oligopeptidase antibody was used as described in section 2.10. 
to check for immunological cross reactivity with purified ZIP and partial purified 
prolyl oligopeptidase. The antibody was raised when rabbits were immunized with a 
peptide containing the N-terminal prolyl oligopeptidase sequence of residues 10-25. 
Figure 3.8.1.1. shows no cross reactivity whatsoever with purified ZIP, once more 
showing a complete difference to prolyl oligopeptidase this time with respect to 
immunological characteristics.
Interestingly, also in Figure 3.8.1.1. partial purified prolyl oligopeptidase from bovine 
serum showed no cross-reactivity with anti-human brain prolyl oligopeptidase. A 
more concentrated prolyl oligopeptidase sample was used as shown in Figure 
3.8.1.2A, which showed some cross reactivity, albeit at a higher molecular weight 
location than expected as bovine serum prolyl oligopeptidase is reported to be ~ 
70kDa (Cunningham and O’Connor, 1998). Therefore it is more than likely just non­
specific reactivity. This is rather interesting when one considers the N-terminal 
residues 10-25 of prolyl oligopeptidase from a host of mammals as below.
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Human 10 YRDETAVQDYHGHKIC 25 
Bovine YRDETAVQDYHGHKIC 
Rat YRDETSVQDYHGHKIC
Mouse YRDETSVQEYHGHKIC
Careful examination of the sequence 10-25 shows no difference whatsoever between 
human and bovine sequence. The rat sequence shows one slight change in position 15 
but as shown in Figure 3.8.1.2.B, it is recognised by the anti-human prolyl 
oligopeptidase antibody. This is unusual when the human and bovine sequences are 
identical but as shown no cross reactivity occurs between the antibody and the 
prepared prolyl oligopeptidase from bovine serum. Even though Cunningham and 
O’Connor (1998) describe the biochemical characteristics of bovine serum prolyl 
oligopeptidase as identical to its cytosolic counterpart, no sequence data is available 
for this serum prolyl oligopeptidase to date. So either there wasn’t enough sample 
present to cross-react with the antibody or more interestingly this serum prolyl 
oligopeptidase displays distinct immunological characteristics to its cytosolic 
counterpart.
4.10. Identification of Z-Pro-prolinal Insensitive Peptidase (ZIP)
The linear order of amino acids in a protein chain (primary structure) ultimately 
determines the three-dimensional structure required for active biological function. It 
was therefore very important to obtain sequence data by N-terminal or internal 
sequencing and so ultimately identify the protein/protease responsible for this second 
Z-Gly-Pro-AMC hydrolysing activity in bovine serum.
Initial analysis of ZIP using N-terminal sequencing as outlined in section 3.9.1. failed 
to identify this protease. As shown in Figure 3.4.2.2. purification using a starting 
volume of 20ml of serum resulted in extremely low levels of protein present just 
possibly visible using silver staining. It was deemed necessary, for successful 
sequence analysis, to provide a coomassie-stained band on a PVDF blot. To obtain 
this band a larger scale purification was necessary. This resulted (Figure 3.9.1.1.) in 
multiple bands present on the stained blot but also the possible band of interest 
located near the 98kDa marker was very faint, with protein detection level too low for 
sequencing. Due to only one reference available on the molecular weight of this
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protein and its subsequent location on denaturing PAGE, the two major bands on the 
blot were sequenced just for clarification. Sequence analysis of the major bands 
present identified BSA just above the 52kDa but the band located below this marker 
was N-terminally blocked so no sequence data was obtained.
A partial purification over three columns was performed in the hope of obtaining 
more target protein for sequencing as outlined in section 3.9.1. Internal sequencing by 
digestion of target protein band with trypsin, purification of the resulting peptides and 
subsequent sequencing and identification, of the N-blocked protein mentioned earlier 
and shown in Figure 3.9.1.2. resulted in the identification of bovine heavy chain IgG 
along with six other proteins. All other sequence data obtained had no link to the 
protease activity of ZIP. Attempts at internal sequencing of the two faint bands 
located below the 97kDa marker (Figure 3.9.2.1.) resulted in too low a protein level 
for peptide detection after digestion and subsequent sequence analysis.
The main difficulties presented in trying to obtain sequence data via these methods 
were a) making sure adequate target protein was present on gel/blot, b) unsure exact 
location of this protein on denaturing PAGE and c) large volume of starting material 
for purification, especially in this case with serum, resulting in multiple contaminants 
present. Therefore it was impossible, especially without a specific antibody to 
recognise ZIP, to locate, sequence and finally identify this protein using samples from 
SDS PAGE gels under denaturing conditions.
An in gel (zymogram) assay was developed and optimised using highly concentrated 
active ZIP sample as outlined in section 2.11.2. and shown in Figure 3.9.2.1. This 
activity assayed allowed the correct protein of interest be located precisely in its 
native form and subsequent sequencing performed. As explained (section 3.9.2.), 
initial analysis of an excised fluorescent band revealed the presence of both IgG and 
fibronectin in the sample. IgG was just co-migrating with ZIP on the native gel, 
whereas fibronectin at first possibly could have been involved in the protease activity 
of ZIP. Planchenault et al. (1990) have reported potential proteolytic activity of 
human plasma fibronectin. Therefore gelatin sepharose was employed (section 
2.11.2.4.) to remove this protein. ZIP activity failed to bind to the resin, thus showing 
that fibronectin was also a contaminant protein co-migrating with ZIP.
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As outlined in section 3.9.2. four separate 20ml purifications were performed; with 
the resulting ZIP activity from each purification pooled, concentrated and further 
chromatography performed using the affinity resin protein G, to remove IgG and 
finally gelatin sepharose for the removal of fibronectin. The final sample was run on a 
large native PAGE gel, viewed under U.V. light (Figure 3.9.2.2.) and the resulting 
fluorescent band excised. This band was digested and the resultant peptides purified 
and individually sequenced at the Harvard University, Microchemistry Facility. 
Correlation of these sequenced peptides with known proteins identified ZIP protein as 
seprase (Figure 3.9.2.3.).
Seprase, a known serine protease is a member of the serine integral membrane 
peptidases. The most interesting feature of these serine integral peptidases is their 
specificity for cleavage of proline containing peptides and macromolecules (Chen el 
al. 2003). Seprase is a gelatinolytic endopeptidase due to its ability to cleave gelatin 
(Aoyama and Chen, 1990; Pineiro-Sanchez et al. 1997). A purified ZIP sample was 
run on a gelatin gel and an area of digestion was seen (results not shown). Even 
though it is not reported to date, it is possible that seprase hydrolyses gelatin al its 
many proline residues.
The detection assays for seprase activity available to date are gelatinase zymography 
or the detection of digested fragments of radiolabelled gelatin (Kelly, 1999). The use 
of Z-Gly-Pro-AMC as substrate in conjunction with a specific prolyl oligopeptidase 
inhibitor would provide a simple, rapid and sensitive assay for detection of this 
protease activity. As reported by Monsky et al. (1994) and Kelly et al. (1998) seprase 
is overexpressed by invasive tumour cells therefore, our specific assay may be highly 
valuable for early detection of elevated seprase activity levels in serum due to the 
onset of tumour progression. Also, there are no specific inhibitors available to date for 
seprase, so knowledge of this enzymes subsite specificity as detailed earlier (section 
4.6.) may be very significant in the design of specific inhibitors for the enzyme and so 
possibly clarifying its role in tumour cell invasion.
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ZIP Seprase
MW (Native) k D a 174* 170
MW (Monomer) k D a 95-96 97
pi 5.68* ~5
pH (Optima) 7.4-8.0* 7.8
Assay Temp. (° C ) 37* 37
Catalytic Type S e r in e  p rotease* S e r in e  p ro te a se
Reaction Catalysed E n d o p ep tid a se* , E n d o p e p tid a se ,
p ro lin e  s p e c if ic p ro lin e  s p e c if ic  ?
Inhibitors D F P , A E B S F * D F P , A E B S F
Gelatinase activity Y e s Y e s
Reference * B im e y  and  O ’ C o n n o r , 
2001
P in e ir o -S a n c h e z  et al. 1997
Table 4.2. Comparison of Some Biochemical Properties of both Enzymes
196
BIBLIOGRAPHY
Abbott, C.A., Baker, E., Sutherland, G.R and McCaughan, G.W. (1994) Genomic 
organization, exact localization, and tissue expression of the human CD26 (dipeptidyl 
peptidase IV) gene. Immunogenetics 40, 331-338.
Abbott, C.A. and Gorrell, M.D. (2002) The Family of CD26/DPIV and Related 
Ectopeptidases. The DPIV Family. In: Ectopeptidases: CD 13/Aminopeptidase N  and 
CD26/Dipeptidylpeptidase IV  in Medicine and Biology. (Langner, J. and Ansorge, S. 
eds.) Kluwer Academic/Plenum Publishers, New York, pp 171-195.
Abbott, C.A., McCaughran, G.W., Levy, M.T., Church, W.B. and Gorrell, M.D. 
(1999) Binding to human dipeptidyl peptidase IV by adenosine deaminase and 
antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a 
predicted p propeller domain. European Journal o f Biochemistry 266, 798-810.
Ashall, F. (1990) Characterisation of an alkaline peptidase of Trypanosoma cruzi and 
other trypanosomatids. Molecular and Biochemical Parasitology 38, 77-88.
Ashall, F., Harris, D., Roberts, H., Healy, N. and Shaw, E. (1990) Substrate 
specificity and inhibitor sensitivity of a trypanosomatid alkaline peptidase.
Biochimica et Biophysica Acta 1035, 293-299.
Aoyagi, T., Nagai, M., Ogawa, K., Kojima, F., Okada, M., Ikeda, T., Hamada, M. and 
Takeuchi, T. (1991) Postatin: A New Inhibitor of Prolyl Endopeptidase, Produced by 
Streptomyces viridochromogenes MH534-30F3, I: Taxonomy, Production, Isolation, 
Physico-Chemical Properties and Biological Activities. Journal o f Antibiotics 44(9), 
949-955.
Aoyama, A. and Chen, W-T. (1990) A 170-kDa membrane-bound protease is 
associated with the expression of invasiveness by human malignant melanoma cells.
Proceedings o f  the National Academy o f Science, USA 87, 8296-8300.
5.0. Bibliography
198
Bakker, A. V., Daffeh, J., Jumg, S., Vincent, L.A., Nagel, A.A., Spencer, R.W., 
Vinick, F.J. and Faraci, W.S. (1991) Novel in Vitro and in Vivo Inhibitors of Prolyl 
Endopeptidase. Bioorganic and Medicinal Chemistry Letters 1(11), 585-590.
Bakker, A. V., Jung, S., Spencer, R.W., Vinick, F.J. and Faraci, S. (1990) Slow Tight- 
Binding Inhibition of Prolyl Endopeptidase by Benzyloxycarbonyl-Prolyl-Prolinal.
Biochemical Journal 271, 559-562.
Barrelli, H., Petit, A., Hirsch, E., Wilk, S., De Nanteuil, G., Morain, P. and Checler, F. 
(1999) S-17092-1, a Highly Potent, Specific and Cell Permeable Inhibitor of Human 
Proline Endopeptidase. Biochemical and Biophysical Research Communications 
257(3), 657-661.
Barrett, A.J. (1994) Classification of Peptidases. Methods in Enzymology 244, 1-15.
Barrett, A.J., Rawlings, N.D. & Woessner, J.F. (1998) Handbook of Proteolytic 
Enzymes. Academic Press, London.
Barrett, A.J. and Rawlings, N.D. (1992) Oligopeptidases, and the Emergence of the 
Prolyl Oligopeptidase Family. Biological Chemistry Hoppe-Seyler 373, 353-360.
Bellemere, G., Morain, P., Vaudry, H. and Jegou, S. (2003) Effect of S 17092, a novel 
prolyl endopeptidase inhibitor on substance P and a-melanocyte-stimulating hormone 
breakdown in the rat brain. Journal o f Neurochemistry 84, 919-929.
Bemardi, G., Giro, M-G. and Gaillard, C. (1972) Chromatography of Polypeptides 
and Proteins on Hydroxyapatite Columns: Some New Developments. Biochimica et 
Biophysica Acta 278, 409-420.
Birney, Y. (2000) PhD Thesis, Dublin City University.
199
Birney, Y.A. and O’Connor, B F. (2001) Purification and Characterisation of aZ-Pro- 
prolinal-Insensitive Z-Gly-Pro-7-amino-4-methyl Coumarin hydrolyzing Peptidase 
from Bovine Serum. A New Proline-Specific Peptidase. Protein Expression and 
Purification 22, 286-298.
Blum, H., Beir, H. and Gross, H.J. (1987) Improved silver staining of plant proteins, 
RNA and DNA in polyacrylamide gels. Electrophoresis 8, 93-99.
Bongers, J., Lambros T., Ahmad, M. and Heimer, E.P. (1992) Kinetics of dipeptidyl 
peptidase IV proteolysis of growth hormone-releasing factor and analogs. Biochimica 
et Biophysica Acta 1122, 147-153.
Burleigh, B.A. and Andrews, N.W. (1998) Signalling and host cell invasion by
Trypanosoma cruzi. Current Opinion in Microbiology 1, 461-465.
Burleigh, B.A. and Andrews, N.W. (1995) A 120-kDa Alkaline Peptidase from 
Trypanosoma cruzi Is Involved in the Generation of a Novel Ca2+-signaling Factor for 
Mammalian Cells. The Journal o f  Biological Chemistry 270(10), 5172-5180.
Burleigh, B.A., Caler, E.V., Webster, P. and Andrews, N.W. (1997) A Cytosolic 
Serine Endopeptidase from Trypanosoma cruzi Is Required for the Generation of Ca2H 
Signaling in Mammalian Cells. The Journal o f  Cell Biology 136(3), 609-620.
Burleigh, B.A. and Woolsey, A.M. (2002) Cell Signalling and Trypanosoma cruzi 
invasion. Cellular Microbiology 4(11), 701-711.
-C-
Caler, E.V., Morty, R.E., Burleigh, B.A. and Andrews, N.W. (2000) Dual Role of 
Signaling Pathways Leading to Ca2+ and Cyclic AMP Elevation in Host Cell Invasion 
by Trypanosoma cruzi. Infection and Immunity 68(12), 6602-6610.
Caler, E.V., de Avalos, S.V., Haynes, P.A., Andrews, N.W. and Burleigh, B.A. (1998) 
Oligopeptidase B-dependent signalling mediates host cell invasion by Trypanosoma 
cruzi. The EMBO Journal 17(17), 4975-4986.
2 0 0
Camargo, A.C., Caldo, H. and Reis, M.L. (1979) Susceptibility of a Peptide Derived 
from Bradykinin to Hydrolysis by Brain Endo-Oligopeptidases and Pancreatic 
Proteinases. The Journal o f  Biological Chemistry 254(12), 5304-5307.
Camargo, A.C M., Almeida, M.L.C. and Emson, P.C. (1984), Involvement of Endo- 
Oligopeptidases A and B in the Degradation of Neurotensin by Rabbit Brain, Journal 
o f Neurochemistry, 42(6), 1758-1761.
Checler, F., Vincent, J.P. and Kitabgi, P. (1986) Purification and Characterisation of a 
Novel Neurotensin-Degrading Peptidase from Rat Brain Synaptic Membranes. The
Journal o f  Biological Chemistry 261(24), 11274-11281.
Chen, W-T., Kelly, T. and Ghersi, G. (2003) DPPIV, Seprase, and Related Serine 
Peptidases in Multiple Cellular Functions. Current Topics in Developmental Biology 
54, 207-231.
Chevallier, S., Goeltz, P., Thibault, P., Banville, D. and Gagon, J. (1992) 
Characterization of a Prolyl Endopeptidase From Flavobacterium meningosepticum: 
Complete Sequence and Localization of the Active-Site Serine. The Journal o f  
Biological Chemistry 267(12), 8192-8199.
Cunningham, D. (1996) PhD Thesis, Dublin City University
Cunningham, D.F. and O’Connor, B.F. (1997a) Identification and initial 
characterization of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 
7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH- 
Mec)-hydrolysing peptidase in bovine serum. European Journal o f  Biochemistry 244, 
900-903.
Cunningham, D.F. and O’Connor, B.F., (1997b) Proline Specific Peptidases. 
Biochimica et Biophysica ACTA 1343, 160-186.
2 0 1
Cunningham, D.F. and O’Connor, B.F., (1998) A study of prolyl endopeptidase in 
bovine serum and its relevance to the tissue enzyme. Biochemistry and Cell Biology 
00, 1-16.
Darmoul, D., Lacasa, M., Baricault, M., Marguet, D., Sapin, C., Trotot, P. (1992) 
Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell 
lines HT-29 and Caco-2. Cloning of the complete human coding sequence and 
changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. The 
Journal o f  Biological Chemistry 267, 4824-4833.
David, F., Bernard, A.M., Pierres, M. and Marguet, D. (1993) Identification of Serine 
624, Aspartic Acid 702, and Histidine 734 as the Catalytic Triad Residues of Mouse 
Dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine 
hydrolases. The Journal o f  Biological Chemistry 268(23), 17247-17252.
De Meester, I., Belyaev, A., Lambeir, A-M., De Meyer, G.R.Y., Van Osselaer, N., 
Haemer, A. and Scharpe, S. (1997) In Vivo Inhibition of Dipeptidyl peptidase IV 
Activity by Pro-Pro-diphenyl-phosphonate (Prodipine). Biochemical Pharmacology 
54, 173-179.
De Meester, I., Korom, S., Van Damme, J. and Scharpe, S. (1999) CD26, let it cut or 
cut it down. Immunology Today 20(8), 367-375.
De Meester, I., Vanhoof, G., Hendriks, D., Demuth, H-U., Yaron, A. and Scharpe, S. 
(1992) Characterisation of dipeptidyl peptidase IV (CD26) from human lymphocytes. 
Clinica Chimica Acta 210, 23-34.
De Meester, I., Vanhoof, G., Lambeir, A-M. and Scharpe, S. (1996) Use of 
immobilised adenosine deaminase (EC 3.5.4.4) for the rapid purification of native 
human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). Journal o f  Immunological 
Methods 189, 99-105.
2 0 2
Demuth, H-U, Baumgrass R., Schaper, C., Fischer, G. and Barth, A. (1988) 
Dipeptidyl peptidase IV-Inactivation with TV-Peptidyl-O-Aroyl Hydroxlamines. 
Journal o f  Enzyme Inhibition 2,129-142.
De Wied, D., Gaffori, O., van Ree, J.M. and de Jong, W. (1984) Central target for the 
behavioural effects of vasopressin neuropeptides. Nature 308, 276-277.
Diefenthal, T., Dargatz, H., Witte, V., Reipen, G. and Svendsen, I. (1993) Cloning of 
proline-specific endopeptidase gene from Flavobacterium meningosepticum: 
expression in Escherichia coli and purification of the heterlogous protein. Applied 
Microbiology and Biotechnology 40, 90-97.
Dobers, I ,  Grams, S., Reutter, W. and Fan, H. (2000) Roles of cysteines in rat 
dipeptidyl peptidase IV/CD26 in processing and proteolytic activity. European 
Journal o f  Biochemistry 267, 5093-5100.
Dobers, J., Zimmermann-Kordmann, M., Leddermann, M., Schewe, T., Reutter, W. 
and Fan, H. (2002) Expression, purification, and characterization of human dipeptidyl 
peptidase IV/CD26 in SfP insect cells. Protein Expression and Purification 25, 527- 
532.
Donlon, J. and Kaufman, S. (1980) Relationship Between the Multiple Forms of Rat 
Hepatic Phenylalanine Hydroxylase and Degree of Phosphorylation. The Journal o f  
Biological Chemistry 255(5), 2146-2152.
Dowling, O. (1998) PhD Thesis, Dublin City University.
Dunn, M.J. (1989), Initial Planning. In: Protein Purification Methods-A Practical 
Approach. (Harris, E.L.V. and Angal, S. eds.) IRL Press, Oxford, pp 10-15.
Durand, A., Villard, C., Giardina, T., Perrier, J., Juge, N. and Puigserver A. (2003) 
Structural Properties of Porcine Intestine Acylpeptide Hydrolase. Journal o f  Protein 
Chemistry 22(2), 183-191.
203
Durinx, C., Lambeir, A.M., Bosmans, E., Falmagne, J-B., Berghmans, R., Haemers, 
A., Scharpe, S. and De Meester, I. (2000) Molecular characterization of dipeptidyl 
peptidase activity in serum. Soluble CD26/dipeptidyl peptidase IV is responsible for 
the release of X-Pro dipeptides. European Journal o f Biochemistry 267, 5608-5613.
Dresdner, K., Barker, L.A., Orlowski, M. and Wilk S. (1982) Subcellular Distribution 
of Prolyl Endopeptidase and Cation-Sensitive Neutral Endopeptidase in Rabbit Brain.
Journal o f  Neurochemistry 38(4), 1151-1154.
Drucker, D.J. (2003) Therapeutic potential of dipeptidyl peptidase IV inhibitors for 
the treatment of type 2 diabetes. Expert Opin. Invest. Drugs 12(1), 87-100.
Engel, M., Hoffman, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., 
Huber, R., Bode, W., Demuth, H-U. and Brandstetter, H. (2003) The crystal structure 
of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic 
mechanism. Biochemistry 100(9), 5063-5068.
Feese, M., Scaloni, A., Jones, W.M., Manning, J.M. and Remington, S.J. (1993) 
Crystallization and Preliminary X-ray Studies of Human Erythrocyte Acylpeptide
Hydrolase. Journal o f  Molecular Biology 233, 546-549.
Fink, A.L. (1987) Acyl Group Transfer-The Serine Proteinases, In: Enzyme 
Mechanisms. (Page, M.I. and Williams, A. ed.), Royal Society of Chemistry, pp. 159- 
177.
Fischer, G., Heins, J. and Barth, A. (1983) The Conformation Around the Peptide 
Bond Between the Pi- and P2-Positions is Important for Catalytic Activity of Some 
Proline-Specific Proteases. Biochimica et Biophysica Acta 742, 452-462.
Fleisher, B. (1994) CD26: a surface protease involved in T-cell activation. 
Immunology Today 15(4), 180-184.
204
Flentke, G., Munoz. E., Huber, B., Plaut, A.G., Kettner, C.A. and Bachovchin, W.W.
(1991) Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro 
dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
Proceedings o f  the National Academy o f sciences, USA 88,1556-1559.
Friedman, T.C., Orlowski, M. and Wilk, S. (1984) Prolyl Endopeptidase: Inhibition In 
Vivo by N-Benzyloxycarbonyl-Prolyl-Prolinal. Journal o f  Neurochemistry 42(1), 
237-241.
Fulop, V., Bocskei, Z., and Polgar, L. (1998) Prolyl oligopeptidase: an unusual ß- 
propeller domain regulates proteolysis. Cell 94, 161-170.
Fulop, V., Szeltner, Z., Renner, V. and Polgar, L. (2001) Structures of Prolyl 
Oligopeptidase Substrate/ Inhibitor Complexes: use of inhibitor binding for titration
of the catalytic histidine residue. The Journal o f Biological Chemistry 276(2), 1262- 
1266.
Fulop, V., Szeltner, Z. and Polgar, L. (2000) Catalysis of serine oligopeptidases is 
controlled by a gating filter mechanism. EMBO reports 1(3), 277-281.
Gade, W. and Brown, J.L. (1978) Purification and Partial Characterization of a-N- 
Acylpeptide Hydrolase from Bovine Liver. The Journal o f  Biological Chemistry 
253(14), 5012-5018.
Gerczei, T., Keseru, G.M. and Naray-Szabo, G. (2000) Construction of a 3D model of 
oligopeptidase B, a potential processing enzyme in prokaryotes. Journal o f  Molecular 
Graphics and Modelling 18, 7-17.
Ghersi, G., Dong, H., Goldstein, L.A., Yeh, Y., Häkkinen, L., Laijava, H.S. and Chen, 
W-T. (2002) Regulation of Fibroblast Migration on Collagenous Matrix by a Cell 
Surface Peptidase Complex. The Journal o f  Biological Chemistry 277(32), 29231- 
29241.
205
Gilmartin, L. and O’Cuinn, G. (1999) Dipeptidyl peptidase IV and aminopeptidase P, 
two proline specific enzymes from the cytoplasm of guinea-pig brain: their role in 
metabolism of peptides containing consecutive pralines. Neuroscience Research 34, 
1 - 11 .
Goldstein, L.A., Ghersi, G., Pineiro-Sanchez, M.L., Salamone, M., Yeh, Y., Flessate, 
D. and Chen, W-T. (1997) Molecular cloning of seprase: a serine integral membrane 
protease from human melanoma. Biochimica et Biophysica Acta 1361, 11-19.
Goosens, F., De Meester, L, Vanhoof, G., Hendriks, D., Vriend, G. and Scharpe, S., 
(1995) The purification, characterisation and analysis of primary and secondary- 
structure of prolyl oligopeptidase from human lymphocytes. Evidence that the enzyme 
belongs to the a/p  hydrolase fold family. European Journal o f  Biochemistry 233, 432- 
441.
Goosens, F., De Meester, I., Vanhoof, G. and Scharpe, S. (1996) Distribution of 
Prolyl Oligopeptidase in Human Peripheral Tissues and Body Fluids. European 
Journal o f  Chemical and Clinical Biochemistry 34, 17-22.
Goosens, F., Vanhoof, G., De Meester, I., Augustyns, K , Borloo, M., Tourwe, D., 
Haemers, A. and Scharpe, S. (1997) Development and evaluation of peptide-based 
prolyl oligopeptidase inhibitors: introduction of N-benzyloxycarbonyl-prolyl-3- 
fluoropyrrolidine as a lead in inhibitor design. European Journal o f  Biochemistry 
250(1), 177-183.
Gorrell, M.D., Gysberg, V. and McCaughan, G.W. (2001) CD26: A Multifunctional 
Integral Membrane and Secreted Protein of Activated Lymphocytes. Scandinavian 
Journal o f  Immunology 54, 249-264.
Gutheil, W. and Bachovchin, W.W. (1993) Separation of L-Pro-DL-boroPro into its 
Component Diastereomers and Kinetic Analysis of their Inhibition of Dipeptidyl 
Peptidase IV. A New Method for the Analysis of Slow, Tight-Binding Inhibition. 
Biochemistry 32(34), 8723-8731.
206
Grellier, P., Vendeville, S., Joyeau, R., Bastos, I.M.D., Drobecq, H., Frappier, F., 
Teixeira, A.R.L., Schrevel, J., Davioud-Charvet, E., Sergheraert, C. and Santana, J.M.
(2001) Trypanosoma cruzi Prolyl Oligopeptidase Tc80 Is Involved in Nonphagocytic 
Mammalian Cell Invasion by Trypomastigotes. The Journal o f  Biological Chemistry 
276(50), 47078-47086.
Griffiths, E. C. (1987) Clinical Applications of Thyrotropin-Releasing Hormone 
(Editorial Review). Clinical Science 73, 449-457.
Harwood, V.J., Denson, J.D., Robinson-Bidle, K.A. and Schreier, H J. (1997) 
Overexpression and Characterization of a Prolyl Endopeptidase from the 
Hyperthermophilic Archaeon Pyrococcus furiosus. Journal o f  Bacteriology 179(11), 
3613-3618.
Harwood, V.J. and Schreier, H.J. (2001) Prolyl Oligopeptidase from Pyrococcus 
furiosus. Methods in Enzymology 330, 445-454.
Heins, J., Welker, P., Schonlein, C., Bom, I., Hartrodt, B., Neubert, K., Tsuru, D. and 
Barth, A. (1988) Mechanism of proline-specific proteinases: (I) substrate specificity 
of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from 
Flavobacterium meningosepticum. Biochimica et Biophysica Acta 954, 161-169.
Heinze, S., Ritzau, M., Ihn, W., Hulsmann, H., Schlegel, B., Domberger, K., Fleck, 
W.F., Zerlin, M., Christner, C., Grafe, U., Kullertz, G. and Fischer, G. (1997) 
Lipohexin, a New Inhibitor of Prolyl Endopeptidase from Moeszia lindtneri (HK1- 
0054) and Paecilomyces sp. (HKI-0055; HKI-0096) I. Screening, Isolation and 
Structure Elucidation. The Journal o f  Antibiotics 50(5), 379-383.
Hoffman, T. and Demuth, H-U. (2002) Therapeutic Strategies Exploiting DP IV 
inhibition.Target disease: Type 2 Diabetes. In: Ectopeptidases: CD13/Aminopeptidase 
N  and CD26/Dipeptidylpeptidase IV  in Medicine and Biology. (Langer, J. and 
Ansorge, S., eds.) Kluwer Academic/Plenum Publishers, New York. pp. 259-278.
207
Hopsu-Havu, V.K. and Glenner, G.G. (1966) A new dipeptide naphthylamidase 
hydrolysing glycyl-prolyl-beta-naphthylamide. Histochemie 7, 197-201.
Irazusta, J ,  Larrinaga, G., Gonzalez-Maeso, J., Gil, J., Meana, J.J. and Casis, L.
(2002) Distribution of prolyl endopeptidase activities in rat and human brain. 
Neurochemistry International 40, 337-345.
Ikehera, Y., Ogata, S. and Misumi, Y. (1994) Dipeptidyl-peptidase IV from rat liver. 
Methods in Enzymology 244, 2f 5-227.
Ishikawa, K., Ishida, H., Koyama, Y., Kawarabayasi, Y., Kawahara, J., Matsui, E. and 
Matsui, I. (1998) Acylamino Acid-releasing Enzyme from the Thermophilic Archaeon 
Pyrococcus horikoshii. The Journal o f  Biological Chemistry 273(28), 17726-17731.
Iwaki-Egawa, S., Watanabe, Y., Kikuya, Y. and Fujimoto, Y. (1998) Dipeptidyl 
peptidase IV from Human Serum: Purification, Characterization, and N-Terminal 
Amino Acid Sequence. Journal o f  Biochemistry 124(2), 428-433.
-J-
Jones, W.M. and Manning, J.M. (1988) Substrate specificity of an 
acylaminopeptidase that catalyses the cleavage of the blocked amino termini of 
peptides. Biochimica et Biophysica Acta 953, 357-360.
Jones, W.M., Scaloni, A., Bossa, F., Popowicz, A.M., Schneewind, O. and Manning, 
J.M. (1991) Genetic relationship between acylpeptide hydrolase and acylase, two 
hydrolytic enzymes with similar binding but different catalytic specificities.
Proceedings o f  the National Academy o f Science USA 88, 2f94-2198.
Jones, W.M., Scaloni, A. and Manning, J.M. (1994) Acylaminoacyl peptidase.
Methods in Enzymology 244, 227-231.
208
Juhasz, T., Szeltner, Z., Renner, V. and Polgar, L. (2002) Role of the Oxyanion 
Binding Site subsites SI and S2 in the Catalysis of Oligoepeptidase B, a Novel Target 
for Antimicrobial Chemotherapy. Biochemistry 41, 4096-4106.
Kabashima T., Yoshida, T., Ito, K. and Yoshimoto, T. (1995) Cloning, sequencing 
and expression of the dipeptidyl peptidase IV gene from Flavobacterium 
meningosepticum in Escherichia coli. Archives o f  Biochemistry and Biophysics 320, 
123-128.
Kahyaoglu, A., Haghjoo, K., Kraicsovits, F., Jordan, F., and Polgar, L. (1997) 
Benzyloxycarbonylprolylprolinal, a transition-state analogue for prolyl 
oligopeptidase, forms a tetrahedral adduct with catalytic serine, not a reactive 
cysteine. Biochemical Journal 322, 839-843.
Kalwant, S. and Porter, A. G. (1991) Purification and Characterisation of Human 
Brain Prolyl Endopeptidase. Biochemical Journal 276, 237-244.
Kanatani, A., Masuda, T., Shimoda, T., Misoka, F., Sheng Lin, X., Yoshimoto, T., 
and Tsuru, D. (1991), Protease II from Escherichia colv. Sequencing and Expression 
of the Enzyme Gene, and Characterisation of the Expressed Enzyme. Journal o f  
Biochemistry 110(3), 315-320.
Kanatani, A., Yoshimoto, T., Kitazono, A., Kokubo, T. and Tsuru, D. (1993) Prolyl 
Endopeptidase from Aeromonas hydrophilia: Cloning, Sequencing, and Expression of 
the Enzyme Gene, and Characterisation of the Expressed Enzyme. Journal o f  
Biochemistry 113, 790-796.
Kato, T., Okada, M. and Nagatsu, T. (1980) Distribution of Post-Proline Cleaving 
Enzyme in Human Brain and the peripheral Tissues. Molecular and Cellular 
Biochemistry 32, 117-121.
209
Katsube, N., Sunaga, K , Chuang, D. and Ishitani, R. (1996) (3NO-1603, a potential 
antidementia drug, shows neuroprotective effects and increases ni3-muscarinic 
receptor mRNA levels in differentiating rat cerebellar granule neurons. Neuroscience 
Letters 214, 151-154.
Kelly, T. (1999) Evaluation of seprase activity. Clinical & Experimental Metastasis 
17, 57-62.
Kelly, T., Kechelava, S., Rozypal, T.L., West, K.W. and Korourian, S. (1998) 
Seprase, a Membrane-Bound Protease, Is Overpressed by Invasive Ductal Carcinoma 
Cells of Human Breast Cancers. Modern Pathology 11(9), 855-863.
Kenny, A. J., Booth, A.G., George, S.G., Ingram, J., Kershaw, D., Wood, EJ. and 
Young, A.R. (1976) Dipeplidyl peptidase IV, a Kidney Brush-Border Serine 
Peptidase. Biochemical Journal 155,169-182.
Kimura, K-I, Kanou, F., Takahashi, H , Esumi, Y., Uramoto, M. and Yoshihama, M. 
(1997) Propeptin, a new inhibitor of prolyl endopeptidase produced by Microbispora 
Journal o f  Antibiotics 50, 373-378.
Kimura, A., Yoshida, I., Takagi, N. and Takahashi, T. (1999) Structure and 
Localization of the Mouse Prolyl Oligopeptidase Gene. The Journal o f Biological 
Science 274(34), 24047-24053.
Kobayashi, K , Lin, L-W., Yeadon, J.E., Klickstein, L.B. and Smith, J.A. (1989) 
Cloning and Sequence Analysis of a Rat Liver cDNA Encoding Acyl-peptide 
Hydrolase. The Journal o f  Biological Chemistry 264(15), 8892-8899.
Koida, M. and Walter, R. (1976) Post-Proline Cleaving Enzyme: Purification of this 
Endopeptidase by Affinity Chromatography. Journal o f Biological Chemistry 
251(23), 7593-7599.
2 1 0
Koreeda, Y., Hayakawa, M., Ikemi, T. and Abiko, Y. (2001) Isolation and 
characterization of dipeptidyl peptidase IV from Prevotella loescheii ATCC 15930. 
Archives o f  Oral Biology 46, 759-766.
Komblatt, M.J., Mpimbaza, G.W. and Lonsdale-Eccles, J.D. (1992) Characterisation 
of an endopeptidase of Trypanosoma brucei brucei. Archives o f Biochemistry and 
Biophysics 293(1), 25-31.
Kreig, F. and Wolf, N. (1995) Enzymatic peptide synthesis by the recombinant 
proline-specific endopeptidase from Flavobacterium meningosepticum and its 
mutationally altered Cys556 variant. Applied Microbiology and Biotechnology 42, 
844-852.
Laemmli, U.K. (1970) Cleavage of Structural proteins during assembly of the head of 
structural bacteriophage T4. Nature 227, 680-685.
Laitinen, K.S.M., van Groen, T., Tanila, H., Venalainen, J., Mannisto, P.T. and 
AlafuzofF, I. (2001) Brain prolyl oligopeptidase activity is associated with neuronal 
damage rather than P-amyloid accumulation. Clinical Neuroscience and 
Neuropathology 12(15), 3309-3312.
Li, J., Wilk, E. and Wilk, S. (1996) Inhibition of Prolyl Oligopeptidase by Fmoc- 
Aminoacylpyrrolidine-2-Nitriles. Journal o f Neurochemistry 66(5), 2105-2112.
Li, J., Wilk, E. and Wilk, S. (1995) Aminoacylpyrrolidine-2-nitriles: Potent and 
Stable Inhibitors of Dipeptidyl-Peptidase IV (CD26). Archives o f Biochemistry and 
Biophysics 323(1), 148-154.
Lojda, Z. (1977) Studies on glycyl-proline naphthylamidase. I. Lymphocytes. 
Histochemistry 54, 299-309.
2 1 1
Lonsdale-Eccles, J.D. and Grab, D.J. (2002) Trypanosome hydrolases and the blood- 
brain barrier. TRENDS in Parasitology 18(1), 17-19.
Lorey, S., Faust, J., Mrestani-Klaus, C., Kahne, T., Ansorge, S., Neubert, K. and 
Buhling, F. (2002) Transcellular Proteolysis Demonstrated by Novel Cell Surface- 
associated Substrates of Dipeptidyl Peptidase IV (CD26). The Journal o f  Biological 
Chemistry 277(36), 33170-33177.
-M-
Maes, M., Goosens, F., Schärpe, S., Calabrese, J., Desnyder, R. and Melt/er, H.Y. 
(1995) Alterations in plasma prolyl endopeptidase activity in depression, mania and 
schizophrenia: effects of antidepressants, mood stabilisers and antiphsychotic drugs.
Psychiatry Research 58, 217-225.
Maes, M., Goosens, F., Schärpe, S., Meitzer, H.Y., D’Hondt, P. and Cosyns, P. (1994) 
Lower Serum Prolyl Endopeptidase Enzyme Activity in Major Depression: Further 
Evidence that Peptidases Play a Role in the Pathophysiology of Depression.
Biological Psychiatry 35, 545-552.
Makinen, P-L., Makinen, K.K. and Syed, S.A. (1994) An Endo acting Proline- 
Specific oligopeptidase from Treponema denticola ATCC 35405: Evidence of 
Hydrolysis of Human Bioactive Peptides. Infection and Immunity 62, 4938-4947.
Manning, J.M. (1998), Acylaminoacyl-peptidase. In: Handbook o f  Proteolytic 
Enzymes. (Barrett, A.J., Rawlings, N.D. and Woessner, J.F. eds.) Academic Press, 
London, pp. 384-385.
Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.M., Pierres, M., Nielsen, P., 
Ribel, U., Watanabe, T., Drucker, D.J. and Wagtmann, N. (2000) Enhanced insulin 
secretion and improved glucose tolerance in mice lacking CD26. Proceedings o f  the 
National Academy o f  Sciences, USA 97(12), 6874-6879.
2 1 2
Marguet, D., Bernard, A-M., Vivier, I., Darmoul, D., Naquet, P. and Pierres, M. 
(1992) cDNA Cloning for Mouse Thymocyte-activating Molecule. A multifunctional 
ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. The
Journal o f Biological Chemistry 267(4), 2200-2208.
Marighetto, A., Touzani, K., Etchamendy, N , Torrea, C.C., De Nanteuil, G., Guez, 
D., Jaffard, R. and Morain, P. (2000) Further Evidence for a Dissociation Between 
Different Forms of Mnemonic Expressions in a Mouse Model of Age Related 
Cognitive Decline: Effects of Tacrine and S 17092, a Novel Prolyl Endopeptidase 
Inhibitor. Learning and Memory 7, 159-169.
Martin, R.A., Cleary., D.L., Guido, G.M. Zurcher-Neely, H.A., Kubiak., T.M. (1993) 
Dipeptidyl peptidase IV (DPIV) from pig kidney cleaves analogs of bovine growth 
hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. 
Extended DPP IV substrate specificity?. Biochimica et Biophysica Acta 1164, 252- 
260.
McDonald, J.K., Callahan, P.X., Ellis, S. and Smith, RE. (1971) Polypeptide 
degradation by dipeptidyl peptidase II (cathepsin C) and related peptidases. In: Tissue 
Proteinases. (Barrett, A.J. and Dingle, J.T., eds.) pp. 69-107.
McMahon, G., Collins, P. and O’Connor, B. (2003) Characterisation of the active site 
of a newly discovered and potentially significant post-proline cleaving endopeptidase 
called ZIP using LC-UV-MS. The Analyst 128(6), 670-675.
Mentlein, R. (1988) Proline residues in the maturation and degradation of peptide 
hormones and neuropeptides. FEBS Letters 234(2), 251-256.
Mentlein, R. (1999) Dipeptidyl peptidase IV (CD26)-role in the inactivation of 
regulatory peptides. Regulatory Peptides 85, 9-24.
Mentlein, R., Dahms, P., Grandt, D. and Kruger, R. (1993) Proteolytic processing of 
neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regulatory peptides 49, 
133-144.
213
Misumi, Y., Hayashi, Y., Arakawa, F. and Ikehara, Y. (1992) Molecular cloning and 
sequence analysis of human dipeptidyl-peptidase IV, a serine proteinase on the cell 
surface Biochimica et Biophysica Acta 1131, 333-336.
Mitta, M., Asada, K., Uchimura, Y., Kimizuka, F., Kato, I., Sakiyama, F and 
Tsunasawa, (1989), The Primary Structure of Porcine Liver Acyl amino Acid- 
Releasing Enzyme Deduced from cDNA Sequences, Journal o f  Biochemistry, 106, 
548-551.
Mitta, M., Miyagi, M., Kato, I. and Tsunasawa, S. (1998) Identification of the 
Catalytic Triad Residues of Porcine Liver Acylamino Acid-Releasing Enzyme. 
Journal o f  Biochemistry 123, 924-931.
Miyagi, M., Sakiyama, F., Kato, I. and Tsunasawa, S. (1995) Complete Covalent 
Structure of Porcine Liver Acylamino Acid-Releasing Enzyme and Identification of 
Its Active Site Serine Residue. Journal o f  Biochemistry 118, 771-779.
Monsky, W.L., Lin, C-Y., Aoyama, A., Kelly, T., Akiyama, S.K, Mueller, S.C. and 
Chen, W-T. (1994) A Potential Marker Protease of Invasiveness, Seprase, Is 
Localized on Invadopodia of Human Malignant Melanoma Cells, Cancer Research, 
54, 5702-5710.
Moriyama, A., Nakanishi, M. and Sasaki, M. (1988) Porcine Muscle Prolyl 
Endopeptidase and its Endogenous Substrates. Journal o f  Biochemistry 104, 112-117.
Moriyama, A. and Sasaki, M. (1983) Porcine Liver Succinyltrialanine p-Nitroanilide 
Hydrolytic Enzyme. Its Purification and Characterization as a Post Proline Cleaving 
Enzyme. Journal o f Biochemistry 94, 1387-1397.
Morty, R.E., Fulop, V. and Andrews, N.W. (2002) Substrate Recognition Properties 
of Oligopeptidase B from Salmonella enterica Serovar Typhimurium. Journal o f  
Bacteriology 184(12), 3329-3337.
214
Morty, RE., Lonsdale-Eccles, J.D., Morehead, J., Caler, E.V., Mentele, R., 
Auerswald, E.A., Coetzer, T.H.T., Andrews, N.W. and Burleigh, B.A. (1999) 
Oligopeptidase B from Trypanosoma brucei, a New Member of an Emerging 
Subgroup of Serine Oligopeptidases. The Journal o f  Biological Chemistry 274(37), 
26149-26156.
Morty, R.E., Lonsdale-Eccles, J.D., Mentele, R., Auerswald, E.A. and Coetzer, T.H.T. 
(2001) Trypanosome-Derived Oligopeptidase B Is Released into the Plasma of 
Infected Rodents, Where It Persists and Retains Full Catalytic Activity. Infection and 
Immunity 69(4), 2757-2761.
Morty, R.E., Troeberg, L., Pike, R.N., Jones, R., Nickel, P., Lonsdale-Eccles, J.D. and 
Coetzer, T.H.T. (1998) A trypanosome oligopeptidase as a target for the trypanocidal 
agents pentamidine, diminazene and suramin. FEBS Letters 433, 251-256.
Nagatsu, T., Hino, M., Fuyamada, H., Hayakawa, T. and Sakakibara, S. (1976) New 
chromogenic substrates for X-prolyl dipeptidyl aminopeptidases. Analytical 
Biochemistry 74, 466-476.
Nakajima, T., Ono, Y., Kato, A., Maeda, J. and Ohe, T. (1992) Y-29794-a non­
peptide prolyl endopeptidase inhibitor that can penetrate into the brain. Neuroscience 
Letters 141, 156-160.
Nishikata, M. (1984) Trypsin-like protease from soybean seeds. Purification and some 
properties. JBiochem (Tokyo) 95(4), 11691177.
Nomura, K. (1986) Specificity of Prolyl Endopeptidase. FEBS Letters 209(2), 235- 
237.
Noula, C., Kokotos, G., Barth, T. and Tzougraki, C. (1997) New fluorogenic 
substrates for the study of secondary specificity of prolyl oligopeptidase Journal o f  
Peptide Research 49, 46-51.
215
Ogasawara, W., Ogawa, Y.. Yano, K., Okada, H. and Morikawa, Y. (1996) Dipeptidyl 
Aminopeptidase IV from Pseudomonas sp. W024. Bioscience, Biotechnology and 
Biochemistry 60(12), 2032-2037.
Ogata, S., Misumi, Y. and Ikehara, Y. (1989) Primary Structure of Rat Liver 
Dipeptidyl Peptidase IV Deduced from its cDNA and Identification of the NH2- 
terminal Signal Sequence as the Membrane-anchoring Domain. The Journal o f 
Biological Chemistry 264(6), 3596-3601.
Ohkubo, I., Huang, K., Ochiai, Y., Takagaki, M. and Kani, K. (1994) Dipeptidyl 
peptidase IV from Porcine Seminal Plasma: Purification, Characterisation and N- 
Terminal Amino Acid Sequence. Journal o f  Biochemistry 116, 1182-1186.
O’Leary, R.M. and O’Connor, (1995) Identification and localisation of a 
synaptosomal membrane prolyl endopeptidase from bovine brain. European Journal 
o f Biochemistry 221, 277-283.
O’Leary, R., Gallagher, S.P. and O’Connor, B. (1996) Purification and 
Characterization of a Novel Membrane-bound Form of Prolyl Endopeptidase fro 
Bovine Brain. International Journal o f Biochemistry and Cell Biology 28(4), 441-449.
Oliveria, E.B., Martins, A.R. and Camargo, A.C.M. (1976) Isolation of Brain 
Endopeptidases: Influence of Size and Sequence of Substrates Structurally Related to 
Bradykinin. Biochemistry 15(9), 1967-1974.
Orlowski, M., Wilk, E., Pearce, S. and Wilk, S. (1979) Purification and Properties of a 
Prolyl Endopeptidase from Rabbit Brain. Journal o f Neurochemistry 33(2), 461-469.
Pacaud, M. and Richaud, C. (1975) Protease II from Escherichia coli. Purification and 
Characterization. Journal o f  Biological Chemistry 250(19), 7771-7779.
216
Park, J E., Lentner, M C., Zimmerman, R.N., Garin-Chesa, P., Old, L.J. and Rettig, 
W.J. (1999) Fibroblast activation protein, a dual specificity serine protease expressed 
in reactive tumour stromal fibroblasts. The Journal o f Biological Chemistry 274, 
36505-36512.
Petit, A., Barelli, H., Morain, P. and Checler, F. (2000) Novel proline endopeptidase 
inhibitors do not modify Aß40/42 formation and degradation by human cells 
expressing wild-type and Swedish mutated ß-amyloid precursor protein. British 
Journal o f  Pharmacology 130, 1613-1617.
Pineiro-Sanchez. M.L., Goldstein, L.A., Dodt, J., Howard, L., Yeh, Y. and Chen, W- 
T. (1997) Identification of the 170-kDa Melanoma Membrane-bound Gelatinase 
(Seprase) as a Serine Integral Membrane Protease. The Journal o f  Biological 
Chemistry 272(12), 7595-7601.
Planchenault, T., Vidmar, S.L., Imhoff, J-M., Blondeau, X., Emod, I., Lottspeich, F 
and Keil-Dlouha, V. (1990) Potential Proteolytic Activity of Human Plasma 
Fibronectin: Fibronectin Gelatinase. Biological Chemistry Hoppe-Seyler 371, 117- 
128.
Polgar, L. (1991) pH Dependant Mechanism in the Catalysis of Prolyl Endopeptidase 
from Pig Muscle. European Journal o f  Biochemistry 197, 441-447.
Polgar, L. (1992a) Structural Relationship between Lipases and Peptidases of the 
Prolyl Oligopeptidase Family. FEBSLetter 311(3), 281-284.
Polgar, L. (1992b) Prolyl Endopeptidase Catalysis: A Physical Rather Than a 
Chemical Step is Rate-Limiting. Biochemical Journal 283(3), 647-648.
Polgar, L. (1994) Prolyl Oligopeptidase. Methods in Enzymology 244,189-215.
Polgar, L. (1997) A potential Processing Enzyme in Prokaryotes: Oligopeptidase B, a
New Type of Serine Peptidase. PROTEINS: Structure, Function and Genetics 28, 
375-379.
217
Polgar, L. (1999) Oligopeptidase B: A New Type of Serine Peptidase with a Unique 
Substrate-Dependant Temperature Sensitivity. Biochemistry 38, 15548-15555.
Polgar, L. (2002a) The Prolyl oligopeptidase family. Cellular and Molecular Life 
Sciences 59, 349-362.
Polgar, L. (2002b) Structure-Function of Prolyl Oligopeptidase and its Role in 
Neurological Disorders. Current Medicinal Chemistry - Central Nervous System 
Agents 2, 251-257.
Polgar, L., Kollat, E. and Hollosi, M. (1993) Prolyl oligopeptidase catalysis: 
Reactions with thiono substrates reveal substrate-induced conformational change to be 
the rate-limiting step. FEBSLetters 322(3), 227-230.
Polgar, L. and Szabo, E. (1992) Prolyl Endopeptidase and Dipeptidyl Peptidase IV are 
Distantly Related Members of the Same Family of Serine Proteases. Biological 
Chemistry Hoppe-Seyler 373, 361-366.
Pospisilik, J.A., Hinke, S.A., Pederson, R.A., Hoffman, T., Rosche, F., Schlenzig, D., 
Glund, K., Heiser, U , McIntosh. C.H.S. and Demuth, H-U. (2001) Metabolism of 
glucagons by dipeptidyl peptidase IV (CD26). Regulatory Peptides 96, 133-141.
Puschel, G., Mentlein, R. and Heymann, E, (1982) Isolation and Characterization of 
Dipeptidyl Peptidase IV from Human Placenta. European Journal o f  Biochemistry 
126, 359-365.
Radhakrishna, G. and Wold, F. (1989) Purification and Characterization of an N- 
Acylaminoacyl-peptide Hydrolase from Rabbit Muscle. The Journal o f  Biological 
Chemistry 264(19), 11076-11081.
Rahfeld, J., Schierhorn, M., Hartrodt, B., Neubert, K. and Heins, J. (1991) Are 
diprotin A (Ile-Pro-Ile) and diprotin B (Val-Leu-Pro) inhibitors or substrates of 
dipeptidyl peptidase IV?. Biochimica et Biophysica Acta 1076, 314-316.
218
Raphel, V., Giardina, T., Guevel, L., Perrier, J., Dupuis, L., Guo, X-J. and Puigserver, 
A. (1999) Cloning, Sequencing and Further characterization of acylpeptide hydrolase 
from porcine intestinal mucosa. Biochimica et Biophysica Acta 1432, 371-381.
Rasmussen, H.B., Branner, S., Wiberg, F.C. and Wagtmann. N. (2003) Crystal 
structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog 
Nature Structural Biology 10,19-25.
Rawlings, N.D. and Barrett, A.J. (1993) Evolutionary families of peptidases. 
Biochemical Journal 290, 205-218.
Rawlings, N.D. and Barrett, A.J. (1994) Families of Serine Peptidases. Methods in 
Enzymology 244, 19-61.
Rawlings, N.D., Polgar, L. and Barrett, A.J. (1991) A New Family of Serine-Type 
Peptidases Related to Prolyl Oligopeptidase. Biochemical Journal 219, 907-911.
Reinhold, D., Bank, U., Buhling, F., Kahne, T., Kunt, D., Faust, J., Neubert, K. and 
Ansorge, S. (1994) Inhibitors of dipeptidyl peptidase IV (DPIV, CD26) specifically 
suppress proliferation and modulate cytokine production of strongly CD26 expressing 
U937 cells. Immunobiology 192, 121-136.
Reinhold, D., Kahne, T., Steinbrecher, A., Wrenger, S., Neubert, K , Ansorge, S. and 
Brocke, S. (2002) The Role of Dipeptidyl peptidase IV (DP IV) Enzymatic Activity in 
T Cell Activation and Autoimmunity. Biological Chemistry 383, 1133-1138.
Rennex, D., Hemmings, B.A., Hofsteenge, J. and Stone, S.R. (1991) cDNA Cloning 
of Porcine Brain Prolyl Endopeptidase and Identification of the Active-Site Seryl 
Residue. Biochemistry 30, 2195-2203.
Richards, P.G., Johnston, M.K. and Ray, D.E. (2000) Identification of Acylpeptide 
Hydrolase as a Sensitive Site for Reaction with Organophosphorus Compounds and a 
Potential Target for Cognitive Enhancing Drugs. Molecular Pharmacology 58, 577- 
583.
219
Robison, K.A., Bartley, D.A., Robb, F T. and Schreier, H.J. (1995) A gene from the 
hyperthermophile Pyrococcus furiosus whose deduced product is homologous to 
members of the prolyl oligopeptidase family of proteases. Gene 152,103-106.
Roe, S. (1989) Separation Based on Structure, In: Protein Purification Methods-A 
Practical Approach. (Harris, E.L.V. and Angal, S. eds) IRL Press, Oxford, pp. 175- 
244.
Rosen, J., Tomkinson, B., Pettersson, G. and Zetterqvist, O. (1991) A Human Serine 
Endopeptidase, Purified with Respect to Activity Against a Peptide with 
Phosphoserine in the Pi' Position, is Apparently Identical with Prolyl Endopeptidase. 
The Journal o f Biological Chemistry 266(6), 3827-3834.
Rupnow, J.H , Taylor, W.L., and Dixon, J.E. (1979) Purification and Characterization 
of a Thyrotropin-Releasing Hormone Deamidase from Rat Brain. Biochemistry 18(7), 
1206-1212.
Saito, M., Hashimoto, M., Kawaguchi, N., Shibata. H., Fukami, H., Tanaka, T. and 
Higuchi, N. (1991), Synthesis and Inhibitory Activity of Acyl-Peptidyl-Pyrrolidine 
Derivatives Toward Post Proline Cleaving Enzyme: A study of Subsite Specificity. 
Journal o f Enzyme Inhibition 5, 51-75.
Sattar Abdus, A.K.M., Yamamoto, N., Yoshimoto, T. and Tsuru, D. (1990) 
Purification and Characterization of an Extracellular Prolyl Endopeptidase from 
Agaricus bispora. Journal o f Biochemistry 107,256-261.
Scaloni, A., Barra, D., Jones, W.M. and Manning, J.M. (1994) Human Acylpeptide 
Hydrolase. Studies on its thiol groups and mechanism of action. The Journal o f 
Biological Chemistry 269(21), 15076-15084.
2 2 0
Scaloni, A., Ingallinella, P., Andolfo, A., Jones, W., Marino, G. and Manning, J.M. 
(1999) Structural investigations on human erythrocyte acylpeptide hydrolase by mass 
spectrometric procedures. Journal o f  Protein Chemistry 18(3), 349-360.
Scaloni, A., Jones, W.M., Barra, D., Pospischil, M., Sassa, S., Popowicz, A., 
Manning, L.R., Schneewind, O. and Manning J.M. (1992) Acylpeptide Hydrolase: 
Inhibitors and Some Active Site Residues of the Human Enzyme. The Journal o f  
Biological Chemistry 267(6), 3811-3818.
Schecter, I. and Berger, A. (1967) On the size of the active site in proteases. I. Papain. 
Biochemical and Biophysical Research Communications 27, 157-162.
Schlabach, T.D. (1984) Postcolumn Detection of Serum Proteins with the Biuret and 
Lowry Reactions Analytical Biochemistry 139, 309-315.
Schulz, I., Gerhartz, B., Neubauer, A., Holloschi, A., Heiser, U., Hafner, M. and 
Demuth, H.U. (2002) Modulation of inositol 1,4,5-triphosphate concentration by 
prolyl endopeptidase inhibition. European Journal o f  Biochemistry 269, 5813-5820.
Sedo, A. and Malik, R. (2001) Dipeptidyl peptidase IV-like molecules: homologous 
proteins or homologous activities. Biochimica and Biophysica Acta 1550, 107-116.
Shannon, J.D., Bond, J.S. and Bradley, S.G. (1982) Isolation and Characterization of 
an intracellular serine protease from Rhodococcus erythropolis. Archives o f  
Biochemistry and Biophysics 219(1), 80-88.
Shibuya-Saruta, H., Kasahara, Y. and Hashimoto, Y. (1996) Human Serum Dipeptidyl 
peptidase IV (DPPIV) and its unique properties. Journal o f  Clinical Laboratory 
Analysis 10, 435-440.
Shinoda, M., Matsuo, A. and Toide, K. (1996) Pharmacological studies of a novel 
prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery 
occlusion. European Journal o f  Pharmacology 305, 31-38.
2 2 1
Shinoda, M., Miyazaki, A. and Toide, K. (1999) Effects of a novel prolyl 
endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and 
peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis 
magnocellularis. Behavioural Brain Research 99, 17-25.
Shinoda, M., Toide, K , Ohsawa, I. and Kohsaka, S. (1997) Specific Inhibitor for 
Prolyl Endopeptidase Suppresses the Generation of Amyloid p Protein in NG108-15 
Cells. Biochemical and Biophysical Research Communication 235, 641-645.
Shirasawa, Y., Osawa, T. and Hirashima, A. (1994) Molecular Cloning and 
Characterization of Prolyl Endopeptidase from Human T cells. Journal o f  
Biochemistry 115, 724-729.
Smith, K.P., Krohn, K.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, 
M.D., Fujimoto, E.K., Gorke, N.M., Olson, B.J. and Klenk, D.C. (1985) Measurement 
of Protein Using Bicinchoninic Acid. Analytical Biochemistry 150, 76-85.
Sokolik, C.W., Chyau Liang, T. and Wold, F. (1994) Studies on the specificity of 
acetylaminoacyl-peptide hydrolase. Protein Science 3, 126-131.
Song, K.S. and Raskin, I. (2002) A Prolyl Endopeptidase-Inhibiting Benzofuran 
Dimer from Polyozellus multiflex. Journal o f  Natural Products 65, 76-78.
Stone, SR., Rennex, D., Wikstrom, P., Shaw, E. and Hofsteenge, J. (1991) 
Inactivation of Prolyl Endopeptidase by Peptidylchloromethane: Kinetics of 
Inactivation and Identification of Sites of Modification. Biochemical Journal 276, 
837-840.
Sudo, J. and Tanabe, T. (1985) Distributions of post-proline cleaving enzyme-, 
converting enzyme-, trypsin- and chymotrypsin-like activities in various nephron 
segments and in brush-border membranes isolated from rat kidney. Chem Pharm Bull 
(Tokyo) 33(4), 1694-1702.
2 2 2
Szeltner, Z., Renner, V. and Polgar, L. (2000) Substrate- and pH-dependant 
contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a 
paradigm of the serine oligopeptidase family. Protein Science 9, 353-360.
Szeltner, Z., Renner, V. and Polgar, L. (2000) The Noncatalytic P-Propeller Domain 
of Prolyl Oligopeptidase Enhances the Catalytic Capability of the Peptidase Domain. 
The Journal o f  Biological Chemistry 275(20), 15000-15005.
Tate, S.S. (1981) Purification and Properties of a Bovine Brain Thyrotropin- 
Releasing-Factor Deamidase: A Post-Proline Cleaving Enzyme of Limited 
Specificity. European Journal o f  Biochemistry 118, 17-23.
Tiruppathi, C , Miyamoto, Y., Ganapathy, V., Roesel, R.A., Whitford, G.M. and 
Leibach, F.H. (1990), Hydrolysis and Transport of Proline-containing Peptides in 
Renal Brush-border Membrane Vesicles from Dipeptidyl Peptidase IV-positive and 
Dipeptidyl IV-negative Rat Strains, The Journal o f  Biological Chemistry, 265(3), 
1476-1483.
Tiselius, A., Hjerten, S. and Levin, O. (1956) Protein Chromatography on Calcium 
Phosphate Columns. Archives o f  Biochemistry and Biophysics 65, 132-155.
Toide, K., Iwamoto, Y., Fujiwara, T. and Abe, H. (1995a) JTP-4819: A Novel Prolyl 
Oligopeptidase Inhibitor with Potential as a Cognitive Enhancer. Journal o f  
Pharmacology and Experimental Therapeutics 274(3), 1370-1378.
Toide, K., Ohamiya, K., Iwamoto, Y. and Kato, T, (1995b) Effect of a Novel Prolyl 
Endopeptidase Inhibitor, JTP-4819, on Prolyl Endopeptidase Activity and Substance 
P-and Arginine-Vasopressin-Like Immunoreactivity in the Brains of Aged Rats. 
Journal o f Neurochemistry 65(1), 234-240.
223
Toide, K., Shinoda, M., Fujiwara, T. and Iwamoto, Y. (1997b) Effect of a Novel 
prolyl Endopeptidase Inhibitor, JTP-4819, on Spatial Memory and Central 
Cholinergic Neurons in Aged Rats. Pharmacology Biochemistry and Behaviour 56(3), 
427-434.
Toide, K., Shinoda, M., Iwamoto, Y., Fujiwara, T., Okamiya, K. and Uemura, A. 
(1997a) A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating 
Alzheimer’s disease. Behavioural Brain Research 83, 147-151.
Troeberg, L., Pike, R.N., Morty, R.E., Berry, R.K., Coetzer, T.H.T. and Lonsdale- 
Eccles, J.D. (1996) Pro teases from Trypanosoma brucei brucei. Purification, 
characterisation and interactions with host regulatory molecules. European Journal o f  
Biochemistry 238, 728-736.
Tsuda, M., Muraoka, Y., Nagai, M., Aoyagi, T. and Takeuchi, T. (1996) Postatin, a 
New Inhibitor of Prolyl Endopeptidase, VIII. Endopeptidase Inhibitory Activity of 
Non Peptidyl Postatin Analogues. The Journal o f  Antibiotics 49(10), 1022-1030.
Tsuru, D. (1998) Oligopeptidase B. In: Handbook o f  Proteolytic Enzymes. (Barrett, 
A.J., Rawlings, N.D. and Woessner, J.F. eds.) Academic Press, London, pp. 375-376.
Tsuru, D. and Yoshimoto, T. (1994) Oligopeptidase B: Protease II from Escherichia 
coli. Methods in Enzymology 244, 201-215,
Tsuru, D., Yoshimoto, T., Koryama, N. and Furukawa, S. (1988) Thiazolidine 
Derivatives as Potent Inhibitors Specific for Prolyl Endopeptidase. Journal o f 
Biochemistry 104, 580-568.
-W-
Wagner, L., Naude, R , Oelofsen, W., Naganuma, T. and Muramoto, K. (1999) 
Isolation and partial characterization of dipeptidyl peptidase IV from ostrich kidney. 
Enzyme and Microbial Technology 25, 576-583.
224
Wallen, E.A.A., Christiaans, J.A.M., Forsberg, M.M., Venalainen, J.I., Mannisto, P.T. 
and Gynther, J. (2002) Dicarboxylic Acid bis (L-Prolyl-pyrrolidine) Amides as Prolyl 
Oligopeptidase Inhibitors. Journal o f Medicinal Chemistry 45(20), 4581-4584.
Walter, R. (1976) Partial Purification and Characterization of Post-Proline Cleaving 
Enzyme: Enzymatic Inactivation of Neurohypophyseal Hormones by Kidney 
Preparations of Various Species Biochimica et Biophysica Acta 422,138-158.
Walter, R. and Yoshimoto, T. (1978) Post-proline Cleaving Enzyme: Kinetic Studies 
of Size and Stereospecificity of its Active Site. Biochemistry 17(20), 4139-4144.
Walter, R , Shlank, H., Glass, J.D., Schwartz, I.L. and Kerenyi, T.D. (1971) 
Leucylglycinamide Released from Oxytocin by Human Uterine Enzyme. Science 173, 
827-829.
Walter, R , Simmons, W.H. and Yoshimoto, T. (1980) Proline Specific Endo- and 
Exopeptidases. Molecular and Cellular Biochemistry 30(2), 111-127.
Wilk, S. (1983) Prolyl Endopeptidase. Life Sciences 33(22), 2149-2157.
Wilk, S. and Orlowski, M. (1983) Inhibition of Rabbit Brain Prolyl Endopeptidase by 
N-Benzyloxycarbonyl Prolyl-Prolinal, A Transition State Aldehyde Inhibitor. Journal 
o f Neurochemistry 41, 69-75.
Wilk, S., Benuck, M., Orlowski, M. and Marks, N. (1979) Degradation of Luteinizing 
Hormone-Releasing Hormone (LHRH) by Brain Prolyl Endopeptidase with Release 
of Des-Glycineamide LHRH and Glycineamide. Neuroscience Letters 14, 275-279.
Willand, N., Joossens, J., Gesquiere, J.C., Tartar, A.L., Michael Evans, D. and Roe, 
M.B. (2002) Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV 
inhibitor NVP-DPP728 Tetrahedron 58, 5741-5746.
225
Willard, H., Merrill, L.L., Dean, J.A. and Settle, F.A. (1988) Fluorescence and 
phosphorescence spectrometry. In: Instrumental Methods o f  Analysis. Wadsworth 
Publishing Company, California, pp. 197-223.
Williams, R.S.B., Cheng, L., Mudge, A.W. and Harwood, A.J. (2002) A common 
mechanism of action for three mood stabilizing drugs. Nature 417, 292-295.
Williams, R.S.B., Eames, M., Ryves, W.J., Viggars, J. and Harwood, A.J. (1999) Loss 
of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) 
trisphosphate. The EMBO journal 18(10), 2734-2745.
Williams, R.S.B. and Harwood, A.J. (2000) Lithium therapy and signal transduction. 
Tips 21, 61-64.
Yokosawa, H., Nishikata, M. and Ishii, S. (1984) N-Benzyloxycarbonyl-Valyl- 
Prolinal, a potent Inhibitor of Post-Pro line Cleaving Enzyme. Journal o f  Biochemistry 
95, 1819-1821.
Yoshimoto, T. and Tsuru, D. (1982) Proline-Specilic Dipeptidyl Aminopeptidase 
from Flavobacterium meningosepticum. Journal o f Biochemistry 91, 1899-1906.
Yoshimoto, T. and Walter, R. (1977) Post-proline Dipeptidyl Aminopeptidase 
(Dipeptidyl Aminopeptidase IV) from Lamb Kidney. Biochemica et Biophysica Acta 
485, 391-401.
Yoshimoto, T., Abdus Sattar, A.K.M., Hirose, W. and Tsuru, D. (1987a) Studies on 
Prolyl Endopeptidase from Carrot (Daucus carota): Purification and Enzymatic 
Properties. Biochimica et Biophysica Acta 916, 29-37.
Yoshimoto, T., Fischl, M. Orlowski, R.C. and Walter, R. (1978) Post-proline cleaving 
endopeptidase and post-proline dipeptidyl aminopeptidase. Comparison of two 
peptidases with high specificity for proline residues. The Journal o f Biological 
Chemistry 253, 3708-3716.
226
Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H. and Tsuru, D. 
(1987b) Specific Inhibitors for Prolyl Endopeptidase and their Anti-Amnesic effect. 
J.Pharmacobio-Dyn. 10, 730-735.
Yoshimoto, T., Kanatani, A., Shimoda, T., Inaoka, T., Kokubo, T. and Tsuru, D.
(1992) Prolyl Endopeptidase from Flavobacterium meningsepticum: Cloning and 
Sequencing of the Enzyme Gene. Journal o f  Biochemistry 110, 873-878.
Yoshimoto, T., Miyozaki, K., Haraguchi, N., Kitazono, A., Kabashima, T. and Ita, K. 
(1997) Cloning and expression of the cDNA encoding prolyl oligopeptidase (PE) 
from bovine brain. Biological Pharmacology Bulletin 20,1047-1050.
Yoshimoto, T., Nishimura, T., Kita, T. and Tsuru, D. (1983) Post Proline Cleaving 
Enzyme (Prolyl Endopeptidase) from Bovine Brain. Journal o f  Biochemistry 94, 
1179-1190.
Yoshimoto, T., Ogita, K , Walter, R., Koida, M and Tsuru, D. (1979) Post Proline 
Cleaving Enzyme: Synthesis of a New Fluorogenic Substrate and Distribution of the 
Endopeptidase in Rat Tissues and Body Fluids of Man. Biochimica et Biophysica Acta 
569, 184-192.
Yoshimoto, T., Sattar, A.K.M.A., Hirose, W. and Tsuru, D. (1988) Studies of Prolyl 
Endopeptidase from Shakashimeji (Lyophyllum cinerascens): Purification and 
Enzymatic Properties. Journal o f  Biochemistry 104, 622-627.
Yoshimoto, T., Simons, W.H., Kita, T. and Tsuru, D. (1981) Post-Proline Cleaving 
Enzyme from Lamb Brain. Journal o f  Biochemistry 90, 325-334.
Yoshimoto, T., Tabira, J., Kabashima, T., Inoue, S. and Kiyoshi, I. (1995) Protease II 
from Moraxella lacunata: Cloning, Sequencing, and Expression of the Enzyme Gene, 
and Crystallization of the Expressed Enzyme. Journal o f  Biochemistry 117, 654-660.
227
Yoshimoto, T., Walter, R. and Tsuru, D, (1980) Proline-Specific Endopeptidase from 
Flavobacterium: Purification and Properties. The Journal o f  Biological Chemistry 
255(10), 4786-4792.
228
APPENDIX
6.0. APPENDIX
6.1. Enzyme Activity Quantification
One unit of enzyme activity is defined as the amount of enzyme, which releases 1
nanomole o f AMC per minute at 37°C (unit = nmoles.min'1).
Derivation
AMC released = X^M
= Xpmoles/L'1
The assay uses 400^1 Z-Gly-Pro-AMC and lOOfal enzyme
Enzyme activity = X (400x 10~6) .^moles.L'2.L.min1 
(100 x 10'6) 60
= X (jmoles.L'^min1 
15
= X (1000) nmoles.ml'1.min1 
15(1000)
= X nmoles.ml'1.min1 
15
= X units.ml"1 
15
Also: AMC released (X) is also defined as fluorescent intensity divided by the slope
of the appropriate AMC standard curve so,
Enzyme activity = Fluorescent Intensity nmoles.min'1.ml'1
Slope of filtered std. curve x 15
= Fluorescent Intensity units.ml'1
Slope of filtered std. curve x 15
6.2. Purification Table Calculations
Total activity (unit): Units of enzyme activity, calculated from fluorescent intensity 
as described in section 6.1.
Total protein (mg): mg/ml of protein estimated from appropriate BS A standard curve 
x volume of sample in mis.
Specific activity (unit/mg): Total activity/Total protein.
Purification factor: Specific activity of sample/Specific activity of starting sample 
(serum).
Recovery (%): (Total activity of sample/Total activity of starting sample) x 100.
6.3. Error Bars
Error bars on all enzyme activity graphs represent the standard error of the mean of 
triplicate fluorescence values. The standard error (SE) of the mean is defined as:
SE = a/Vn”
Where:
a is the standard deviation i.e. ^variance (variance = (a2 + b2 + c2)/3, where a, b & c are 
the triplicate values).
n is the number of repeat values measured (three in this case).
6.4. Kinetic Analysis
6 .4 .1 .  K m D e t e r m in a t io n
T h e  M ic h a e lis  co n sta n t, o r  Km as it  is  u s u a lly  k n o w n , is  d e fin e d  a s  th e  substrate 
concentration which gives rise to a velocity equal to half the maximal velocity. T h is  
co n stan t c a n  b e  a n a ly se d  b y  m e a su r in g  r e a c t io n  v e lo c it y  ( V )  a t v a r io u s  co n cen tratio n s 
o f  su b strate, th e  d a ta  g iv in g  r is e  to  th e  w e ll- k n o w n  M ic h a e lis -M e n te n  h y p e r b o la  
c u rv e . O n c e  an  e n z y m e -c a ta ly s e d  r e a c tio n  fo l lo w s  n o rm a l M ic h a e lis -M e n te n  k in e tics , 
d a ta  c a n  b e  a p p lie d  to  a  n u m b e r  o f  k in e tic  m o d e ls  s u c h  as:
L in e w e a v e r - B u r k :  P lo t  o f  1 / flu o rescen t in te n sity  v e rsu s  1/su b strate  con cen tratio n . 
T h e  in te rce p t o f  th e  lin e  o n  th e  y - a x is  g iv e s  a  d ire ct rea d o u t o f  1/V m « and  the 
in terce p t o f  th e lin e  o n  th e  x -a x is  g iv e s  -1/K „,. T h e  s lo p e  o f  th e  lin e  is  e q u a l to  Km/V.
E a d ie - H o fs te e :  P lo t  o f  f lu o r e s c e n t in te n s ity  v e rs u s  flu o r e s c e n t in ten sity/su b stra te  
co n cen tratio n . T h e  in te rc e p t o n  th e  y - a x is  rep rese n ts  l/Vmax, w h ile  th e  s lo p e  is  g iv e n  
a s-K n ,.
H a n e s - W o o lf :  P lo t  o f  su b stra te  c o n c e n tra tio n /flu o re sc e n t in te n sity  v e rsu s  su b strate  
co n cen tratio n . T h e  in te rce p t o n  th e  x - a x is  g iv e s  - K m, and  o n  th e  y - a x is  Km/Vm»*. T h e  
s lo p e  is  1/V .
6 .4 .2 . IQ  D e te r m in a t io n s
K i  o r  in h ib itio n  c o n sta n t is  th e  d is s o c ia t io n  co n sta n t fo r  th e  e n z y m e -in h ib ito r  
c o m p le x . K i  fo r  c o m p e tit iv e  in h ib itio n  is  c a lc u la te d  as fo llo w s ,
Ki= Kmill
F  *P P  F
W h e r e :
K i  is  th e  in h ib itio n  c o n sta n t
Km  is  th e  M ic h a e lis  c o n sta n t w ith  n o  in h ib ito r  p rese n t
[I] is  th e  in h ib ito r  c o n c e n tra tio n
Kmlpp m e a n s  th e  n e w  o r  “ ap p a ren t”  v a lu e  o f  K m in  th e  p re se n c e  o f  I, th e  in h ib ito r. 
M e a s u re d  as fo r  Km  (s e c tio n  6 .4 .1 .) .
W h e n  in h ib itio n  is n o t  c o m p e titiv e , the K i  v a lu e  is  c a lc u la te d  as fo llo w s ,
Where:
K j is th e  in h ib itio n  co n stan t
V nax is  th e  m a x im u m  v e lo c it y  w ith  n o  in h ib ito r  p rese n t 
[I] is  th e  in h ib ito r  c o n cen tra tio n
V nuXapp m ea n s th e  n e w  o r  “ ap p aren t”  v a lu e  o f  V max in  th e  p re se n c e  o f  I, an 
u n c o m p e tit iv e  o r  n o n -c o m p e tit iv e  in h ib itor.
6.4.3. Types of Reversible Inhibition
In h ib ito rs  can  b e  d iv id e d  in to  tw o  g ro u p s, r e v e rs ib le  and  irrev ersib le . R e v e r s ib le  
in h ib itio n  in v o lv e s  n o n c o v a le n t  fo r c e s  th a t b in d  in h ib ito rs  to  e n zy m e s. T h e r e  are  
s e v e ra l ty p e s  o f  r e v e rs ib le  in h ib itio n : c o m p e tit iv e , u n c o m p e tit iv e , n o n  c o m p e tit iv e  
and  m ix e d . D is tin g u is h e d , u s in g  th e  L in e w e a v e r -B u r k  p lo t , b y  d e te rm in in g  th e  e f fe c t  
O f in h ib ito r  o n  Km, Vmax an d  K m /V m a x -
Competitive Inhibition: In v o lv e s  th e  b in d in g  o f  an  in h ib ito r  to th e  e n z y m e  fo r m in g  
a n  e n z y m e -in h ib ito r  c o m p le x  T h e  in h ib ito r  b e a rin g  a  stru ctu ra l an d  c h e m ic a l 
s im ila r ity  to  th e su b stra te  b in d s to  th e a c t iv e  s ite  th u s  c o m p e tin g  w ith  it  fo r  substrate.
1
In  c o m p e tit iv e  in h ib itio n , th e  s lo p e  o f  th e  L in e w e a v e r -B u r k  p lo t  in crea ses. T h e  K m 
v a lu e  a ls o  in c re a se s  b u t th e  Vmax v a lu e  is  u n ch a n g ed . T h is  ty p e  o f  in h ib itio n  is  
r e c o g n is e d  b y  p lo ts  in te r se c tin g  at a  c o m m o n  p o in t o n  th e  p o s it iv e  y -a x is .
iv
Uncompetitive inhibition: In v o lv e s  b in d in g  o n ly  to  th e  e n z y m e -su b stra te  c o m p le x  to  
p re v e n t c a ta ly s is .
T h is  ty p e  o f  in h ib it io n  c a u se s  a  d e c re a s e  in  Km  an d  V max. T h e r e  is  n o  c h a n g e  in  th e  
s lo p e  o f  th e  L in e w e a v e r -B u r k  p lo t. It is  id e n tifie d  b y  th e  p r e s e n c e  o f  p a r a lle l lin e s  in  
th e  L in e w e a v e r -B u r k  p lot.
Non-competitive inhibition: In v o lv e s  b in d in g  e q u a lly  to  e n z y m e  an d  e n zy m e - 
su b strate  co m p le x .
T h is  ty p e  o f  in h ib itio n  c a u se s  a  d e c re a s e  in  Vmax a lo n g  w ith  Km  re m a in in g  th e  sam e. 
T h e  s lo p e  o f  th e  L in e w e a v e r -B u r k  p lo t  in c re a se s  a n d  is  re c o g n is a b le  b y  p lo ts  
in te rse c tin g  a t a  c o m m o n  p o in t o n  th e  n e g a tiv e  x -a x is .
Mixed Inhibition: T h e s e  in h ib ito rs  b in d  u n e q u a lly  to  b o th  e n z y m e  a n d  e n z y m e - 
su b strate  c o m p le x  T h e r e  c a n  b e  tw o  c a se s  w ith  th e s e  in h ib ito rs ,
M ix e d  c o m p e tit iv e -n o n -c o m p e tit iv e  in c re a se  Km  and  d e c re a s e  VmaX. T h e y  c a u s e  a n  
in c re a se  in  th e  L in e w e a v e r -B u r k  s lo p e  an d  a re  id e n tifie d  b y  p lo ts  in te rse c tin g  a b o v e  
th e  n e g a tiv e  p o rtio n  o f  th e  x -a x is .
v
M ix e d  n o n -c o m p e tit iv e -u n c o m p e tit iv e  d e c re a s e  b o th  K m  a n d  V « « .  T h e  L in e w e a v e r -  
B u r k  p lo t  s lo p e  is  in c re a se d  an d  p lo ts  in te r s e c tin g  b e lo w  th e  n e g a t iv e  p o rtio n  o f  th e  x -  
a x is  id e n tify  th is  ty p e  o f  in h ib itio n .
6.4.4. IC50 Determination
T h e  c o n c e n tra tio n  o f  in h ib ito r  th a t r e d u c e s  e n z y m e  v e lo c it y  b y  5 0 %  is  k n o w n  a s  th e  
I C 50 v a lu e . It  c a n  b e  d e te rm in e d  g r a p h ic a lly  as s h o w n  b e lo w .
log(IC5o)
log[Competitor]
